Construction and Characterisation of a Herpes Simplex Virus Mutant Deficient for Vmw65-Mediated Stimulation of Immediate Early Gene Transcription by Ace, Christopher Ian
 
 
 
 
 
 
 
https://theses.gla.ac.uk/ 
 
 
 
 
Theses Digitisation: 
https://www.gla.ac.uk/myglasgow/research/enlighten/theses/digitisation/ 
This is a digitised version of the original print thesis. 
 
 
 
 
 
 
 
 
Copyright and moral rights for this work are retained by the author 
 
A copy can be downloaded for personal non-commercial research or study, 
without prior permission or charge 
 
This work cannot be reproduced or quoted extensively from without first 
obtaining permission in writing from the author 
 
The content must not be changed in any way or sold commercially in any 
format or medium without the formal permission of the author 
 
When referring to this work, full bibliographic details including the author, 
title, awarding institution and date of the thesis must be given 
 
 
 
 
 
 
 
 
 
 
 
 
 
Enlighten: Theses 
https://theses.gla.ac.uk/ 
research-enlighten@glasgow.ac.uk 
CONSTRUCTION AND CHARACTERISATION 
OF A HERPES SIMPLEX VIRUS MUTANT 
DEFICIENT FOR VMW65-MEDIATED STIMULATION OF 
IMMEDIATE EARLY GENE TRANSCRIPTION
by
CHRISTOPHER IAN ACE
A thesis presented for the degree of 
Doctor of Philosophy
in
The faculty of Science,
University of Glasgow
Institute of Virology, 
Church Street,
Glasgow Gil 5JR.
February 1989
ProQuest Number: 10999268
All rights reserved
INFORMATION TO ALL USERS 
The quality of this reproduction is dependent upon the quality of the copy submitted.
In the unlikely event that the author did not send a com p le te  manuscript 
and there are missing pages, these will be noted. Also, if material had to be removed,
a note will indicate the deletion.
uest
ProQuest 10999268
Published by ProQuest LLC(2018). Copyright of the Dissertation is held by the Author.
All rights reserved.
This work is protected against unauthorized copying under Title 17, United States C ode
Microform Edition © ProQuest LLC.
ProQuest LLC.
789 East Eisenhower Parkway 
P.O. Box 1346 
Ann Arbor, Ml 48106- 1346
TABLE OF CONTENTS
ACKNOWLEDGEMENTS
SPMMARY
ABBREVIATIONS
INTRODUCTION
1. THE HERPESVIRUSES 1
1.1 CLASSIFICATION 1
1.2 PATHOGENICITY 2
1.3 INTERACTIONS BETWEEN HOST CELL AND VIRUS 4
1.3.1 Latency _ ._ 4
1.3.2 Transformation 6
1.3.3 Alteration of host cell macromolecular 7
synthesis
1.4 THE STRUCTURE OF HERPESVIRUS GENOMES 8
1.4.1 Genome arrangement 8
1.4.2 Structure of the HSV-1 genome 8
1.4.3 The nucleotide sequence of HSV-1 10
1.5 HSV REPLICATION 11
1.5.1 Overview 11
1.5.2 Cell penetration 13
1.5.3 HSV transcript processing 13
1.5.4 IE genes 14
1.5.5' IE polypeptides 15
1.5.6 Regulation of early gene expression 19
1.5.7 Regulation of late gene expression 21
1.5.8 Enzymes 22
1.5.9 Structural polypeptides 23
1.5.10 DNA replication 24
1.5.11 Genes required for DNA replication 25
1.5.12 DNA packaging and assembly of virions 26
2. REGULATION OF IE GENE EXPRESSION
2.1 Cis-acting regulatory sequences
2.2 A transinducing IE gene regulatory 
factor (TIF)
2.3 Vmw65 associates with cellular factors 
at TAATGARAT elements
3. REGULATION OF EUKARYOTIC GENES TRANSCRIBED 
BY RNA POLYMERASE II
3.1 Promoters, upstream elements and enhancers
3.2 Properties of transcription factors
3.3 Mechanism of transcription activation
MATERIALS AND METHODS
4. MATERIALS
4.1 Chemicals
4.2 Radiochemicals
4.3 Oligonucleotides
4.4 Enzymes
4.5 Cells
4.6 Tissue culture medium
4.7 Viruses
4.8 Plasmids
4.9 Bacterial strains
4.10 Bacterial culture medium
4.11 Commonly used buffers
5. METHODS
5.1 CONSTRUCTION AND PREPARATION OF PLASMIDS
5.1.1 Restriction enzyme digests
5.1.2 Separation of DNA fragments by non­
denaturing gel electrophoresis
5.1.3 Purification of DNA fragments from gels
5.1.4 Ligation of DNA fragments
5.1.5 Transformation of E.coli
5.1.6 Analysis of transformed E. coli colonies
5.1.7 Large scale preparation of plasmid DNA
5.1.8 Estimation of DNA concentration
5.2
5.2.1
5.2.2
5.2.3
5.2.4
5.2.5
5.2.6
5.2.7
5.2.8
5.2.9
5.2.10
5.2.11
5.3
5.3.1
5.3.2
5.3.3
5.3.4
5.3.5
5.3.5.1
5.3.5.2
5.3.5.3
5.3.6
5.3.7
5.4
5.4.1
5.4.2
5.4.3
5.4.3.1
5.4.3.2
5.4.4
5.4.5
FUNCTIONAL ANALYSIS OF PLASMIDS 
Transfection of plasmid DNA into cells 
Preparation of cell extracts 
Estimation of protein concentration 
TK assays of transfected cells 
CAT assays of transfected cells 
Marker rescue analysis
In vitro transcription and translation of 
plasmids
3*-end labelling of probes
Gel retardation assay with proteins
synthesised in vitro
SDS polyacrylamide gel electrophoresis 
Nuclear extracts
CONSTRUCTION AND PREPARATION OF VIRUSES 
Tissue culture
Co-transfection of virus DNA and plasmid
DNA into cells
Isolation of virus plaques
Small-scale preparation of total
virus-infected cell DNA
Southern blot analysis of virus DNA
Internal labelling of probes by nick
translation
Transfer of DNA to nitrocellulose 
DNA/DNA hybridisation
Large-scale preparation of virus stocks 
Large-scale preparation of virus DNA
ANALYSIS OF VIRUSES 
Titration of virus stocks 
Virus particle counts 
Virus adsorption assay
Preparation of [ H]-thymidine-labelled 
virus
Estimation of virion adsorption rate 
Quantitation of viral DNA in nuclei 
Extraction of virion proteins for gel 
retardation assays
52
52
53
53
54 
54
54
55
55
56
56
57
57
57
57
58 
58
58
58
59
59
60 
60
60
60
61
61
61
61
62
62
62
63
63
63
63
64
64
64
65
65
66
66
66
66
67
67
67
68
68
68
69
69
70
70
71
71
72
Virus transinduction assay
Dot blot analysis of virus mRNA
Preparation of cytoplasmic RNA
Transfer of RNA to nitrocellulose
DNA/RNA hybridisation
Internal labelling of probes by
primer-extension
SI nuclease analysis of mRNA 5* terminus 
5"-end labelling of probes 
DNA/RNA hybridisation and SI nuclease 
digestion
Denaturing polyacrylamide gels 
Analysis of viral proteins 
Radiolabelling of viral polypeptides - 
Preparation of samples for SDS-PAGE 
Determination of incorporation of 
radiochemicals in labelled substrates 
TK assays of infected cells 
Virus complementation assay 
Virulence assay
OBJECTIVE
VMW65 IS ESSENTIAL FOR VIRUS VIABILITY
ANALYSIS OF IN-FRAME INSERTION MUTATIONS 
IN PLASMID ENCODED VMW65 
Construction of insertion mutants 
Constuction of plasmid pIE4/5CAT 
Transinducing activity of insertion 
mutants
Construction and analysis of deletion 
mutant plasmids
Expression of mutant Vmw65 polypeptides 
in vitro
Formation of a protein-DNA complex 
directed by Vtnw65 synthesised in vitro
6.3.7 Marker rescue of ts2203 by insertion 74
mutants
6.4 ANALYSIS OF A VIRUS CONTAINING A MUTATION 76
IN VMW65
6.4.1 Construction of a mutant virus containing 76
an insertion within the Vmw65 gene
6.4.2 Marker rescue of inl814 77
6.4.3 The efficiecy of plaque formation by 77
inl814 is markedly reduced and dependent
on cell type
6.4.4 Adsorption and penetration of cells by 78
inl814
6.4.5 vmw65 of inl814 does not direct the 78
formation of IEC
6.4.6 inl814 does not exhibit virion-mediated 80
transinduction of IE genes
6.4.7 Immediate early gene expression in 80
inl814-infected cells
6.4.8 Early and late gene expression in 82
inl814-infected cells
6.4.9 Complementation of inl814 by VmwllO 83
6.4.10 inl814 has reduced virulence in mice 83
DISCUSSION 85
7.1 FUNCTIONAL REGIONS OF THE VMW65 POLYPEPTIDE 85
7.2 CONSEQUENCES OF TRANSINDUCTION IN HSV-1 IN 88
TISSUE CULTURE
7.3 SPECULATIONS ON THE BIOLOGICAL RELEVANCE OF 92
VMW65 DURING IN VIVO INFECTION
7.4 FUTURE PROSPECTS 95
REFERENCES
ACKNOWLEDGEMENTS
I thank Professor J.H. Subak-Sharpe for providing 
me with the opportunity to work and make use of all the 
facilities at the Institute.
I would like to express my particular thanks to Dr. 
Chris Preston, my supervisor, for his guidance, advice, 
critisism and inspiration throughout the work presented in, 
and the preparation of, this thesis.
I thank Jim Aitken for determining virus particle
counts.
I have greatly appreciated the help and friendship 
of many colleagues at the Institute over this period; in 
particular, my thanks to the members of lab 204 for genial 
interaction, and to Trevor Paterson for entertainment.
Thank you GUBCC, for providing excellent 
extra-curricular activity, and the odd game of cricket as 
well.
Finally, I am indebted to my parents, Alan and 
Carole Ace, for providing constant moral and financial 
support during the course of this work.
The author was supported by a Medical Research 
Council Research Training Award. Unless specified otherwise, 
the work presented in this thesis was undertaken by the 
author.
SUMMARY
Herpes simplex virus (HSV) gene expression can be 
classified into three phases, immediate early (IE), early 
and late. The 5 IE genes are the first to be transcribed 
after infection and the products (IE polypeptides) are 
essential for early and late gene expression. A distinctive 
feature of HSV gene activation is the stimulation of IE 
transcription by the late polypeptide Vtnw65, the major 
tegument protein. The transinduction of IE transcription by 
Vtnw65 is dependent on the cis- acting regulatory element 
TAATGARAT which is located in the promoters of all IE genes. 
Polypeptide Vmw65 interacts with cell factors, including the 
"octamer"-binding transcription factor, OCT-1, to form a 
complex (named IEC) which binds specifically to DNA 
sequences containing TAATGARAT and it is thought that IEC is 
an important mediator of IE gene transinduction. Thus,
Vtnw65 is involved in initiation of virus gene expression at 
a very early stage of infection. In addition to its role as 
an IE gene activator, Vmw65 is essential for virion assembly 
during the latter stages of infection and as a result large 
scale insertions or deletions in the polypeptide are not 
tolerated by the virus. The aim of the project was to 
investigate, by in vitro mutagenesis, the importance and 
relevance of Vmw65 as an IE gene transinducer in viral 
infection. The approach taken initially was to analyse the 
effect of small oligonucleotide insertions in cloned 
fragments of the gene, in an attempt to map domains within 
the polypeptide important for IE transinduction and for 
virion assembly.
A series of ten plasmids each with a 12 base pair, 
BamHI linker, insertion in the gene encoding vmw65 of HSV-1 
was constructed. The plasmids were analysed for their 
transinducing activity in transient cotransfection 
experiments, and mutant polypeptides synthesised in vitro 
were analysed for their ability to form IEC in gel 
retardation experiments. The ability of mutant polypeptides 
to be correctly assembled into virus particles was assayed 
by the insertion plasmids' ability to marker rescue a ts
virion assembly defective mutant of HSV-2 whose lesion 
resides in the Vraw65 homologue and which does not affect the 
transinducing function. It was found that approximately 50%
of the insertions abolished the ability of Vmw65 to
transinduce IE promoters and that those polypeptides 
defective in activity did not form IEC, and vice versa.
This striking correlation between complex formation and 
stimulation of transcription is convincing evidence that IEC
is an essential intermediate of IE transinduction. When the
mutant plasmids were analysed for their virion assembly 
phenotype, again approximately 50% were non-functional but 
the regions important for virion assembly mapped to regions 
distinct from those required for transinduction.
One of the plasmid mutations which abolished 
transinduction but which had a wild-type (wt) virion 
assembly phenotype was introduced into virus by intra-typic 
recombination. A virus, named in!814, containing the 
linker mutation was isolated and its DNA characterised by 
Southern blotting. A distinctive feature of inl814 was its 
reduced ability to grow and produce plaques in tissue 
culture cells at low multiplicities of infection (moi). The 
plaquing efficiency of _inl814 was cell-type dependent and 
was reduced by 100-fold in BHK and Vero cells and as much as 
10,000-fold in HFL cells. The mutant virus produced 
equivalent numbers of virion particles as wt HSV-1 stocks 
and analysis of virus adsorption to cells and DNA migration 
to the nucleus showed that in!814 was able to enter cells 
efficiently and that the infectivity of the virus particles 
was normal. Therefore the impaired growth of _inl814 is 
unlikely to result from -a defect in virion structure. A 
"revertant" virus was constructed by marker rescue of in!814 
with a DNA fragment containing a wt coding sequence of 
Vtaw65. This rescued virus behaved as wt HSV-1, indicating 
that the phenotype of in!814 does not result from a second 
site mutation.
Vmw65 expressed by in!814 did not associate with 
cellular factors to form IEC and the virus was incapable of 
activating IE promoters that had been transfected into 
cells. The intrinsic level of IE gene expression by in!814 
at high moi was reduced but not dramatically lower than wt
HSV-1 levels. The mutant virus expressed mRNA transcripts
and polypeptides whose abundance was reduced by 4 to 5-fold
for IE genes 1 and 2, and 2-fold for IE genes 4 and 5.
However, the product of IE gene 3 was expressed in amounts
comparable to those of wt HSV-1. In contrast to the
situation for IE gene expression, the mutant virus
synthesised early and late gene products to wt levels at
high moi However, the relative levels of these proteins
were dramatically reduced at low moi in Ini814. The growth
defect of iril814 at low moi was shown to result directly
from underexpression of IE polypeptides since the plaqueing
efficiency of the mutant increased when titrated on cells
transfected with plasmids expressing the product of IE gene
1, VmwllO. The virulence of the mutant in mice was reduced
3 5to between 10 and 10 -fold as measured by
determinations, suggesting that the effect of Vftiw65 in vivo 
may resemble its effect seen at low moi in tissue culture.
The observations suggest that Vmw65 is required in 
order to stimulate IE gene expression and this function is 
essential for productive infection under conditions of low 
multiplicity. At high moi the transinducing activity of 
Vfttw65 becomes redundant, presumably because the basal level 
of IE gene transcription at high copy number is sufficient 
for virus growth. Although the growth of the mutant virus 
in tissue culture at high moi is unimpaired, the role of 
Vmw65 during in vivo infection is clearly important and it 
could therefore be regarded as a target for anti-viral 
drugs.
ABBREVIATIONS
Standard nomenclature for SI units of weights and 
measurements has been used. Abbreviations not defined in 
the relevant area of text are listed below.
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INTRODUCTION
The subject of this thesis concerns the mutational 
analysis of the herpes simplex virus type 1 (HSV-1) 
immediate-early (IE) gene regulator, Vmw65, and the 
consequences of IE transinduction during virus infection.
In the Introduction, a brief background to the biology of 
the HSV is given (section 1), with attention focused on the 
control of HSV-1 IE gene transcription (section 2). A 
review of transcription control mechanisms in other 
eukaryotic systems is also included (section 3).
t
1. THE HERPESVIRUSES
1.1 CLASSIFICATION
The family Herpesviridae is comprised of more than 
80 species which infect a wide range of higher eukaryotic 
hosts (Roizman and Batterson, 1985). Membership of this 
family is based on four distinct morphological features:
(i) The core is an electron dense fibrillar spindle and
is surrounded by the double-stranded DNA of the viral genome 
(Epstein, 1962; Furlong et al., 1972; Nazerian, 1974).
(ii) The capsid is icosahedral in shape, approximately
lOOnm in diameter and is composed of 162 capsomeres which
surround the core (Wildy et al., 1960).
(iii) The tegument, an ill-defined layer of proteinaceous
material, is located between the capsid and the envelope 
(Schwartz and Roizman, 1969; Morgan et a l ., 1968; Roizman 
and Furlong, 1974).
(iv) The envelope, surrounding the capsid and tegument,
is derived from budding through the nuclear membrane and 
harbours numerous virus-encoded glycoprotein spikes (Morgan 
et al ., 1959; Wildy et a l ., 1960; Asher et a l ., 1969; Spear 
and Roizman, 19 72).
Although the herpesviruses as a family exhibit a 
very diverse array of biological properties, one 
characteristic common to all is the ability to persist in a
latent state in their hosts. Herpesviridae have been 
classified into three sub-families (alpha, beta and 
gammaherpesvirinae) based on criteria of host range, 
duration of reproductive cycle, cytopathology and 
characteristics of latent infection (Matthews, 1982;
Roizman, 1982). The herpesviruses have also been classified 
on the basis of the arrangement of characteristic repeated 
DNA sequences within their genomes (Roizman et a l ., 1981; 
Roizman and Batterson, 1985).
(i) Alphaherpesvirinae can have a wide or narrow
host-range in tissue culture. The reproductive cycle is 
short (less than 24h) and causes complete destruction of 
infected cells. Latent infection is frequently established 
in neuronal cells. Members of this sub-family include the 
human herpesviruses HSV-1, HSV-2 and VZV.
(ii) Betaherpesvirinae have a narrow host-range in
tissue culture, frequently restricted to the species or 
genus of the natural host. Virus replication and lytic 
progression is slow, and infection results in an enlargement 
of cells. Latent infections are generally established in 
secretory glands, lympho-reticular cells and kidneys. HCMV 
is a member of this sub-family.
(iii) Gammaherpesvirinae have a limited host range which
is usually retricted to the family or order to which the 
A
host belongs. Members of this family replicate only in T or 
B lymphocytes in vivo, and latent infection is frequently 
established in lymphoid tissue. This sub-family includes 
the human herpesvirus EBV.
1.2 PATHOGENICITY
HSV-1 and HSV-2 HSV-1 is widespread in the human 
population and causes vesicular lesions of the mouth, lips 
and nasal membranes ("cold sores"), ocular keratitis and 
occasionally more severe symptoms including encephalitis, 
particularly in immunocompromised individuals (Smith et al., 
1941; Gallardo, 1943; Rawls, 1985). HSV-2 is the agent of
sexually transmitted genital herpes. The two viruses are 
closely related and some overlaps in their clinical 
manifestations exist (Whitley, 1985). HSV-1 and HSV-2 often 
establish latency in trigeminal and sacral ganglia 
respectively, with periodic recurrence of lytic infection 
leading to outbreaks of lesions at peripheral sites (Klein, 
1982? Knox et al ., 1982; Hill, 1985).
VZV VZV is the causative agent of chickenpox 
(varicella), a childhood disease resulting from a primary 
infection, and shingles (herpes zoster), a localised 
vesicular condition which occurs in adults and appears to be 
caused by reactivation of latent VZV (Weller, 1958; Gelb,
1985).
HCMV HCMV infects the majority of the human 
population, usually resulting in a mild or subclinical 
condition. However, infection in neonates is sometimes 
associated with neurological damage (Alford and Britt,
1984). HCMV infections also cause complications in 
immunosuppressed individuals, particularly in organ 
transplant or blood transfusion patients (Ho, 1982). 
Outbreaks of HCMV infection also occur in patients with 
acquired immune deficiency syndrome (AIDS). In addition, 
HCMV has been implicated in the development of cervical 
cancer, since HCMV DNA can be detected in a small proportion 
of biopsies from patients with cervical intraepithelial 
neoplasia (Fletcher et al., 1986).
EBV EBV infects B lymphocytes and is the causative 
agent of infectious mononucleosis. The virus is also 
associated with Burkitt's lymphoma, nasopharIngeal carcinoma 
and lymphomas of immunosuppressed individuals (Neiderman et 
al., 1976? Miller, 1985).
HHV6 HHV6 was first isolated from immunosuppressed 
patients, although it can infect T cells in vitro and is 
linked to specific childhood illness (Salahuddin et al.,
1986).
1.3 INTERACTIONS BETWEEN HOST CELL AND VIRUS
1.3.1 Latency
An important property of HSV is the ability to 
establish latency and coexist with its host in a 
non-infectious state (Stevens and Cook, 1971; Baringer and 
Swoveland, 19 73; Galloway et al ., 19 79; McLennan and Darby, 
1980). After infection at peripheral skin sensory nerve 
cell sites, HSV-1 travels intra-axonally down nerves to 
ganglionic neurones. The latent state is characterised by 
the prolonged association of the viral genome in host 
neuronal tissue, during which time no infectious virus can 
be isolated (Hill, 1985). The definition of latency is an 
operational one based on experiments performed on animals in 
vivo: infectious virus cannot be recovered from latently 
infected nervous tissue following homogenisation but can be 
recovered following cultivation of explanted tissue in vitro 
(Wildy et al ., 1982). The role of the peripheral nervous 
system in harboring latent HSV was first postulated by 
Goodpasture (1929) based on studies using rabbits. Stevens 
and Cook (19 71) demonstrated that HSV established long-term 
"silent infections" in mice by recovering latent virus after 
cultivation of sensory ganglia explanted 4 months after the 
primary infection. Latent HSV was first isolated from the 
trigeminal ganglia of humans taken at post-mortem by 
Baringer and Swoveland (19 73). McLennan and Darby (1980) 
identified latent HSV ts mutants in the neuronal cell bodies 
of mice that reactivated at the PT but could only develop 
viral antigen (detected by immunoflorescence) at the NPT.
The study of ts mutants by others has revealed that viral 
DNA synthesis may be irrelevant in the establishment of 
latent infection in mice since some DNA positive and DNA 
negative mutants are equally able to establish latent 
infections, although some mutants of both categories were 
latency negative (Subak-Sharpe et a l ., 1974; Marsden et al ., 
1976; Stevens, 1981; Clements and Subak-Sharpe, 1983).
Using solution hybridisation techniques, Puga et 
a l . (19 78) were the first to detect HSV specific DNA in 
sensory ganglia from latently infected mice. Latent HSV 
genomes exist in a form other than unit length, linear DNA
5and it is not clear whether the viral molecules are 
maintained in circular or concatemeric forms (Rock and 
Fraser, 1983; Efstathiou et al., 1986). The latent DNA 
does, however, appear to exist in an episomal state rather 
than being integrated in cellular DNA (Mellerick an, Fraser,
A
19 87). Reactivation of latent HSV can be triggered by 
trauma, nerve damage or various stimuli to the neurone or 
dermatome (Stevens, 1975; Wildy et al., 1982; Hill, 1985).
Recently, it has been shown that the HSV-1 genome 
is not completely silent during latency. A region of the 
genome near the IE-1 gene is transcriptionally active during 
latent infections, giving rise to two RNA species, which 
result from splicing, called the latency associated 
transcripts or LAT (Stevens et a l ., 1987; Wechsler et al., 
1988). The LAT is complimentary (antisense) to IE-1 mRNA 
and partially overlaps the 3*-end of the IE-1 gene (Deatly 
et al., 1987; Puga and Notkins, 1987; Rock et a l ., 1987;
Spivak and Fraser, 1987; Stevens et a l ., 1987; Wagner et 
al., 1988; Wechsler et a l ., 1988). At present, the only
evidence for the involviment of the LAT in latency is its
A
presence in latently-infected ganglionic neurones, although
the transcript is envisaged to play a role in the
establishment and/or maintenance of HSV-1 latency.
In vitro latency systems have been developed in
tissue culture cells harbouring non-replicating HSV in order
to improve understanding of the molecular events that govern
latent infections (O’Neill, 1977; Wigdahl et a l ., 1982;
Youssoufian et al ., 1982; Nilheden et al., 1985; Shiraki and
Rapp, 1986; Russell and Preston, 1986). Using HSV mutants,
Russell and Preston (19 86) have demonstrated that only
limited gene expression, probably of IE genes, is necessary
for the latent state to be both established and reactivated
in vitro. Indeed, VmwllO (the product of IE gene 1) has
------------------------------  on superinfection,
been directly implicated in the reactivation event since v
dll403( a mutant containing a deletion in IE gene l) fails
to reactivate HSV-2 in vitro (Russell et al, 1987).
Furthermore, adenovirus vectors that carry the IE-1 gene
reactivate latent HSV-2 whereas HSV-1 mutants that contain
mutations in IE-1, and specifically mutations that delete
the "zinc finger" activating region of the polypeptide
(Everett, 1987), do not reactivate latent virus (R.Harris, 
personal communication). These results imply that vmwllO 
modulates reactivation via transcription activation events.
1.3.2 Transformation
HSV-2 has been found associated with cervical 
cancer (Naib et a l ., 1966? Rawls et a l ., 1969; Nahmias et 
al., 1970), although the evidence for a causal link remains 
obscure. Although regions of the HSV genome have been 
detected in cervical intraepithelial neoplasia 
(pre-malignant cancer) and implicated in the transformation 
of rat cells to a malignant phenotype in tissue culture, it 
appears that retention of HSV-2 DNA is not required to 
maintain the transformed phenotype (Galloway and McDougall, 
1983, Cameron et a l ., 1985). Using in vitro tissue culture 
systems, three distinct nonhomologous morphological 
transforming regions (mtr I, mtr II and mtr III) have been 
mapped in the genomes of HSV-1 and HSV-2 (Camacho and Spear, 
1978; Reyes et a l ., 1979; Jariwalla et al, 1980; Galloway et 
al., 1984). The mtr III region in HSV-2, contained in the 
Bglll c fragment, is composed of two independent 
transforming and immortalising regions, both of which are 
required for oncogenesis (Jariwalla et al ., 1983; Jariwalla 
et al ., 1986). However, these regions do not contain entire 
coding sequences for any one gene and no evidence exists to 
suggest that a viral protein is involved in the 
transformation process. Therefore it seems unlikely that 
the expression of stably inserted viral genes in cellular 
DNA is a function of transformation, particularly as HSV 
does not carry a viral oncogene analogous to those found in 
retroviruses or small DNA tumour viruses. Rather, a "hit 
and run" hypothesis for the oncogenic potential of HSV is 
favoured, whereby malignancy may develop from a transient or 
lasting disruption of normal cellular events to which HSV 
may have contributed (Galloway and McDougall, 1983; Macnab,
1987). Indeed, some cellular proteins, possibly including 
heat shock-related polypeptides, accumulate to high levels 
only in HSV-transformed cells (Macnab et a l ., 19 85 and 
personal communication). However, their significance
regarding the transformed state and the factors responsible 
for their induction are unknown. These proteins are also 
induced in normal HSV infections (Macnab et al.y 1985).
. . .  fu
Alternatively, insertion of HSV DNA sequences proximal^ or 
within certain cellular gene loci may cause the 
inactivation, rearrangement or enhanced expression of 
critical cell-growth control genes. Indeed, the mtr regions 
of HSV all have the potential to adopt stem/loop structures, 
a feature reminiscent of insertion-like sequences which 
activate genes through enhancer-like activity (Galloway et 
al., 1984; Jones et al., 1986). In addition, HSV has been 
shown to act as a mutagen in infected cells (Pilon et al.,
1986). The mutagenic activity of HSV could be an effect of 
virus-encoded enzymes involved in DNA biosynthesis that 
could cause a disruption in the pool of nucleotides 
necessary for error-free replication of cellular DNA. 
Therefore, the potential of HSV to cause mutations may be a 
significant property regarding an infected cell's 
predisposition to transformation.
Whatever the role of HSV in cervical cancer, 
transformation by mtrs or other HSV sequences occurs at low 
frequencies and certainly not by a one step mechanism 
(Macnab, 1987). It is more likely that HSV may act as a 
co-carcinogen in the development of tumours, in conjunction 
with other factors such as human papillomavirus (zur Hausen, 
1982; Durst et al ., 1983; Boshart et a l ., 1984).
1.3.3 Alteration of host macromolecular synthesis
Many host cell functions and gross changes in 
cellular protein synthesis accompany infection of permissive 
cells with HSV-1 or HSV-2. Cellular DNA and RNA synthesis 
is inhibited (Roizman and Roane, 1964), mitosis ceases 
(Wildy et a l ., 1961) and there is a rapid shut-off of most 
host polypeptide synthesis (Sydiskis and Roizman, 1966,
19 67) accompanied by a general degradation of cellular mRNAs 
(Nishoika and Silverstein, 1977, 1978; Schek and 
Bachenheimer, 1985). HSV-2 is, in general, more efficient 
at host protein synthesis inhibition than HSV-1. (Powell and 
Courtney, 1975; Pereira et al., 1977; Fenwick et al ., 1979, 
Schek and Bachenheimer, 1985) but the control of host
shut-off is poorly understood. Cells infected with 
UV-irradiated virus or infected in the presence of 
actinomycin D exhibit rapid shut-off of host protein 
synthesis, implying that the process is mediated by one or 
more virion components (Sydiskis and Roizman, 1967; Fenwick 
and Walker, 1979; Fenwick et al., 1979; Schek and 
Bachenheimer, 19 85). Indeed, mutants of HSV-1 have been 
isolated that are defective for virion associated host 
shut-off (vhs mutants) and the gene responsible identified 
as UL41 (Read and Frenkel, 1983; Kwong et al., 1988). 
However, complete shut-off requires the expression of early 
and perhaps late genes, indicating that there is a secondary 
shut-off event in addition and distinct from the virion 
associated mechanism (Honess and Roizman, 1974; Marsden et 
a l ., 1976; Nishioka and Silverstein, 1978; Stenberg and 
Pizer, 1982). Secondary host shut-off may be mediated by a 
virus-encoded product or alternatively, might be the result 
of virus promoters competing with cellular promoters for 
host transcription factors.
In contrast to the overall reduction in cellular 
mRNA and protein synthesis levels during HSV infection, the 
synthesis of some cellular proteins, possibly including heat 
shock proteins and ubiquitin, are stimulated early in 
infection (Notarianni and Preston, 1982; La Thangue et a l ., 
1984; Macnab et al., 1985 and personal communication; Patel 
et a l ., 1986; Latchman and Kemp, 19 87). Kemp et al. (19 86) 
have implicated the involvement of virion components, 
possibly including the HSV-1 IE gene transinducing factor 
Vmw65, in the stimulation of transcription of certain 
cellular genes. Such alterations in cellular gene 
expression during the initial stages of infection could 
ultimately determine the fate of an infection, whether it be 
lytic, latent or transforming.
1.4 THE STRUCTURE OF HERPESVIRUS GENOMES
1.4.1 Genome arrangement
Herpesvirus genomes consist of linear duplex DNA 
molecules (Becker et al. , 1968) of molecular weights ranging 
from 80 to 150xl06 depending on species (Roizman and
9Furlong, 1974). The base composition of herpesvirus DNA 
varies considerably; VZV has a G+C content of 46%, 
Pseudorabies virus (PRV) 73% and HSV-1 68.3% (Ben-Porat and 
Kaplan, 1962; Kieff et al ., 1971, Ludwig et al ., 1972; 
McGeoch et al., 1988). Members of the herpesvirus family 
have been grouped according to the pattern of repeated 
sequences in their genomes (Roizman, 1982) although these 
structural criteria do not correlate with the biological 
classification. Figure 1 shows the genome arrangement of 
representative members of the herpesviridae.
1.4.2 Structure of the HSV-1 genome
Early studies of HSV-1 DNA, based on observations 
of self-annealing molecules by electron microscopy, revealed 
that the molecule was composed of two covalently linked 
segments, designated long (L) and short (S). Each segment" 
contained unique sequences (U) flanked by a pair of distinct 
inverted repeat sequences (R), of which one of each was 
terminal (T) and one internal (I) (Sheldrick and Berthelot, 
1974). The molecule also exhibits terminal redundancy due 
to the presence of a short (approximately 400bp) terminal 
direct repeat, called the "a" sequence. One or more 
additional copies of the "a" sequence are located internally 
at the "joint" between the L and S segments, but in the 
opposite orientation to the terminal repeats (Wadsworth et 
al., 1975; Wagner and Summers, 1978; figure 1). The "a" 
sequences are responsible for mediating inversion events 
between the L and S segments such that four 
sequence-orientation isomers of the molecule are possible 
(Delius and Clements, 1976; Wilkie, 1976). Isomerisation of 
the genome occurs by intramolecular recombination at the "a" 
sequences, probably during HSV DNA replication (Weber et 
a l . , 1988). One isomer, chosen arbitrarily, is designated 
as the prototype for purposes of genomic map representations 
(Roizman et al., 1979; figure 2). In addition to the "a" 
sequences and inverted repeats, HSV-1 contains a number of 
small tandem reiterated sequence elements that vary in copy 
number (McGeoch et al., 1988).
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Fig. 1. Arrangement of sequences in herpesvirus genomes. 
Examples of genome types A to F are channel catfish virus 
(CCV), herpesvirus saimiri (HVS), Epstein-Barr virus (EBV), 
varicella zoster virus (VZV), herpes simplex virus (HSV) and 
murine cytomegalovirus (MCMV) respectively. Lines represent 
unique sequences and arrowed lines show possible inversions. 
Open boxes are large OlKb) repeats and shaded boxes are 
repeats of small reiterated sequences; arrowheads above 
boxes denote whether repeats are direct or inverted. The 
small terminal direct and internal inverted repeats of HSV 
("a" sequences) are indicated. The number of isomers of 
each molecule are also given.
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1.4.3 The nucleotide sequence of HSV-1
The complete nucleotide sequence of the HSV-1 
genome (strain 17) has now been determined (Davison and 
Wilkie, 1981; Murchie and McGeoch, 1982? McGeoch et a l ,
19 85; McGeoch et al., 19 86, McGeoch et al ., 19 88). Other 
herpesviruses whose complete sequences are known are VZV 
(Davison and Scott, 1986;) and EBV (Baer et a l ., 1984). The 
genome of HSV-1 comprises 152260 residues, although the 
exact lengh varies due to small reiterations and "a" 
sequences which differ in copy number. On the basis of open 
reading frame (ORF) predictions, the genome is estimated to 
encode 70 unique genes (2 are repeated); 56 in UT (107.943Ju
Kb), 12 in Ug (12.979 Kb), one in each of TR^ and IR^ (9.214 
Kb) and one in each of TRg and IRg (6.677 Kb) (McGeoch et 
al., 1988; figure 2). The genes of HSV-1 are quite densely 
packed in the genome; 79% of Ug and 89% of UL is occupied by 
ORFs which are considered to code for proteins (Rixon and 
McGeoch, 1985; McGeoch et a l ., 1988). It is clear from the 
close apposition or overlap of adjacent coding regions that 
in many cases transcriptional control elements must overlap
with the polypeptide coding region of adjacent genes.
tke.
The overall G+C content ofygenome is high (68.3%)
and some regions of the genome are extremely G+C-rich, in
particular the protein coding sequences of IE genes 1
(75.4%) and 3 (81.5%). The extreme ratio of G+C versus A+T
in these genes is manifest in a large amount of G+C-rich
codons, notably biased towards a G or C in the redundant
third position. A preference for high G+C codon usage
(resulting in restricted amino acid utilisation) is not
understood, but the situation has probably arisen
independently of protein functional demands (McGeoch et a l .,
1986; Perry et al ., 1986). McGeoch et a l . (1986) propose
that much of the coding region DNA has evolved towards a
ootential for encoding common and innocuous residues such as
.in the first two positions 
alanine (whose codons contain only G and , tnereby
introducing an element of "plasticity" in the event of 
mutation.
A knowledge of the complete nucleotide sequence of 
HSV-1 will revolutionise the identification of virus 
polypeptides and analysis of their function. For instance,
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Fig. 2. Layout of genes in the genome of HSV-1. The HSV-1 genome is shown on four successive lines, 
with unique regions represented by solid lines and major repeat elements as open boxes as in Fig. 1. The 
lower scale represents kilobases, numbered from the left terminus, and the upper scale represents 
fractional map units. The sizes and orientations of proposed functional ORFs are shown by arrows. 
Overlaps of adjacent, similarly oriented ORFs are not shown explicitly. Locations of proposed 
transcription polyadenylation sites are indicated as short vertical bars. Locations o f  origins o f DNA 
replication are shown as X. In the U L region, on the first three lines, genes UL1 to UL56 are labelled. In 
the Us region, on the bottom line, genes US1 to US12 are labelled. The locations of inlrons in the 
coding regions of gene UL15 and the two copies (TRL and IR L) of the IE110 gene are indicated.
Properties of HSV-l-encoded proteins
(taken directly from McGeoch et al., 1988).
Gene
No. of 
residues M*  Function or properties
IEUO (19) IE transcriptional regulator (IEUO)
(222)
(534)
775 Total 78452
UL1 224 24932 Hydrophobic N terminus
UL2 334 36326
UL3 235 25607 Hydrophobic N terminus
UL4 199 -
UL5 882 98710 DNA replication; ATP-utilizing?
UL6 676 74087 Virion protein
UL7 2% 33057
UL8 750 79921 DNA replication
UL9 851 94246 DNA replication
ULIO 473 51389 Multiply hydrophobic
UL11 96 10486
UL12 626 67503 Deoxyribonuclease
UL13 518 57193
UL14 215 23454
UL15 (343) -
(392)
735 Total 80918
UL16 373 40440
UL17 703 74577
UL18 318 34268
UL19 1374 149075 Major capsid protein
UL20 222 24229 Multiply hydrophobic
UL21 535 57638
UL22 838 90361 Virion glycoprotein H
UL23 376 40918 Thymidine kinase
UL24 269 29474
UL25 580 62666 Virion protein
UL26 635 62466 Capsid protein
UL27 904 100287 Virion glycoprotein B
UL2S 785 85573
UL29 1196 128342 DNA replication; major DNA-
UL30 1235
binding protein 
136413 Replicative DNA polymerase
UL31 306 33951
UL32 5% 63946 Locus of immune cytolysis
UL33 130
resistance mutation
14436
UL34 275 29788 Virion protein;
UL35 112
hydrophobic C terminus
12095
UL36 3164 335841 Virion protein
UL37 1123 120549
UL38 465 50260 Virion protein
UL39 1137 124043 Large subunit of ribonucleotide reductase
Table 1. (continued)
Gene
NO. Ol 
residues M*  Function or properties
UL40 340 38017 Small subunit of ribonucleotide reductase
UL41 489 54914 Virion protein causing host shut-off
UL42 488 51156 DNA replication; DNA-binding protein
UL43 434 44905 Multiply hydrophobic
UL44 511 54995 Virion glycoprotein C
UL45 172 18178 Hydrophobic N terminus
U U 6 718 78239
UL47 693 73812
UL48 490 54342 Major tegument protein; 
activator of IE genes
UL49 301 32252
UL50 371 39125 Deoxyuridine triphosphatase
UL51 244 25468
UL52 1058 114416 DNA replication
UL53 338 37570 Multiply hydrophobic
UL54 512 55249 IE transcriptional regulator (IE63)
UL55 186 20491
UL56 197 21182
IE175 1298 132835 IE transcriptional regulator (IE175)
US1 420 46521 IE protein (IE68)
US2 291 32468
US3 481 52831 Protein kinase
US4 238 25236 Virion glycoprotein G
US5 92 9555 Putative glycoprotein
US6 394 43344 Virion glycoprotein D
US7 390 41366 Virion glycoprotein I
US8 550 59090 Virion glycoprotein E
US9 90 10026 Tegument phosphoprotein
USIO 312 34053 Virion protein
US11 161 17756
US12 88 9792 IE protein (IE12)
References are cited in the original paper (McGeoch 
et al. , 1988).
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a powerful method for correlating gene and product relies on 
the ability to raise antisera against synthetic 
oligopeptides, predicted to occur in HSV-encoded proteins 
from sequence data. In addition, targeted mutagenesis of 
coding regions (based on sequence knowledge) will greatly 
assist the elucidation of polypeptide functions and their 
importance to virus viability (Longnecker and Roizman, 1987; 
Weber et al., 1987). Potential gene function can also be 
assigned by comparing the computer analysis of predicted 
protein sequences of an unknown gene with those of 
characterised genes in data banks.
Many viral proteins have already been identified 
and assigned to gene loci by the study of mutants (Stow et 
a l ., 1978; Preston et al., 1979b; Parris et al., 1980;
Conley et al., 1981; Knipe et a l ., 1981) and analysis of 
intertypic recombinants (Marsden et a l ., 1978; Preston et 
a l ., 1978; Morse et al., 1978). HSV transcripts have been 
mapped by SI mapping and Northern blotting analysis (e.g. 
Rixon and McGeoch, 1985) and correlated with gene products 
translated in vitro (Anderson et a l ., 1980; Preston and 
McGeoch, 1981; Rixon and McGeoch, 1984). The function of 
some proteins has also been determined by analysis of 
polypeptide activity in heterologous expression/assay 
systems using cloned genes (Preston and Cordingley, 1982; 
Everett, 1984b; Campbell et a l ., 1984; Preston and Fisher,
19 84). However, the function and identity of of a large 
number of gene products have yet to be characterised.
Figure 2 and table 1 summarise the map location of HSV-1 
ORFs and genes encoding proteins with known functions (taken 
directly from McGeoch et al. , 19 88).
1.5 HSV REPLICATION
1.5.1 Overview
The replication of HSV is coordinated by temporal
control of gene expression. The classification of three 
groups of genes, immediate-early (IE), early (E) and late 
(L) (Clements et al ., 1977), or alpha, beta and gamma 
(Honess and Roizman, 1974) is based on their kinetics and
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expression in the absence and presence of metabolic 
inhibitors of translation or DNA replication (Jones and 
Roizman, 1979; Kozak and Roizman, 1974). The IE genes are 
the first to be transcribed and their expression does not 
require de novo protein synthesis, whereas early and late 
gene expression is dependent on prior synthesis of IE 
polypeptides (Honess and Roizman, 1974; Clements et a l .,
19 77). IE genes are expressed directly after release of DNA 
into the nucleus and, as discussed in section 2.2, their 
expression is stimulated by a component of the infecting 
virus particle (Post et al. , 1981; Batterson and Roizman,
1983).
The IE proteins are potent regulators of HSV gene 
expression, able to activate E and L genes and repress IE 
genes (Everett, 19 84b; O'Hare and Hayward, 1985a,b; Gelman 
and Silverstein, 1985; Quinlan and Knipe, 1985; DeLuca and 
Schaffer, 1985; Gelman and Silverstein, 1986; Rice and 
Knipe, 1988; Roberts et al. , 1988; Sekulovich et al ., 1988). 
In particular the IE gene 3 product, Vmwl75, is an essential 
control factor in the transition from IE to E and L stages 
of gene regulation (Preston, 19 79a; Dixon and Schaffer,
1980; Watson and Clements, 1980). Early genes, which are 
involved in the synthesis of viral DNA, are abundantly 
expressed in the absence of DNA replication (Swanstrom et 
al., 1975). One early polypeptide, the major DNA-binding 
protein (MDBP), has been implicated in the general 
repression of HSV genes (Godowski and Knipe, 19 83, 19 85,
19 86). Immediate early gene expression may also be subject 
to negative regulation by post transcriptional control 
mechanisms (Kozak and Roizman, 1974; Harris-Hamilton and 
Bachenheimer, 19 85). Late genes are most abundantly 
expressed following the onset of DNA replication (Swanstron 
and Wagner, 19 74; Powell et al ., 19 75). Two sub-classes of 
L genes, ganuna^ and gamma2 / exist. Gamma^ genes are 
transcribed in the absence of viral DNA synthesis whereas 
gamma 2  genes require DNA replication before their full 
expression is attained (Jones and Roizman, 19 79; Holland e^ t 
al.-, 1980; Gibson and Spear, 1983; Johnson and Everett,
19 86a). Many of the late proteins are structural components
of the virion.
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1.5.2 Cell penetration
HSV particles adsorb to cell surfaces and penetrate 
predominantly by fusion of the virion envelope with the 
cellular membrane. The virus encoded glycoprotein gB, 
present in the virus envelope, is required for fusion since 
mutants with defective gB are capable only of binding to 
cells (Sarmiento et al., 1979; Little et al., 1981). The 
viral capsids then migrate to nuclear pores where they 
disassemble and DNA is released into the nucleus. The HSV 
mutant, tsB7, is blocked at the stage of DNA release 
indicating that a viral-encoded protein is important for 
this process (Knipe et al . , 19 81; Batterson et al ., 19 83).
1.5.3 HSV transcript processing
The mechanism by which HSV DNA is transcribed and 
mRNAs processed is fundamentally similar to that for 
cellular RNA polymerase II genes. HSV mRNAs are transcribed 
in the nucleus by host RNA polymerase II (Ben-Zeev and 
Becker, 1977; Costanzo et a l . , 1977). The transcripts are 
processed at the 5 ’-terminus by capping, at the 3'-terminus 
by polyadenylation and are internally methylated 
(Bachenheimer and Roizman, 1972; Silverstein et al ., 1973; 
Bartoski and Roizman, 19 76; Moss et al ., 19 77). The 
3*-flanking sequences of HSV genes contain the sequence 
YGTGTTYY, thought to be important for the termination of 
transcripts (McLaughlan et a l . , 19 85).
Splicing of HSV mRNAs is rare (Frink et al., 1981, 
1983; Watson et al., 1981, Costa et al ., 1985). This is in 
contrast to many viruses, including CMV and EBV, which 
generate multiple individual mRNAs with common 5 1 and 3 1 
termini, thereby providing an economic use of template DNA. 
HSV-1 IE mRNAs 4 and 5 are spliced within their common 5* 
untranslated regions located within TRg and IRg (Watson et 
al., 1981; Rixon and Clements, 1982), and IE gene 1 contains 
two introns within the coding sequence (Perry et al ., 1986). 
One gene in the segment (UL15) is also spliced and 
contains two ORFs in separate exons (Costa et a l ., 19 85; 
McGeoch et al ., 1988). The transcript found associated with 
latent infections (LAT) is also spliced but only a tentative
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ORF has been designated (Wechsler et a l ., 1988). The
purpose of these splicing events does not appear to be
related to gene compression since the introns do not lie
within overlapping reading frames. In fact, only a small
degree of reading frame overlap exists in the genome. US10
and US11 are the only HSV genes in US whose products are
actually known to be encoded by overlapping reading frames
(Rixon and McGeoch, 1984; figure 3). In addition, there are
11 proposed overlaps of coding sequence within U (McGeoch
Li
et_al., 1988). Many HSV transcripts, although not spliced, 
partially overlap and are arranged in nested groups with 
unique 5' ends and common 3* ends, as is the case for the 
mRNAs of genes US10, 11 and 12 (Hall et al., 1982; Costa et 
al., 1983; Rixon and McGeoch, 1984; figure 3). Families of 
genes with common 5* ends and different 3' ends are also 
found and are the result of readthrough of polyadenylation ■ 
sites (Anderson et a l ., 1981; Hall et al, 1982).
1.5.4 IE genes
IE gene expression peaks about 2-3h after 
adsorption but IE mRNAs can still be detected in the 
cytoplasm at late times (Harris-Hamilton and Bachenheimer,
19 85; Godowski and Knipe, 19 86). During infection in the 
presence of cycloheximide, large quantities of IE mRNAs 
accumulate (Preston, 1979a). There is no transcription of E 
and L genes since protein synthesis is inhibited and IE 
polypeptides are required for the switch to E and L mRNA 
synthesis. Using these "immediate-early" conditions 
Clements et al. (19 79) were able to map IE mRNA transcripts 
to the genome. There are 5 IE genes, the locations of which 
are shown in figures 2 and 15. IE genes 1 and 3 are located 
within the long and short inverted repeats respectively, and 
are therefore present in two copies each (Watson et al.,
19 79; Anderson et a l ., 19 80; Mackem and Roizman, 19 80; Rixon 
et al., 1982). The promoter and 5' untranslated leader 
sequences of IE genes 4 and 5 (encoding Vmw6 8 and Vmwl2 
respectively) are located within the short repeat and thus 
are common to both, but the coding sequences differ since 
they are located in the unique segments of the genome 
(Watson e t a l . , 1981; Rixon and Clements, 1982; figure 3).

Fig. 3. Transcripts in Ug of HSV-1. The 12 genes are 
encoded by 13 transcripts (McGeoch et a l ., 1985; Rixon and 
McGeoch, 19 85). The probable coding regions (boxes) and 
non-coding regions (lines) are indicated, and the direction 
of transcription is shown by arrows. Known polypeptide 
functions are indicated below the genes. g? indicates a 
suspected glycoprotein (McGeoch, 1985) and a protein kinase 
has been assigned to US3 (McGeoch and Davison, 19 86; Frame 
et a l . , 19 87). 11 of the mRNA species (UL3 to (JL12) belong
to transcript families with 3' co-terminal ends. Part of 
the coding sequences of US10 and US11 overlap in different 
reading frames (Rixon and McGeoch, 1984).
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IE gene 2 is located in the long unique segment of the 
genome.
IE transcription does not require de novo synthesis 
of viral or host proteins (Kozak and Roizman, 1974; Clements 
et__al., 1977) but the transcription of IE genes is 
stimulated 5 to 10-fold by the major tegument protein of the 
infecting virion, Vmw65 (Post et al ., 1981; Campbell et al ., 
19 84; section 2.2). In these respects the regulation of IE 
genes is unique within the viral genome. The regulation of 
IE genes is discussed in detail in section 2.
1.5.5 IE polypeptides
The 5 IE polypeptides vmwllO (ICPO), Vmw63 (ICP27), 
Vtawl75 (ICP4), Vmw68 (ICP22) and Vmwl2 (ICP47) are named 
according to their mobility by SDS-PAGE analysis and 
correspond to the products of IE genes 1 to 5 respectively.- 
The IE proteins are all phosphorylated and located within 
the nucleus with the exception of Vmwl2 (Pereira et al., 
1977; Marsden et al., 1978, 1982; Preston 1979b; Fenwick and 
Walker, 19 79; Ackermann et al. , 1984). The functions of IE 
polypeptides have been elucidated by the study of virus 
mutants and, more recently, short-term transient 
transfection assays using cloned genes in tissue culture. 
Although the function of Vmwl2 remains obscure, roles 
involved in the regulation of gene expression have been 
associated with the other IE proteins:
Vlnwl75 This polypeptide is critical for HSV replication 
due to its central role in the transcriptional programme. 
Various conditional HSV-1 mutants containing lesions within 
IE gene 3 (most notably tsK) fail to synthesise E an/vL 
proteins at the NPT and cannot replicate viral DNA (Marsden 
et al ., 1976; Preston et al., 1979a; Dixon and Schaffer,
1980; Watson and Clements, 1978, 1980). Temperature shift 
experiments using such mutants show that Vmwl75 is 
continuosly required for E and L gene expression and 
suppression of IE genes (Watson and Clements, 1978, 1980, 
Preston, 1979a; Dixon and Schaffer, 1980). The phenotype of 
ts vrnwl75 mutants ranges from being non-permissive for E 
gene expression to partially or completely permissive
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(DeLuca et al., 1984). However, some mutants which are 
permissive for E gene expression are nevertheless restricted 
in viral DNA synthesis and underproduce late gene products, 
suggesting that vmwl75 may have a direct role in DNA 
replication.
In transient expression assays using cloned IE-3 
genes, E and L genes are activated by Vmwl75 (Everett,
1984b; DeLuca and Schaffer, 1985; Gelman and Silverstein,
19 85; O'Hare and Hayward 1985a,b; Quinlan and Knipe, 19 85; 
Mavromara-Nazos et al. , 1986). Vtnwl75 has been implicated 
in the autoregulation of IE gene expression due to the 
observation that ts Vtowl75 mutants overproduce IE 
transcripts at the NPT (Dixon and Schaffer, 1980). Indeed 
plasmids that express Vmwl75 can repress transcription from 
the IE-3 promoter (O'Hare and Hayward, 19 85b). The other .IE 
promoters can be repressed by vmwl75 under certain 
conditions in transfection assays (DeLuca and Schaffer,
1985; Gelman and Silverstein, 1987a,b). During infection 
however, products of later genes may be involved in the 
turn-off of IE gene expression (Godowski and Knipe, 19 86) 
and IE gene 3 seems to be the only one that is efficiently 
repressed at the level of transcription (Weinheimer and 
McKnight, 1987). Transactivation and repression of HSV 
promoters has also been demonstrated in vitro using 
partially purified Vmwl75 (Beard et a l ., 1986; Pizer et al., 
19 86).
Vmwl75 has been shown to bind specifically to the 
target consensus sequence 5'-ATGCTG-3' present at the
op
transcription start site^its own gene, IE gene 3 (Beard et 
a l . , 1986; Faber and Wilcox, 1986; Kristie and Roizman, 
1986a; Muller, 1987) and it^3 thought that this process 
mediates autoregulation (Gelman and Silverstein, 1987b; 
Muller, 1987; Roberts et a l ., 1988). However, it is unclear 
whether vmwl75 binds transactivation-specific promoter 
sequences present in other viral genes (Everett, 1984a; 
Eisenberg et al., 1985; Coen et al., 1986; Kristie and 
Roizman, 1986a,b; Michael et al., 1988).
In order to elucidate the mechanism of Vmwl75, 
mutational analysis of the gene has been undertaken. An 
amino-terminal region of the polypeptide, which is highly
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conserved in the VZV counterpart, was shown to be 
particularly important for both transactivation and 
repression functions in transfection studies (DeLuca and 
Schaffer, 1987, 1988; Paterson and Everett, 1988a,b). Both 
of these activities correlated with the ability of the 
protein expressed in transfected cells to bind the 
VJnwl75-specific consensus sequence in gel retardation assays 
(Paterson and Everett, 1988b). Paterson and Everett (1988b) 
propose a model whereby Vmwl75 mediates transactivation by 
association with cellular factors (e.g. TFIID) at promoter 
sequences (e.g. TATA boxes). Repression might then occur 
only if this complex were in the vicinity of a high affinity 
Vtawl75 binding site, which may block the progression of the 
transcription machinery.
VmwllO To date no ts mutants in IE gene 1 have been 
isolated. However, VmwllO has been shown to be a potent 
activator of viral and cellular promoters in transient assay 
systems in tissue culture (Everett, 1984b; O'Hare and 
Hayward, 1985a,b; Quinlan and Knipe, 1985; Gelman and 
Silverstein, 1985; Mavromara-Nazos et al., 19 86). An HSV-1 
mutant, d!1403, was constructed that contained a large 
deletion in the IE-1 gene and this resulted in a protein 
that was inactive in transient assays (Stow and Stow, 19 86; 
Perry et al., 1986). The deletion mutant grew inefficiently 
at low multiplicities of infection (moi), its growth yield 
being approximately 50 to 100-fold lower than wild-type (wt) 
virus. However, at high moi the mutant expressed normal 
amounts of viral proteins and replicated DNA as well as wt 
virus. The high particle/pfu ratio of dll403 (approximately 
700) resulted from a reduced ability to initiate productive 
infection at low moi and not from a defect in the virus 
particle (Stow and Stow, 1986, 1989). The conclusion is 
that VmwllO is not absolutely essential in tissue culture, 
but at low moi viruses that lack the polypeptide exhibit a 
defect that can be overcome by increasing the number of 
infecting viruses. VmwllO may therefore ensure that 
sufficient viral gene expression for lytic infection can 
occur at low moi; i.e. under conditions when Vmwl75 alone is 
insufficient to commit the cell to the lytic cycle. Similar
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conclusions have been reached more recently in studies using 
other insertion and deletion mutants constructed in the gene 
(Sacks and Schaffer, 1987; R.D. Everett, personal 
communication).
In transfection studies, VmwllO has been shown to 
transactivate a wide variety of viral and cellular promoters 
either by itself or in combination, either additively or 
synergistically, with vmwl75 (Everett, 1984b, 1986; O'Hare 
and Hayward, 1985; Quinlan and Knipe, 1985; Gelman and 
Silverstein, 19 86). However, the observation that an IE-3 
deletion mutant, that expresses little if any vmwl75 coding 
sequences, is unable to grow in normal cells suggests that 
VmwllO fails to activate E gene expression in the absence of 
Vmwl75 during infection (DeLuca et a l ., 19 85). This 
observation also argues against transdominant repression of 
VmwllO by abnormal Vmwl75 polypeptides in non-productive 
infections using ts Vmwl75 mutants at the NPT.
Regions of the polypeptide that are involved in the 
intrinsic and synergistic activation effects have been 
defined by in vitro mutagenesis (Everett, 1987, 1988a). The 
synergism between Vmwl75 and VmwllO is largely dependent on 
the intregrity of the carboxy-terminal region of the 
polypeptide, whereas mutations in this region do not greatly 
affect the ability of the protein to activate by itself. 
Therefore, two different mechanisms of activation may work 
and synergy may require an association between VmwllO and 
Vmwl75. To date, no information regarding the DNA binding 
properties of the polypeptide is available, although a 
sequence of the coding region containing a consensus "metal 
finger binding domain" (Berg, 1986) was absolutely essential 
for the activity of VmwllO in the absence of Vmwl75.
Vmw63 This protein, the product of IE gene 2, is an 
essential regulatory polypeptide. A number of ts Vmw63 
mutants have been isolated and have been shown to 
overproduce vmwl75 and VmwllO at the NPT (Sacks et— al.,
19 85). However, the mutants were able to synthesise normal 
levels of E proteins and DNA replication was not blocked, 
although they exhibited a severe reduction of late gene 
expression, notably of gB (Rice and Knipe, 19 88).
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In transfection assays, Everett, (1986), 
demonstrated that Vtow63 can further activate expression of 
the late gene promoter of VP5 above levels attained with 
VtowllO and Vmwl75, but only when all three proteins were 
present; Vtaw63 had no effect by itself or in other 
combinations on other promoters tested including those of TK 
and gD. Recently, Vmw63 has been shown to both activate and 
repress a variety of HSV promoters in transfection assays 
when VmwllO and vmwl75 are also present (Rice and Knipe, 
1988; Sekulovich et al., 1988). In general, these results 
are consistent with the observations that ts Vmw63 mutants 
both overexpress and fail to express subsets of gene class 
products at the NPT (Sacks et al., 19 85).
Vmw68 No ts mutants with lesions in the IE-4 gene have 
been isolated to date. A deletion mutant which removed the 
carboxy terminal third of Vmw68 was constructed (Post and 
Roizman,1981) which exhibits poor growth and reduced 
expression of at least one L gene in some cell lines (Sears 
et a l ., 1985). In addition, the mutant was not 
neurovirulent in mice.
ytnwl2 There are no ts mutants in IE gene 5 and in fact 
viable deletion mutants have been constructed that lack the 
whole gene, indicating that the protein does not play an 
important role during infection in tissue culture 
(Longnecker and Roizman, 1986; Umene, 1986; Brown and 
Harland, 1987).
1.5.6 Regulation of early gene expression
Peak expression of the early genes occurs 4-6h post 
adsorption, although there is more variation in their 
kinetics of expression than for the IE genes. For example, 
although the large sub-unit of ribonucleotide reductase 
(r r ^ ) has predominantly early kinetics, it can still be 
detected in the presence of cycloheximide and in ts Vmwl75 
mutants that fail to express E genes at the NPT (Preston,
19 79a; DeLuca et al., 1985). Thus RRX has been classed as a 
beta1 gene product (Roizman and Batterson, 19 85). Some 
genes, including gD, are detected at early times but they
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are not fully expressed until after the onset of DNA 
replication (Gibson and Spear, 1983; Johnson and Everett 
1986a). Genes whose expression is moderately dependent on 
DNA replication have been described as early-late (EL), 
leaky late (beta gamma) and gamma^ (Roizman and Batterson, 
1985; Wagner, 1985; Harris-Hamilton and Bachenheimer, 1985).
Early gene promoters have been studied in detail
in an attempt to identify induction-specific sequences (Coen
et al ., 1986; Eisenberg et al, 1985; Everett, 1983/ 1984a;)
Early promoters contain upstream sequences necessary for
full expression such as a CAAT box and GC-rich Spl sites for
TK, and AG-rich regions for gD. The TATA box of these
promoters is probably the main factor involved in the
response to viral products, although other promoter elements
are important (McKnight et a l ., 19 81; McKnight and
Kingsbury, 1982; Everett, 1983, 1984a; El Kareh et al.,
1985; Coen et al, 1986;). Indeed the SV40 promoter, which
is poorly responsive to HSV infection, can be transactivated
when its TATA box is substituted with that of the gD
promoter which suggests that HSV IE proteins can substitute
for or directly modulate the TATA box transcription factor
TFIID at HSV TATA box regions (Everett, 1988b). It should
be noted however that although many HSV promoters contain
homolgies to TATA, CAAT and GC-rich elements, there is a 
A
great deal of diversity between promoters of the same class 
(Wagner, 1985; Mackem and Roizman, 1982c). These 
differences may account for the variation in the level of 
expression in equivalent groups of genes (Honess and 
Roizman, 19 74; O'Hare and Hayward, 19 85a; Harris-Hamilton 
and Bachenheimer, 1985).
An important observation made by Everett (19 83, 
1984b) was that a heterologous promoter, that of the rabbit 
beta globin gene, was also transactivated by HSV infection. 
When integrated into the viral genome, the beta globin gene 
was regulated with the kinetics of an E gene, suggesting 
that E gene promoter selectivity is not exclusively 
dependent on viral-specific sequences (Smiley et_al., 1987). 
Interestingly, the endogenous cellular copy of the beta 
globin gene in rabbit kidney cells did not respond to HSV-1 
infection, indicating that genes respond differently to
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trans—acting factors depending on whether they are 
chromatin-associated or extrachromosomal.
1.5.7 Regulation of late gene expression
Late gene product accumulation peaks by 10-l6h post 
adsorption, approximately 2h after the peak of viral DNA 
synthesis (Munk and Sauer, 1964; Roizman, 1969; Wilkie,
19 73). Analysis of viral-induced polypeptides under 
conditions of virus DNA synthesis inhibition using chemical 
inhibitors or ts DNA” mutants reveals that late gene 
expression requires DNA replication to occur (Swanstrom and 
Wagner, 1974; Honess and Roizman, 1974; Powell et al., 1975; 
Marsden et a l ., 19 76; Jones and Roizman, 19 79; Holland et 
al., 1980; Conley et al., 1981; Pederson et al. , 1981).
Late genes have been classed as either "leaky late"
(gamma^), whose expression is reduced but still detectable 
in the absence of DNA replication, or "true late" (g a m n ^ ), 
whose expression is very hard to detect under these 
conditions (Wagner, 1985; Roizman and Batterson, 1985). The 
major capsid protein, Vmwl55, is an example of a leaky late 
protein while US11 exhibits true late characteristics, even 
to the extent that cloned US11 genes require plasmid DNA 
replication in cis for maximal expression in transient 
transfection assays (Johnson and Everett, 1986a,b; Johnson 
et al., 1986). These experiments used an HSV origin of DNA 
replication and the US11 promoter linked to an assayable 
gene, and it was found that only the TATA box region was 
required for fully efficient regulated expression upon HSV 
infection (Johnson and Everett, 1986b). This contrasts with 
the upstream requirement of E promoters which need regions 
upstream of the TATA box for full expression upon infection. 
In addition, the early promoter of gD is regulated as a true 
late promoter in the absence of its upstream region if 
linked to an origin of DNA replication (Johnson et al.,
1986). The reasons how or why viral DNA replication leads 
to L gene induction is not understood. It is unlikely to be 
due simply to an increase in copy number of promoters, since 
E genes would then also be expected to be dependent on DNA 
synthesis. Replication could possibly cause a change in the 
DNA template and provide a switch for L gene expression, or
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perhaps part of the replication machinery is needed in situ 
to initiate L gene transcription. However, analysis of 
mutants indicates that the IE gene products Vmw63 and Vmw68 
are involved in L gene induction since these viruses 
underexpress certain late proteins (Sears et a l .f 1985;
Sacks et a l ., 1985; section 1.5.5). In addition, L gene 
promoters, like those of E genes, are activated by IE 
proteins in transfection assays (Dennis and Smiley, 1984; 
DeLuca et al, 1985; Mavromara-Nazos et al. , 1986, Everett, 
1986; section 1.5.5).
1.5.8 Enzymes
Many of the E proteins identified to date have 
enzymic activity and play roles in the metabolism or 
synthesis of viral DNA. The known virally encoded enzymes* 
are thymidine kinase (TK) (Kit and Dubbs, 1963; Jamieson et 
al ., 1976), alkaline exonuclease (Morrison and Keir, 1968; 
Moss et a l ., 19 79), DNA polymerase (Keir et al ., 1966; 
Chartrand et al ., 1979, 1980), ribonucleotide reductase (RR) 
(Cohen, 1972; Dutia, 1983), dUTPase (Wohlrab and Francke, 
1980; Preston and Fisher, 1984), uracil DNA glycosylase 
(Worrad and Caradonna, 1988; Mullaney et a l ., 1989) and 
protein kinase (McGeoch and Davison, 1986; Purves et a l .,
19 86; Frame et al., 1987).
Analysis of mutants has revealed that DNA 
polymerase is essential for growth in tissue culture 
(Chartrand et al. , 1980) whereas the TK, dUTPase, uracil DNA 
glycosylase, protein kinase and alkaline exonuclease 
proteins are not required for virus replication (Dubbs and 
Kit, 1964; Fisher and Preston, 1986; Mullaney et al ., 1989; 
Purves et a l . , 1987; S. Weller , 13th International 
Herpesvirus Workshop abstracts, Irvine 1988). Mutants 
containing ts lesions in ribonucleotide reductase have been 
isolated, indicating that it is an essential polypeptide 
(Preston et al., 1984, 1988; Dutia, 1983). However, 
Goldstein and Weller (1988) have shown that viruses in which 
the RR gene is deleted are viable in growing cells at 34°C 
but not at 39.5°C. They suggest that a cellular factor, 
capable of complementing viral RR, is present in growing 
cells at lower temperatures but inactive at 39.5 C .  Thus
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the requirement of viral RR is largely dependent on the 
conditions in which infection occurs. RR consists of two 
subunits, one large and one small (Vtawl36 or RR1 , and vmw3 8 
or RR 2 ) (Huszar et a l ., 1983; Bacchetti et a l ., 1984;
Preston et al., 1984). Studies with ts!207 and tsl222, 
combined with immunological studies, show that the two 
subunits are inactive until associated with each other as a 
protein complex (Preston et al., 1984, 1988; Frame et al .,
19 85). A synthetic nonapeptide corresponding to the 
carboxyl 9 amino acids of the small subunit specifically 
inhibited the viral but not the cellular enzyme (Dutia et 
al., 1986; Cohen et al., 1986). It was proposed that 
inhibition of activity resulted from the ability of the 
nonapeptide to competitively inhibit Vmw38 from associating 
with the binding site on Vmwl36. This finding suggests a - 
novel approach to the development of antiviral agents that ' 
block protein:protein interactions between virus 
polypeptides.
The HSV DNA polymerase differs from most eukaryotic 
polymerases by virtue of its 3 1 to 5' exonuclease (proof 
reading) activity (Knopf, 19 79 ). In addition, the HSV 
enzyme is sensitive to phosphonoacetic acid (PAA), a 
pyrophosphate analogue (Leinbach et al., 1976).
1.5.9 Structural polypeptides
HSV virions are estimated to contain between 15 and 
33 polypeptides (Spear and Roizman, 1972; Heine et al.,
19 74) which are grouped into glycoproteins, tegument 
proteins and capsid proteins.
Glycoproteins HSV—1 encodes a minimum of seven 
glycoproteins (gB, gC, gD, gE, gG, gH and g l ), identified by 
their ability to incorporate radiolabelled sugar molecules 
(Spear, 1976; Bauke and Spear, 1979; Buckmaster et al.,
1984; Spear, 1985; Frame et al., 1986; Richman et al., 1986; 
Ackermann et al ., 1986; Longnecker et_al., 1987; Johnson et 
al. , 19 88). One. additional open reading frame , whose 
protein is as yet unidentified, has characteristic 
glycoprotein amino acid sequences (McGeoch, 19 85). The
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glycoproteins are located within the membrane that composes 
the viral envelope and are probably exposed on the surface 
of the virion. Johnson et al . (1984) have implicated gB, gC 
and gD as having roles in cell surface adsorption. In 
addition, gB, gD and gH all play essential roles in the 
ability of HSV to fuse with plasma membranes and penetrate 
cells (Sarmiento et al., 1979; Little et al ., 1981; Minson 
et a l ., 1986; Desai et al ., 1988; Cai et al ., 1988). 
Glycoprotein gD is thought to be an essential cell surface 
receptor-binding polypeptide (Johnson and Ligas, 1988). 
Glycoproteins gE and gl interact specifically with the Fc 
domain of immunoglobulin G (IgG) (Bauke and Spear, 19 79; 
Johnson et al, 1988). Thus it appears likely that several 
glycoproteins, as well as structural proteins (Addison et 
al., 1984), participate in entry of HSV into cells in a 
multistep process.
Tegument proteins These proteins can be identified when 
released from virions in the presence of non-ionic 
detergents, although some associate more tightly to capsids 
than others (Lemaster and Roizman, 1980; Roizman and 
Furlong, 1974; Spear, 1980). Little is known about the 
orientation or the exact number of proteins that comprise 
this region, but polypeptides not classified as 
glycoproteins or capsid proteins are generally referred to 
as tegument proteins. The major tegument protein is Vmw65, 
the subject of this thesis.
Capsid proteins Capsids isolated from infected cells are 
either empty or contain HSV DNA. Empty capsids are made up 
of at least 5 proteins while mature nucleocapsids contain 2 
additional polypeptides, one of which is VP22 (p40)(Gibson 
and Roizman, 1972, 1974; Heilman et al ., 1979; Preston et 
al., 1983). Another polypeptide found in capsids is Vmwl55, 
the major capsid protein.
1.5.10 DNA replication
Upon infection, linear herpesvirus DNA molecules 
circularise (Jean et al., 1977; Jacob and Roizman, 1977) by 
direct ligation of the termini (Jean and Ben-Porat, 1976; 
Davison and Wilkie, 1983; Poffenberger and Roizman, 1985). 
During the initial stages of DNA replication, loops and eyes
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in the DNA molecule are visible by electron microscopy at 
multiple, widely separated loci (Friedman et al., 1977). 
Newly replicated DNA molecules are found in large 
concatemers, in head to tail configuration, which probably 
arise by a rolling circle replication process (Jacob and 
Roizman, 1977; Ben-Porat and Tokazewski, 1977). Electron 
microscopic studies and analysis of defective particles with 
incomplete genomes revealed that HSV DNA contains three 
origins of replication, two within the repeated Rc segment 
(orig) and one within UL (oriL ) (Frenkel et a l ., 1976; Jean 
et al ., 1977; Rixon and Ben-Porat, 1979; Vlazny and Frenkel, 
1981; Spaete and Frenkel, 1982). Studies with mutant 
viruses have shown that deletion of ori^ or one copy of orig 
has little or no effect on virus replication in cultured 
cells (Longnecker and Roizman, 1986; Polvino-Bodnar et a l ;, 
19 87). The cis-acting ori sequences were fine mapped by 
identifying DNA fragments capable of inducing replication of 
bacterial vectors in HSV infected cells. 0rig consists of a 
90bp fragment containing a 45bp palindromic sequence 
featuring 18 centrally located A or T residues flanked by 
G+C-rich tracts, located between the 5' ends of IE mRNAs 3 
and 4/5 (Stow, 19 82: Stow and McMonagle, 1983). 0rij/ 
located in the middle of tJr between the genes encoding DNA
JLi
polymerase and the major DNA-binding protein (MDBP),
contains a 72bp palindrome closely related (85% homologous)
to ori (Gray and Kaerner, 1984; Quinn and McGeoch, 1985;
Weller et a l ., 1985). The potential ability of the origins
to form cruciform structures containing a stretch of low
melting point (AT-rich) DNA probably facilitates strand
separation in these regions of the genome .(Stow, 19 85).
Ori and oriT appear to be functionally identical in 
S L
transient complementation assays (Wu et al ., 1988).
1.5.11 Genes required for DNA replication
The major DNA binding protein (MDBP) is an early 
gene product essential for DNA replication (Conley et—al. ,
19 81), although the function of this protein is not well 
defined. The MDBP is a single-stranded DNA binding protein 
that may reduce the melting temperature at poly(dA).poly(dT) 
DNA tracts (e.g. at origins of DNA replication), thereby
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facilitating strand separation (Powell et al.,1981). The 
MDBP also has a distict role in gene regulation, since ts 
MDBP mutants overexpress gC, and functional MDBP is also 
involved in repression of the IE-3 and Vmwl55 genes 
(Godowski and Knipe, 19 83, 19 85, 1986). Genes required for 
viral DNA synthesis have also been identified by analysing 
the minimal fragments of the HSV genome necessary to support 
replication of plasmid vectors containing HSV origins in 
transient complementation assays (Challberg, 1986; Wu et 
al. , 19 88). Seven genes, based on predicted ORFs, were 
directly required for DNA replication. Two of these genes, 
encoding DNA polymerase and the MDBP, were already known to 
be essential for virus DNA replication by genetic analysis 
of mutants (Hay and Subak-Sharpe, 1976; Chartrand et al. , 
1979; Conley et al., 1981; Weller et a l . , 1983; Coen et al,., 
1984; Gibbs et al. , 1985 ). The others were (JL5, UL8, UL9, - 
UL42 and UL52. The product of gene UL42 is a DNA-binding 
protein (Marsden et al., 1987) and the polypeptide encoded 
by UL9 binds specifically at ori DNA sequences (Olivo et 
al. , 1988). In addition, there is evidence that (JL5 encodes 
a helicase (L. Zhu and S. Weller, 13th International 
Herpesvirus Workshop abstracts, Irvine 1988). By analogy 
with prokaryotic systems, the other gene products might be 
expected to include a primase, a topoisomerase and accessory 
factors which may increase the processivity or efficiency of 
DNA polymerase (Wu et al., 19 88).
1.5.12 DNA packaging and assembly of virions
Mature concatemeric DNA that has been replicated 
undergoes cleavage to produce unit length linear molecules 
which are then encapsidated into virus particles. Cleavage 
of DNA molecules occurs at the "a" sequence present at the 
termini of standard molecules (Davison and Wilkie, 1981; 
Mocarski and Roizman, 1982; Varmuza and Smiley, 1985;
Nasseri and Mocarski, 1988). Stow et al. (1983) showed that 
the "a" sequence is also responsible for encapsidation of 
viral DNA into particles since addition of this sequence to 
plasmids containing HSV origins allowed plasmid DNA to be 
packaged in HSV-1 infected cells. Cleavage of concatemeric 
DNA into unit length genomes is either a prerequisite for, or
occurs concomitantly with, packaging into capsids (Vlazny et 
al. , 1982). Analysis of an HSV mutant, tsil201, showed that 
packaging of DNA requires the processing of a structural 
polypeptide p4 0 (VP22a) to a form of lower electrophoretic 
mobility (VP22) (Preston et al., 1983). Unprocessed forms 
of p4 0 were associated with empty capsids, indicating that 
failure to package DNA was not due to a gross aberration in 
capsid structure (Preston et al., 1983). Another mutant, 
ts!204, which belongs to a different complementation group, 
was also unable to encapsidate DNA, indicating that other 
polypeptides are involved in the process (Addison et al. ,
1984).
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2. REGULATION OF IE GENE EXPRESSION
2 .1 CIS-ACTING REGULATORY SEQUENCES
Post et al. (1981) first demonstrated that 
cis-acting DNA sequences, present in the 5' flanking region 
of IE gene 3, determined the regulatory characteristics of 
IE gene expression. A hybrid gene was constructed that 
comprised the TK coding sequences linked to the promoter and 
upstream sequences of the HSV-1 IE-3 gene. This construct 
was introduced into viral DNA, and in the recombinant virus 
the gene exhibited IE kinetics and was expressed under 
conditions of a cyclohexiraide block/actinomycin release, a 
feature distinctive of IE genes. In addition, transcription 
from the plasmid construct when present in biochemically 
transformed cells was stimulated by superinfection with 
HSV-1 under "immediate early conditions", suggesting that IE 
gene expression was subject to "trans-induction" by a 
virus-encoded factor, later identified as the virion 
component Vmw65 (or transinducing factor, TIF) (Campbell et 
a l . , 1984; next section).
The level of transcription of all 5 IE genes is 
increased by TIF in transformed cells or in transient assays 
(Mackem and Roizman, 1982a,b,c; Cordingley et al ., 1983; 
Preston et al., 1984; Lang et al., 1984; O'Hare and Hayward, 
1985b). Deletion analysis of the promoter and upstream 
sequences of IE genes 4/5, linked to a TK reporter gene, 
revealed that there are essentially two distinct domains 
that confer transcriptional activity (Preston et al., 1984). 
Constitutive or basal levels of transcription were mediated 
efficiently by promoter sequences extending only 69bp 
upstream of the transcription start site. Induced levels 
(approximately 8-fold) of expression by TIF were achieved 
only when sequences extending to nucleotide —335 upstream
were present.
The consensus AT-rich sequence 5'-TAATGARAT-31 
(where R is a purine) which is present in one or more copies 
in either orientation upstream of all HSV-1 and HSV-2 IE 
genes appeared to be essential for stimulation, although 
flanking elememts modulated transcriptional activity 
(Preston et al., 1984; figure 4 and table 2). Additional
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studies of other IE gene upstream sequences revealed a 
similar organisation of promoter and regulatory elements 
(Mackem and Roizman, 1982a; Cordingley et a l ., 1983; Kristie 
and Roizman, 1984; Lang et al., 1984; Bzik and Preston,
19 86; O'Hare and Hayward, 19 87; figure 4 and table 2). A 
synthetic 20-mer oligonucleotide containing the TAATGARAT 
target sequence was sufficient to confer inducibility by 
Vmw65 when linked to a IE promoter/CAT gene construct in 
either orientation and in the absence of other IE 
far-upstream sequences (Gaffney et a l ., 1985). This effect 
was increased when multiple copies of the 20-mer were 
present. Bzik and Preston (19 86) also showed that a 
TAATGARAT element upstream of IE-3 essentially conferred 
inducibility in the absence of other sequences, and that 
flanking GA-rich tracts modulated activation by TIF. These 
GA-rich sequences (also present upstream of IE genes 2 and- 
4/5; figure 4 and table 2) were also capable of activating 
an otherwise non-functional homolgue of TAATGARAT. 
Triezenberg et al. (1988b) place more emphasis on the 
involvement of the GA-rich elements in the Vmw65 response, 
and suggest that induction can be mediated either by 
TAATGARAT or the GA-rich element. Gelman and Silverstein 
(1987b) observed that minimal IE promoters that lacked 
TAATGARAT elements were capable of TIF-mediated induction, 
but only when a high effector/target ratio was used, 
implying that an alternative, target-sequence independent 
mechanism of TIF augmented IE regulation might operate.
In addition to Vmw65 responsive regulatory signals, 
the upstream region of IE-3 and IE-4/5 contains a distinct 
enhancer-like cis-acting sequence (Lang et al., 1984;
Preston and Tannahill, 1984). In the absence of Vmw65, the 
enhancer can stimulate expression from linked promoters in 
an orientation independent manner and at a considerable 
distance from heterologous promoters (Lang et a l ., 1984; 
Preston and Tannahill, 1984). However, unlike classical 
enhancer elements, the HSV enhancer does not function when 
present downstream of a gene (Preston and Tannahill, 1984). 
Deletion analysis of the enhancer suggests that it is 
composed of 3 separate elements, each of which impart a 2 to 
3-fold effect (Bzik and Preston, 1986). Two of these

Fig. 4. Schematic representation of the distribution of 
promoter-regulatory elements in the upstream regions of IE 
genes. The location of four sequence motifs are displayed 
relative to the 5' end of the IE mRNAs (arrowed). The DNA 
sequence and orientation of the elements with respect to the 
IE genes is shown in table 2. The elements are the: TATA 
box, Spl binding site, AT-rich motifs (including "octamer" 
and TAATGARAT sequences) and GA-rich tracts. The nucleotide 
sequences of these promoters were taken from IE genes 1 
(Mackem and Roizman, 19 82b; Perry et al ., 19 86), 2 (Mackem 
and Roizman, 1982b; Whitton et a l ., 1983) 3 and 4/5 (Mackem 
and Roizman, 1982b; Murchie and McGeoch, 1982; McGeoch et
Table 2.
DNA sequence of regulatory elements upstream of IE genes
AT-rich
GA-rich
Spl sites
gene
IE 3
IE 4/5
position
IE 1
IE 2
a
b
c
d
e
f
g
h
IE 3 1
IE 4/5 2
IE 2 3
sequence
-TGCATAATGGAAT-31 
-GCGGTAATGAGAT-3' 
-ATGCTAACGAGGA-3 1
-GCGGTAATGAGAT-3 1 
-ATGCTAATTGCTT-3 1 
-ATGCTAATGAGTT
-ATGCTAATGGGGT- 3 '
- ATGCTAATGATAT- 3 1
-ATGCAAATTGGAA-3 ' 
-ATGAAAATCGGTC-3 ' 
-ATGCTAATTAAAT
• • • • •
-GCGGAACGGAAGCGGAAA-3' 
-GCCGAACCGGGAAG-5' 
-GCGGAAGCGGAAC-3'
-GGGCGG-3' or 
-CCCGCC-3'
* The lettered and numbered elements correspond to 
figure 4 which shows their approximate position upstream of 
the IE genes. The sequences underlined with dots are 
"octamer,,-like and those underlined with dashes are 
TAATGARAT-like.
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elements correspond to the hexanucleotide 5 1-GGGCGG-3' or 
its complement, which binds the cellular transcription 
factor Spl (Jones and Tjian, 1985). The third element 
contains the sequence 5'-GCGGAAAC-3', which shares homology 
with a domain in the SV40 enhancer that binds a factor GTIIA 
(Bzik and Preston, 1986; Xiao et al, 1987), and is similar 
to sequences in the adenovirus and polyoma virus enhancer 
motifs (Weiher et al., 1983; Hearing and Shenk, 1983; 
Herbommel et a l ., 19 84).
Recently the octamer element 5 '-ATGCAAAT-3', a 
regulatory signal common to many other eukaryotic promoters 
and enhancers (see sections 3.1 and 3.2), has been 
implicated in HSV IE gene regulation since a similarity 
exists between this consensus motif and sequences 
overlapping many TAATGARAT elements (Pruijn, 1986; O'Hare. 
and Goding, 1988; Gerster and Roeder, 1988; see section 
2.3). For example an element of the IE-1 gene has the 
sequence 5 1 -ATGCTAATGATAT-3 ' , matching the octamer consensus 
in seven out of eight residues. Workers studying other 
systems have shown that the octamer DNA element is bound by 
at least two cellular protein factors, OTF-1 or NFIII, and 
OTF-2. OTF-1 and OTF-2 are implicated in the regulation of 
human histone H 2 B and immunoglobulin heavy and light chains 
genes respectively (Harvey et a l ., 1982; Falkner et al., 
1986; Sive and Roeder, 1986; Scheidereit et al., 1987; see 
section 3.2). The interaction of cellular factors with 
TAATGARAT elements is disscussed in section 2.2. The 
upstream regulatory regions of IE genes are thus complex, 
modular structures that probably interact with cellular 
factors and Vmw65 with the effect of increasing the 
efficiency of IE mRNA production.
2.2 A TRANS-INDUCING IE GENE REGULATORY FACTOR (TIF)
In transformed cells that harbour a gene construct 
composed of the IE-3 promoter and upstream sequences linked 
to the TK gene, TK expression could be induced on infection 
with TK“ HSV-1, suggesting a role for a virally encoded IE 
transinducing factor (TIF) (Post et a l ., 1981).
Furthermore, TK mRNA synthesis was also induced by 
superinfection at the NPT with an HSV-1 mutant possesing a
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ts defect in Vmwl75 or with UV-inactivated virus, indicating 
that TIF was a protein component of the infecting virion 
(Post et a l ., 1981; Batterson and Roizman, 1983). The 
mutant tsB7, which is defective for capsid uncoating at the 
NPT, was also able to elicit the stimulatory response, 
showing that the TIF was located external to the 
nucleocapsid (Knipe et al. , 1981? Batterson et al, 1983).
The genomic identity of TIF was elucidated by cotransfection 
of cloned restriction fragments of HSV-1 DNA with an IE-TK 
Reporter plasmid (Campbell et al ., 1984). The gene was 
l\ocated and the polypeptide, Vmw65, identified by 
sUb-cloning and immunoprecipitation studies (Campbell et 
al., 1984).
Subsequently, a number of viruses were tested for 
their ability to transinduce HSV IE promoters. While HSV-2 
gave a positive response, PRV, HCMV and adenovirus type 2 ’
were ineffective (Batterson and Roizman, 1983; Campbell and 
Preston, 19 87). However, Vmw65 was able to stimulate 
expression from the PRV IE gene in cotransfection 
experiments, implying that PRV contains induction responsive 
sequences but no corresponding TIF (Campbell and Preston,
19 87). DNA sequence analysis of the upstream region of the 
PRV IE gene revealed the presence of two TAATGARAT-like 
motifs, presumed to mediate the Vmw65 response. In 
addition, the region contained 6 repeats of a 15bp element 
5'-GGCCAATGGGATTTY-3', which contains homology to the CCAAT 
box and also to the strong enhancer of HCMV 
(5 1 -C/ACTAACGGGACTTTCCAA-3 ' ) (Campbell and Preston, 1987; 
Boshart et a l ., 1985). A speculation made from these 
observations is that the PRV 15bp motifs may act as an 
enhancer (possibly including the interaction of 
CCAAT-binding factors) such that the requirement for TIF is 
overcome, and that the presence of TAATGARAT signals in HSV 
is predominantly to increase expression of IE genes that 
lack proximal enhancer elements (e.g. IE genes 1 and 2) 
(Campbell et al . , 1984). Results presented in this thesis 
are consistent with this idea.
The DNA and predicted amino acid sequences of Vmw65 
of HSV-1 have been determined (Dalrymple et al. , 1985?
Pellett et al. , 1985). Sequence homology analysis with
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Vtaw65 has identified a putative 45K TIF homologue in VZV, 
but it is not known if this polypeptide has transinducing 
activity. A distinctive feature of the VZV homologue is 
that it lacks the 80 carboxy-terminal amino acids of Vmw65, 
a highly acidic domain of the protein (Dalrymple et al . , 
1985; Davison and Scott, 1986). Recently it has been shown 
that this acidic region of Vmw65, in common with acidic 
domains of other eukaryotic and prokaryotic activator 
proteins, is important for transinducing activity 
(Triezenberg et al., 1988a; Sadowski et al. , 1988; see 
below). These observations, together with preliminary data 
from T.McKee (personal communication; section 7.1), suggests 
that the VZV homologue may not function as a TIF.
A study done concurrently with work presented in 
this thesis also investigated functional regions of Vmw65 by 
deletion mutagenesis (Triezenberg et al . , 1988a). Two 
functionally distinguishable domains of the polypeptide were 
identified. A domain localised within the carboxy 78 codons 
of the Vmw65 ORF, which is unusually high in acidic residues 
(with a net charge of -18), is critical to the transcription 
activation function. This "acid tail" of Vmw65 appears to 
be analogous to the activating domains of the yeast gene 
activator proteins GCN4 (Hope and Struhl, 1986) and GAL4 (Ma 
and Ptashne, 1987a), which are also markedly acidic, since 
hybrid GAL4-Vmw65 proteins in which the GAL4 acidic region 
is replaced by the carboxy-terminal 7 8 amino acids of Vmw65 
are potent activators of transcription (Sadowski et al ., 
1988; sections 3.2 and 3.3). A second domain of Vmw65, 
located upstream of the acid tail, was also important for 
transinduction. In the absence of the acid tail, the 
amino-terminal segment (approximately between amino acid 
positions 56 and 393) acts to dominantly and specifically 
interfere with the inducing activity of wt Vmw65 
polypeptides. Thus the amino terminal "interfering" domain 
of Vtnw65 may represent the region of the polypeptide 
responsible for tailoring the specificity of Vmw65 
interaction at TAATGARAT elements by association with 
specific cell factors (see next section). Triezenberg et 
a l . (1988a) propose that these truncated proteins retain a 
capacity to interact specifically with cellular DNA-binding
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proteins that mediate interaction with IE cis-regulatory 
sequences, thereby competing with wt Vmw65.
2.3 VMW65 ASSOCIATES WITH CELLULAR FACTORS AT TAATGARAT
ELEMENTS
Initial studies with Vmw65 demonstrated that it was 
not a DNA binding protein (Marsden et al., 1987). Thus it 
was speculated that TIF might mediate transinduction 
indirectly by interacting with cellular proteins, similar to 
mechanisms proposed for other transcription regulators that 
did not directly bind to DNA (e.g. adenovirus ElA).
However, an important difference between Vmw6 5-mediated 
transinduction and gene regulation by other non-DNA binding 
proteins is the requirement for a specific cis-acting target 
sequence (TAATGARAT) located upstream of the basal promoter 
sequences.
Using gel retardation assays and DNAase 1 footprint 
protection analysis, it was demonstrated that unidentified 
cellular factors from uninfected cells specifically bound at 
and/or immediately surrounding the TAATGARAT responsive 
element (Kristie and Roizman, 1987, 1988; Triezenberg, 
1988b). In addition, other workers noted the presence of a 
novel protein complex associating with TAATGARAT elements 
from infected cells or from uninfected cells that had in 
vitro synthesised Vmw65 or purified virion proteins added 
(McKnight et al., 1987; O'Hare and Goding, 1988; Preston et 
al., 1988). In band-shift assays using Vmw65-specific 
antibodies, Preston et a l . (1988) showed that this virus 
induced protein:DNA complex, called the immediate early 
complex (IEC), contained vmw65 and required cell factors for 
its formation. Analysis of mutant TAATGARAT templates 
revealed that the ability to form both the cellular 
protein:DNA complex and the virus induced protein:DNA 
complex was correlated with the induction response in 
transfection assays, suggesting that the two distinct 
complexes are both intermediates involved in transcription 
stimulation by Vmw65 (O'Hare and Goding, 1988; Preston et 
al., 1988). Results presented in this thesis confirm the 
importance of the virus induced complex (IEC) as an 
intermediate of transinduction and demonstrate directly that
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formation of this complex is mediated by Vmw65 (section 
6.3.6) .
It was implied that the cellular factor which binds 
to IE regulatory sequences may recognise a sequence 
homologous to the common eukaryotic octamer element 
5'-ATGCAAAT-3', located 5' to and overlapping the TAAT 
nucleotides of many HSV TAATGARAT sequences (table 2). In 
addition, the participation of the cellular factor was 
thought to be involved in transinduction since octamer 
elements conveyed inducibility when linked to reporter genes 
and competed with TAATGARAT sequences for formation of the 
cell protein:DNA complex (O'Hare and Goding, 19 88).
Recently the cellular factor required for the virus-induced 
complex was identified by Gerster and Roeder (19 88) as the 
octamer binding transcription factor OTFI or OCTI, which is 
probably identical to nuclear factor III (NFIII) (O'Neill 
et a l ., 1988). These workers showed that affinity purified 
OTFI was required to form a Vmw65-induced complex called VIC 
(presumably the same as IEC) at IE-1 regulatory elements 
containing the sequence ATGCTAATGATAT. In addition, they 
demonstrated that both the ATGC and GARAT tracts of 
nucleotides were required for VIC formation, and that 
additional cellular factors as well as Vmw65 and OTFI were 
necessary for complex formation. The TAATGARAT elements of 
IE genes 3 and 4/5 show no obvious homology to the octamer 
element 5' to the TAAT nucleotides (table 2), but Preston et 
a l . (19 88) demonstrated that the IE4/5 TAATGARAT motif is 
still able to form the IEC efficiently. Thus, although many 
aspects of IE target-sequence binding remain unresolved, the 
available evidence suggests that Vmw65 mediates 
transinduction by associating with cellular factors 
including OTFI and at least one other protein to form a 
novel transcription complex which recognises 
octamer/TAATGARAT target elements.
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3. REGULATION OF EUKARYOTIC GENES TRANSCRIBED BY RNA
POLYMERASE II
3.1 PROMOTERS, UPSTREAM ELEMENTS AND ENHANCERS
The principal method of identifying DNA sequence 
elements that control transcription in eukaryotes has been 
to mutagenise DNA sequences near the start of transcription 
and then to test the altered templates either by 
reintroduction into the cell or in some other experimental 
substitute such as in vitro transcription systems. More 
recently, proteins that bind specifically to regulatory DNA 
sequences have been identified and in some cases purified or 
cloned. The current challenge is to understand how specific 
protein:DNA intreactions regulate gene expression.
The cis-acting transcriptional control elements 
identified in eukaryotic genes include core promoters, 
upstream promoter elements (UPEs) and distal enhancer 
elements. The basic components of UPEs and enhancers share 
many properties and may facilitate transcription by a common 
mechanism (Maniatis et a l ., 1987). A typical promoter 
includes an AT-rich region designated the TATA box and one 
or more UPEs, such as the commonly found CCAAT or GGGCGG 
homolgies. The TATA box, regarded as the "core" of most 
promoters, is located between 25-30 bp upstream from the 
beginning of the transcribed sequence and functions 
primarily to ensure that transcripts are correctly and 
accurately initiated, and thus dictates the basal level of 
promoter activity (Nakajima et al., 1988). Upstream 
promoter elements either contribute to basal promoter 
activity by increasing the rate of transcription or mediate 
the action of regulatory factors (Dynan and Tjian, 19 85;
Serfling et al., 1985; Maniatis et al., 1987). The strength 
of promoters is determined by the number and type of UPEs, 
which act independently of orientation but not distance, 
with respect to the TATA box. Examples of other UPEs 
include heat-shock and metal responsive elements. Thus it 
is speculated that specific factors associating with UPEs 
interact with proteins bound at the core promoter by 
stereospecific alignment to facilitate a stimulation in
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transcription (Ptashne, 1988; Dynan and Tjian, 1985;
Maniatis et a l ., 1987; see section 3.3).
Enhancers also increase the rate of transcription 
from promoters but they differ from UPEs in that they can 
act at great distances and even when present downstream of 
transcription units. Enhancers function in either 
orientation and generally contain multiple discrete DNA 
sequence elements, including motifs classed as UPEs in other 
situations, which interact specifically with protein factors 
(Serfling et al., 1985). These characteristics are best 
illustrated by the SV4 0 enhancer which consists of two 
domains, A and B, each composed of multiple sub-regions 
(Zenke et al ., 1986; Fromental et al., 1988). The A and B 
domains alone have weak enhancer activity, but duplication 
of either region separately or in combination leads to a 
high level of activity (Zenke et al., 1986; Herr and Clarke,
1986). The synergistic effect of A and B is independent of 
their relative position or orientation. The sequence 
elements within the enhancer necessary for activity 
associate with specific and distinct DNA-binding protein 
factors which do not effect the binding of each other 
(Wildeman et al., 19 86). These sequence motifs are 
recognised by different proteins in different cell-types, 
and such cell-line dependent interactions are critical for 
enhancer function in the respective cell-types (Davidson et 
a l . , 1986; Nomiyama et al ., 1987). Thus different proteins 
that bind particular sites within a single enhancer 
stimulate transcription in a cell-type specific manner, and 
the complex organisation of viral enhancers may have evolved 
as a means of extending host range.
The organisation of enhancers and promoters that 
contain multiple UPEs is similar, and indeed some of the 
sequence elements of each are interchangeable. For 
instance, the octamer sequence element (51-ATGCAAAT-3') 
contained within the immunoglobulin enhancer is also found 
in a number of other promoters (Bohmann et al., 1987;
Parslow et al., 1987). The structural similarity between 
upstream elements and enhancers is reflected to a degree in 
functional relationship. For example, deletion of UPEs in 
the beta-globin promoter essentially abolishes transcription
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when the enhancer is present far upstream. However, if the 
enhancer is substituted for the deleted UPEs, proximal to 
the TATA box, transcription is restored (Treisman and 
Maniatis, 1985). Therefore the distinction between 
enhancers and promoter elements is somewhat arbitrary, and 
the distance-independent nature of enhancers may simply be 
due to the number of transcription factor recognition 
elements within them, rather than to a fundamental 
difference in their mechanism of operation. This idea is 
consistent with the observation that a single heat-shock UPE 
cannot act at a distance, but duplication of this motif 
gives rise to an element with all the properties of an 
enhancer (Bienz and Pelham, 1986). However, since 
duplication of CCAAT boxes far upstream of a promoter does 
not have the same effect, this point cannot be generalised 
(Bienz and Pelham, 19 86).
Generally, enhancers and UPEs function to regulate 
gene expression in a condition-dependent manner (Maniatis et 
al., 1987). For instance, inducible enhancers respond to 
environmental factors such as cell differentiation (Reichel 
et al., 1987; Velcich and Ziff, 1985; Hen et al., 1985), 
growth factors (Treisman, 1985), heat shock (Bienz and 
Pelham, 1986), viral infection (Goodbourn et al, 1985,1986), 
exposure to heavy metals (Serfling et al., 1985) and 
steroids (e.g. Renkawitz et al., 1984). In addition, such 
elements may only be active at specific times during 
development or the cell cycle, or only in specific tissues 
(Gerster et al., 1987; Maniatis et al., 1987).
3.2 PROPERTIES OF TRANSCRIPTION FACTORS
Purification studies have led to the identification
of factors that interact and activate transcrition through
A
specific DNA sequence elements common to many eukaryotic 
promoters. These proteins include the GGGCGG motif—binding 
factor Spl (Kadonaga et a l ., 19 86,19 87), the CCAAT 
box-binding factor CBF (Chodosh et al., 1988a,b) and the 
TATA box-binding factor TFIID (Sawadoga and Roeder, 1985b). 
Additional factors that are necessary and sufficient for 
transcription from core promoter elements and that appear to 
be generally required for TATA box-containing promoters have
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also been identified (Matsui et al., 1980; Sawadogo and 
Roeder; 1985a). TFIID has been shown to interact directly 
with the TATA and cap site region (Sawadogo and Roeder, 
1985b; Nakajima et a l ., 1988) while others (TFIIB, TFIIE and 
RNA polymerase II) appear to operate at later steps (Fire et 
al. , 1984; Reinberg and Roeder 1987; Reinberg et al., 1987). 
More recently, gene specific factors that operate through 
upstream elements have been purified and shown to function 
in vitro to stimulate transcription from the core promoter 
elements; these include factors that act constitutively, 
such as API (or jun) and USF (or MTLF) (Lee et al., 1987; 
Mermod et al ., 1988; Sawadogo et al ., 1988; van Dyke et al., 
1988), tissue specifically, such as OTFII (or OCT-2) and NF 
kappa B (Scheidereit et al ., 1987; Kawakami et al ., 1988) 
and inducibly, such as OTFI (or OCT-1) and Drosophila h e a t , 
shock factor (Fletcher et al., 1987; Wu et al 1987; 
Wiederrecht et a l ., 1987).
Cloning of genes that encode transacting factors 
has allowed functional analysis of the proteins themselves. 
In the case of the inducible steroid receptor transcription 
factor family, studies have led to the identification of 
highly homologous domains of proteins involved in 
DNA-binding, hormone/ligand-binding and stimulation of 
transcription (Miesfeld et al., 1986; Giguere et al , 1986; 
Kumar et al., 19 86; Godowski et al., 1987). The DNA binding 
domain has a cysteine-rich, zinc-binding "finger" region, a 
structural feature that has been found in many proteins with 
transcriptional regulatory function, most notably in the RNA 
polymerase III gene transcription factor TFIIIA (Miller et 
al., 1986; Berg, 1986; Harrison, 1986). The modular 
organisation of transcription factors is illustrated by 
experiments utilizing constructed hybrid polypeptides. For 
example, when the DNA-binding region of glucocorticoid 
receptor is introduced in place of the corresponding region 
in the progesterone receptor, the fusion protein still 
responds to progesterone but activates transcription from 
glucocorticoid DNA regulatory sequences (Green and Chambon,
1987). Thus the DNA-binding/transcriptional activation 
domain can be physically separated from the region 
responsible for steroid binding. However, chimaeric
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proteins consisting of the ligand-binding domain of either 
the oestrogen receptor (OR) or glucocorticoid receptor (GR) 
linked to the DNA-binding region of the yeast transcription 
factor GAL4 stimulate transcription from promoters 
containing the GAL4-binding sequence in response to hormone 
(Webster et a l . , 1988b). Since the GAL4 DNA-binding region 
alone binds to DNA without activating transcription, there 
must also be a transactivating function located within or 
near the OR and GR ligand-binding domains. Similar studies 
showed that chimaeras consisting of the bacterial LexA 
repressor DNA-binding domain and the rat GR hormone-binding 
domain were unable to stimulate transcription from promoters 
containing the LexA-binding site in CV-1 cells but were 
active in HeLa cells, suggesting the involvement of cellular 
factors (Godowski et al., 19 88). Thus the exact location of 
transactivating domains of steriod receptor molecules and 
their mechanism of action remains unresolved. However, 
hormone-binding appears to be involved in a number of steps 
which lead to "activation" of the DNA-binding domain of the 
steroid receptor (Godowski et a l ., 1987; Miesfeld et al., 
1987; Hollenberg et al., 1987). When the hormone-binding 
domain is deleted, constitutive activation of transcription 
ensues, suggesting that this region normally masks the DNA 
binding/transactivating region of the receptor in the 
absence of hormone. The presence of bound hormone may 
induce a conformational change in the protein that frees the 
DNA-binding or nuclear transfer domain and this process 
might mediate transactivation (Picard and Yamamoto, 1987).
In contrast to the glucocorticoid receptor, 
DNA-binding and transcriptional activation are separable in 
the yeast transcriptional regulatory proteins GAL4 (Brent 
and Ptashne, 1985) and GCN4 (Hope and Struhl, 1986). Thus 
the DNA-binding region of GAL4 can be replaced by that of 
the LexA repressor and the hybrid protein activates 
transcription from yeast genes bearing an upstream LexA 
operator binding-site (Brent and Ptashne, 1985), whereas 
DNA-binding domains on their own are capable of binding 
target sites but not of activating transcription (Keegan et 
al., 1986). Further studies led to the finding that the 
activating domains of yeast proteins GAL4 and GCN4 and the
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human jun (API) protein were functionally interchangeable 
(Struhl, 1987) and that the only similarity between these 
domains was a stretch of amino acids bearing a significant 
net negative charge. Mutational analysis revealed that 
simply the presence of acidic regions, which were not 
conserved at the amino acid sequence level, was required to 
provide activating function (Ma and Ptashne, 19 87b; Hope and 
Struhl, 1986; Hope et al, 1988). It was also apparent that 
the strength of the activating regions corresponds to the 
number of acidic residues present, as exemplified by the 
extremely acidic and highly efficient activating region of 
the HSV-1 transactivator, Vmw65 (Sadowski et al., 1988). In 
summary, the work on yeast transcription factors (reviewed 
by Ptashne, 1988) suggests the following generalisations:
(i) Activators are modular proteins whose activating regions 
are distinct and readily interchangeable. (ii) Although the 
DNA-binding regions are specific structures which interact 
with distinct regulatory sequences, the activating regions 
are less precisely defined domains characterised by an 
excess of acidic residues and perhaps an amphipathic alpha 
helix structure. (iii) Activators that work well in yeast 
also work in mammalian, plant and insect cells indicating a 
conserved mechanism of transcriptional activation (Fischer 
et a l . , 1988; Ma et al., 1988; Kakidani and Ptashne, 1988; 
Webster et a l ., 1988a). (iv) Activating regions can act 
synergistically and in either orientation to stimulate 
transcription (Kakidani and Ptashne, 1988; Webster et al., 
1988b; Lin et al., 1988). (v) Stronger activators work at
greater distances from the promoter (Sadowski et al., 1988).
Recently, the factor that recognises the common 
eukaryotic regulatory sequence 5'-ATGCAAAT-3', the "octamer" 
element, has been purified and cloned (Scheidereit et al., 
1987; Ko et al ., 1988). The octamer element is found 
upstream of a variety of genes including the Ig heavy and 
light chains (Parslow et al., 1984; Falkner and Zachau,
1984; Mason et al., 1985; Ballard and Bothwell, 1986), human 
histone 2B (Sive and Roeder, 1986) and Xenopus snRNAs 
(Mattaj et al . , 1985). This element is also present in the 
SV40 enhancer (Davidson et al . , 1986; Rosales et_al., 1987). 
Two species of transcription factor bind to the octamer
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element in vitro, 0CT1 and 0CT2. 0CT2 is present only in B 
cells and is probably responsible for tissue specific 
activation of Ig genes, whereas 0CT1 is produced in all 
cell-types and is likely to play a more ubiquitous role in 
gene activation (Singh et a l ,, 1986; Augereau and Chambon, 
1986; Mocikat et al .y 1986; Staudt et al., 1986; Schlokat et 
al., 1986; Sive and Roeder, 1986; Bohmann et al ., 1987; 
Fletcher et al., 1987; Pruijn et al. , 1987). Indeed, it has 
recently been shown that 0CT1, but not 0CT2, mediates 
induction of HSV-1 IE genes by associating with the virus 
factor Vmw65 (Gerster and Roeder, 19 88; section 2.3). Thus 
although 0CT1 and 0CT2 bind the same sequence, their protein 
functions do not correlate.
A situation similar to the interaction of 0CT1 and 
Vmw65 in HSV infection has been observed between the 
products of two nuclear proto-oncogenes c-fos and c-jun.
The polypeptide fos is capable of activating transcription 
in yeast cells (Lech et al., 1988), and can induce 
transcription from jun (also called API) responsive genes in 
mammalian cells (Chiu et al., 1988). The jun protein, which 
mediates induction of transcription by phorbol esters such 
as TPA, binds a specific upstream element (TRE) in 
responsive promoters and activates transcription (Lee et 
al. , 1987; Angel et al., 1987, 1988), while fos induces this 
level of expression by associating with jun at the 
regulatory sequence (Franza et a l . , 1988; Chiu et al., 1988; 
Sassone-Corsi et al., 19 88a). However, fos (like Vmw65) 
does not bind DNA directly itself but rather mediates its 
activity via protein:protein interaction (Chiu et al. ,
19 88). The fos-jun protein complex is thought to be 
stabilised by the interaction of a heptad repeat of leucine 
residues (the "leucine zipper") present in both 
polypeptides, and also in an array of other proteins 
(Landschulz et al ., 1988; Kouzarides and Ziff, 1988;
Sassone—Corsi et al., 1988b). Although this mechanism of 
transcriptional induction resembles that seen in HSV IE gene 
expression, jun does not function in a manner completely 
analogous to 0CT1 since, unlike TRE elements in jun 
responsive genes, the absence of octamer elements in IE 
promoters does not decrease the basal level of expression in
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transfection assays (Bzik and Preston, 1986).
The octamer-binding proteins contain conserved 
domains (called POU domains) that include regions which are 
homologous to the proposed DNA-binding homoeobox domains of 
Drosophila developmental regulatory transcription factors 
(Ko et al., 1988; Muller et al., 1988; Scheidereit et al .,
19 88). In addition, POU domains are found in a cell-type 
specific pituitary transcription factor (Pit-1) that also 
binds sequences with homology to the octamer element, and in 
the regulatory factor, unc-86, of the roundworm C. elegans 
(Bodner et a l ., 1988; Ingraham et al., 1988; Finney et al. , 
19 88). Therefore it is speculated that common conserved 
sequence elements upstream of many genes may differentially 
regulate expression by binding a family of different factors 
with common DNA-binding domains, whose availability is 
dependent on the cellular environment, cell-type or stage of 
cell cycle or development.
3.3 MECHANISM OF TRANSCRIPTION ACTIVATION
The activating regions of transcription factors 
such as the yeast regulatory proteins GAL4 and GCN4 
presumably interact with transcription components that are 
common to many organisms (Hope and Struhl, 19 86; Ma and 
Ptashne, 1987a,b; Fischer et al., 1988; Ma et a l ., 1988; 
Kakidani and Ptashne, 1988; Webster et al ., 1988a,b).
Obvious candidates for this interaction include RNA 
polymerase II (Sigler, 1988) and/or various accessory 
factors required for the formation of transcription 
initiation complexes. One of these factors, the TATA 
box-binding protein TFIID, is required for transcription in 
vitro (Sawadogo and Roeder, 1985a,b) and studies using 
partially purified proteins indicate that mammalian upstream 
element-binding transcription factors directly interact with 
TFIID. For example, when the factor ATF, which is involved 
in the regulation of multiple cellular cyclic-AMP induced 
and adenovirus EIA induced genes (Lin and Green, 1988), 
binds its recognition site upstream of a core promoter, it 
induces a conformational change of bound TFIID facilitating 
promoter recognition by RNA polymerase II and additional 
factors TFIIE and TFIIB (Horikoshi et al., 1988a). This
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ATF-induced preinitiation complex has an extended 
DNA-binding domain over the transcription start site and is 
correlated with stimulation of transcription (Horikoshi et 
al., 1988a; Hai et al.f 1988). Thus TFIID is a possible 
common target for the action of eukaryotic activators. 
Evidence for this view comes from experiments in which a 
GAL4 derivative activating protein was shown to alter the 
conformation of DNA-bound TFIID in a manner identical to 
mammalian transcription factors (Horikoshi et al., 1988b). 
The TATA-binding factor TFIID is interchangeable between 
yeast and mammals (Buratowski et al ., 1988; Cavallini et 
al., 19 88) and this observation could account for the 
ability of yeast activators to stimulate transcription of 
mammalian genes and vice-versa. Therefore it is speculated 
that the acidic activating regions of transcription factory 
bound upstream could interact with TFIID to promote the 
formation of a preinitiation complex at the core promoter 
with looping out of intervening DNA (Ptashne, 1986, 1988).
During studies on yeast (GAL4) and viral (Vmw65 of 
HSV-1) transcription factors, it was noticed that 
overproduction or high concentrations of activator protein 
caused repression of genes that lacked the activator 
recognition site while genes containing the relevant 
upstream elements were activated (Gill and Ptashne, 1988; 
Sadowski et al., 1988; Triezenberg et a l ., 1988a). This 
activity was not dependent on the presence of the 
DNA-binding domain (Gill and Ptashne, 1988). Ptashne (1988) 
suggests that this phenomenon, called "squelching", occurs 
when activator regions of transcription factors associate 
with the target protein (e.g. TFIID) off the DNA, thus 
limiting the pool of general transcription factors but 
favouring preinitiation complexes at promoters containing 
specific activator DNA-binding sites. Indeed, the strongest 
activators tended to be the most efficient squelchers (Gill 
and Ptashne, 1988; Triezenberg et al ., 1988a). The 
activating region of Vmw65 of HSV—1 is unusually potent when 
attached to a GAL4 DNA-binding domain (Sadowski et— al.,
1988) and in addition is very efficient at squelching (Gill 
and Ptashne, 1988). It is envisaged that potent activators 
such as Vmw65 may only be used profitably if expressed
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transiently as in a viral infection, since continuous 
expression of powerful cellular activators, and thus 
presumably powerful squelchers, would be harmful to cells 
(Sadowski et al., 1988). Ptashne (1988) speculates that 
cellular systems overcome the risk of squelching by 
harbouring multiple weak activators which, when bound to 
upstream DNA elements, efficiently cooperate to interact 
with bound core promoter transcription factors, but that 
none of them on their own are strong enough to squelch. 
This idea is consistent with observations that upstream 
regions and enhancers contain multiple and distinct 
protein-binding elements (Schaffner et al.,1988; Ondek et 
a l., 1988; Herr and Clarke, 1986; Davidson et al., 1988; 
Froraental et al., 1988).
:■ . . 3 - f -
I ~ V
KV
- ' - r - f
45
MATERIALS AND METHODS
4. MATERIALS
4.1 CHEMICALS
Chemicals were purchased from BDH Chemicals UK, 
Pharmacia Fine Chemicals, Koch-Light Laboratories and Sigma 
(London) Ltd. Solvents were obtained from James Burroughs 
UK Ltd and Koch-Light Laboratories.
4.2 RADIOCHEMICALS
Radiochemicals were obtained from NEN Dupont and 
Amersham International pic.
4.3 OLIGONUCLEOTIDES
Synthetic restriction enzyme linker 
oligonucleotides were obtained from New England Biolabs.
4.4 ENZ YMES
Restriction endonucleases, DNA modifying enzymes 
and enzyme buffers were obtained from Bethesda Research 
Laboratories, New England Biolabs., Nbl Enzymes Ltd, 
Boehringer Mannheim GmbH, and Promega Biotech.
4.5 CELLS
BHK-21 clone 13 cells (Macpherson and Stoker, 1962) 
were used throughout, unless specified otherwise. HFL, Vero 
and HeLa cells (Flow Laboratories) were used for virus 
titrations. HeLa cells were used for nuclear extracts.
4 . 6 TISSUE CULTURE MEDIUM
BHK cells were grown in Glasgow modified Eagle's
medium (GMEM [BusJby et al ., 1964]) supplied by Gibco Ltd, 
supplemented with 10% tryptose phosphate broth, 10% calf 
serum, 100 units/ml penicillin and lOOug/ml streptomycin 
(ETC1 Q ).
HFL cells were grown in GMEM supplemented with 10% 
foetal calf serum, 100 units/ml penicillin and lOOug/ml
streptomycin (EF^g).
Vero cells were grown in EF^q .
HeLa cells were grown in Dulbecco's modified 
Eagle*s medium (Gibco Ltd) supplemented as for EF^q .
The following modified tissue culture media were
Eagle*s medium containing 5% human serum. 
170mM NaCl, 3.4mM KCl, 2mM KH2P04 
(pH7.2).
PBSA plus C a C ^ . ^ O  and MgCl26.H20 both 
at lg/1.
0.6mM EDTA dissolved in PBSA containing 
0.0002% w/v phenol red.
0.25% w/v trypsin dissolved in 
tris-saline.
4.7 VIRUSES
HSV-1 viruses and HSV-1 mutants used or constructed 
in this study were all derived from Glasgow strain 17(syn+ ) 
(Brown et al., 19 73).
The HSV-2 mutant ts2203 was obtained from Dr V.G. 
Preston and was derived from strain HG52 (Timbury, 1971).
4.8 PLASMIDS
Plasmid pMCl (Campbell et al., 19 84) was obtained 
from E.M. Campbell. Plasmids pFTK, pTKl, pTKN7 and pS20TK 
were obtained from C.M.Preston. Plasmid pGEM2 (Promega 
Biotech) was obtained from J.McLauchlan. Plasmids pill 
(Everett, 1987) and pIE3CAT (Stow et al., 1986) were 
obtained from R.Everett.
4.9 BACTERIAL STRAINS
The bacterial strain used was DH-1 from E.coli K12
(Hanahan, 1983).
4.10 BACTERIAL CULTURE MEDIUM
also used:
EHU5
PBSA
PBS
Versene
Trypsin
L.Broth 10g/l NaCl, 10g/l Bactopeptone and 5g/l
L.Broth agar
yeast extract.
L.Broth plus 1.5% w/v agar.
4.11
TBE
E
EEB
SSC
Ampicillin, where appropriate, was added 
to L.broth or L.broth agar at 50ug/ml.
COMMONLY USED BUFFERS
90mM Tris; 90mM Boric acid, lmM EDTA 
(pH8.3).
36mM Tris, 30mM NaH2P04 , lmM EDTA 
(pH8.3).
40mM Tris HCl (pH8.5), 0.5inM sodium 
acetate, lmM EDTA.
150mM NaCl, 15mM trisodium citrate
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5. METHODS
5.1 CONSTRUCTION AND PREPARATION OF PLASMIDS
5.1.1 Restriction enzyme digests
DNA was digested in a final volume of between 10
and lOOul in buffer reaction conditions as specified by the 
manufacturers. The number of units of enzyme added was 
dependent on the activity of the enzyme and the amount of 
DNA present. Reaction mixtures were generally incubated at 
37°C for lh.
For the production of linear partial molecules, DNA 
(2ug) was digested with 2 units of enzyme in the presence of 
10 to 500ug/ml ethidium bromide to identify conditions that- 
produced a maximum of singly cut molecules.
5.1.2 Separation of DNA fragments by non-denaturing gel
electrophoresis
Agarose gels: 200ml horizontal slab gels (260mmxl60mmx5mm)
containing 0.5 to 1.5% (w/v) agarose were electrophoresed in 
E buffer plus 0.5ug/ml ethidium bromide, for approximately 
16h at 50V. Samples were loaded in 2% Ficoll, 20mM EDTA 
(pH7.5), E buffer and 20ug/ml bromophenol blue.
50ml "mini" agarose gels (100mmx70mmx7mm) were also 
used. These gels were electrophoresed in TBE at 4 0V for lh. 
Samples were loaded in 10% glycerol, lxTBE and 20ug/ml 
bromophenol blue. lug/ml ethidium bromide was added prior 
to visualisation of DNA by UV transillumination.
Polyacrylamide gels: Vertical non-denaturing polyacrylamide
ggls were used for resolving DNA fragment smaller than 
0.5kbp.
^ solution of 50ml containing 5 to 10% acrylamide 
(diluted from a stock of 29% acrylamide and 1%
N , N '-methylene-bisacrylamide) and 0.55xTBE was prepared and 
10% APS and 50ul TEMED added immediately prior to pouring 
into a prepared gel sandwich (2 6Ommxl6Ommxlmm). Acrylamide 
was allowed to polymerise and then samples were applied in 
5% glycerol, 0.5xTBE and 20ug/ml bromophenol blue.
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Electrophoresis was carried out in 0.55xTBE at 100-200V for 
3-4h. Bands were visualised by soaking the gel in lug/ml 
ethidium bromide prior to UV illumination, or when DNA bands 
were radiolabelled, by autoradiography of a dried gel.
5.1.3 Purification of DNA fragments from gels
Agarose gels; a slice of agarose containing the required DNA 
fragment was removed from the gel. The DNA was isolated 
from the agarose by electroelution in lxEEB at 20mA/sample 
for l-2h using wells designed for this purpose. The DNA was 
removed in 200ul EEB and was purified by phenol/chloroform 
extraction and precipitation with an equal volume of 
isopropanol at room temperature in the presence of carrier 
E.coli rRNA. Carrier was not added if the DNA was 
subsequently to be used in phosphatase, kinase or primer 
extention reactions.
Polyacrylamide gels: gel slices containing DNA fragments 
were cut into small pieces prior to incubation overnight in 
600ul of gel electroelution buffer (GEB)(0.5M sodium 
acetate, 0.1% w/v SDS, 2mM EDTA, 20mM Tris HCl (pH7.5)) at 
45°C. The sample was then centrifuged for 2min at 13,000rpm 
in a benchtop microfuge and the supernatant retained. The 
acrylamide pellet was incubated for a further 2h in GEB then 
centrifuged as before. Supernatants were pooled and 
filtered through Whatman GF/C paper in a 2ml syringe. The 
DNA was then precipitated by addition of 2 volumes of 
ethanol at -20°C for l-2h.
5.1.4 Ligation of DNA fragments
For ligation of vector sequences to DNA fragments, 
50ng of linearised vector and 200—500ng of purified fragment 
were incubated with 1 unit of T4 ligase in 20mM Tris HCl 
(pH7.6), lOmM MgCl2 , lOmM DTT and 0.6mM ATP in a 4ul
reaction at 15°c for 16h.
To prevent reannealing, the vector was treated with
calf intestinal phosphatase in the same conditions as 
restriction enzyme digestions. The sample was then 
phenol/chloroform extracted and precipitated prior to the
ligation reaction.
Staggered cut termini of DNA fragments were
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converted to blunt ends by treatment with T4 polymerase. 
Reactions contained 0.5 to l.Oug DNA, 33mM Tris HCl (pH7.8), 
66mM potassium acetate, lOmM magnesium acetate, lOOug/ml 
BSA, 200uM dCTP, dGTP, dATP and dTTP plus 4 units of T4 DNA 
polymerase and were incubated at 15°C for 3h.
Phosphorylated oligonucleotide linkers were 
inserted into plasmids by ligation with linear molecules 
using the same procedure as for vector/fragment ligations.
A 50-fold molar excess of linker over plasmid DNA was used. 
DNA ligase was inactivated by heating for 5 min at 60°C and 
the DNA was digested with linker restriction enzyme. Linear 
molecules were resolved by electrophoresis on a 1% agarose 
gel, eluted from the gel and religated.
5.1.5 Transformation of E.coli
10ml of L.Broth was inoculated with 5ul of glycerol 
stock of DH-1 and incubated at 3 7°C overnight. 1ml of this 
culture was added to 9 0ml of L.Broth and the mixture shaken 
at 37°C until the was 0*2 (normally for 2.5h). After
cooling on ice for 10 min, the culture was centrifuged at 
3,000rpm for 15min at 4°C in a Sorvall SS34 rotor.
Bacterial pellets were resuspended in a total of 25ml of ice 
cold lOOmM CaCl2 and incubated on ice for lh. This mixture 
was centrifuged as before and E.coli suspended in 1ml ice 
cold CaCl2 . A portion, usually lOOul, of CaCl^ shocked 
cells was added to 2ul ligation mix (section 5.1.4) and 
incubated on ice for lh. The mixture was then heated at 
42°C for 2min and added to 2ml of L.Broth. Cultures were 
agitated at 37°C for 9 0min and 200ul samples were spread on 
L.Broth agar plates containing ampicillin. Plates were 
incubated at 37°C overnight.
5.1.6 Analysis of transformed E. coli colonies 
Colonies were picked from agar plates into 2ml of
L.Broth and shaken at 37°C for 6h. Chloramphenicol was 
added to a final concentration of 25ug/ml and incubation 
continued overnight at 37°C. The following day the E^coli 
cells were pelleted at 5,000rpm for 5min in a benchtop 
microfuge and the pellet was resuspended in lOOul STET (8% 
w/v sucrose, 5% v/v Triton X100, 50mM EDTA, 50mM Tris HCl
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[pH8.0n containing lmg/ml lysozyme. Following incubation 
at 100 C for lmin the mixture was centrifuged at 13,000rpm 
in a benchtop microfuge for lOmin and the pellets discarded. 
The supernatant was precipitated with lOOul of isopropanol 
at -20 C for 30min. After centrifugation at 13,000rpm for 
5min in a benchtop microfuge the pellets were washed in 
ethanol, dried and resuspended in 30ul H^O.
The "mini-prep" DNA samples were generally assayed 
for the insertion of a fragment by screening for an increase 
in size compared to vector DNA. Further analysis was 
carried out by restriction endonuclease digestion of 
samples.
5.1.7 Large scale preparation of plasmid DNA
Large scale DNA preparations were carried out by 
the "hard lysis" procedure, an adaptation of the method of ‘ 
Guerry et al. (1973).
5ul of glycerol stock of bacteria containing the 
appropriate plasmid was added to 10ml of L. Broth plus 
antibiotic and incubated at 37°C overnight. 0.5ml of this 
stock was used to inoculate 200ml of L.Broth containing 
ampicillin and the culture was shaken at 37°C for 8h. 
Chloramphenicol was then added to a final concentration of 
25ug/ml and incubation continued overnight. The culture was 
centrifuged at 8,000rpm for lOmin in a Sorvall GSA rotor. 
After decanting the supernatant the pellet was suspended in 
5m 1 of 25% w/v sucrose, 50mM Tris (pH8.0), and 2.5ml of 
lOmg/ml freshly prepared lysozyme. The samples were mixed 
and retained on ice for 30min. 2ml of 250mM EDTA (pH7.5) 
was added and after a further 5min 1.5ml of 5M NaCl and 
1.5ml of 20% w/v SDS was mixed with the extract. Incubation 
on ice was continued for 2h and the preparations were 
centrifuged at 20,000rpm for lh at 4 C in a Sorvall SS34 
rotor. The supernatant containing the plasmid DNA was 
further purified by two extractions with phenol/chloroform, 
one with chloroform followed by precipitation in two volumes 
of ethanol at -20°C. DNA was pelleted by centrifugation at 
2,500rpm for 15min in a MSE coolspin centrifuge and 
dissolved in 10ml of TNE (20mM Tris (pH7.5), 100mM NaCl and 
lmM EDTA) plus lOug/ml RNAase. After incubation at 37 C for
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4h, approximately 2mg of proteinase K was added and samples 
maintained at 3 7°C overnight. The proteinase K was removed 
by two phenol/chloroform extractions plus a chloroform 
extraction. Sodium acetate (pH7.0) was added to a 
concentration of 0.3M and DNA was precipitated by addition 
of 0.5 volumes of isopropanol at room temperature for 2h. 
After centrifugation at 5,000rpm for 15min at 20°C in a MSE 
coolspin centrifuge the pellet was washed with ethanol, 
dried and dissolved in 300ul H20.
5.1.8 Estimation of DNA concentration
A series of dilutions of plasmid DNA, linearised 
with appropriate restriction enzyme, was prepared. The 
samples were electrophoresed beside DNA of known 
concentration and photographed on Polaroid 665 film under UV 
illumination. Concentration of DNA was estimated from 
densitometric traces on a negative film.
5.2 FUNCTIONAL ANALYSIS OF PLASMIDS
5.2.1 Transfection of plasmid DNA into cells
Plasmid DNA was transfected into BHK cells using 
the calcium phosphate precipitation technique, a 
modification of the method of Shen et al., (1982).
Cocktails were prepared containing plasmid DNAs 
plus carrier to a total of 3ug, 66ul of 2xHeBS (260mM NaCl,
9. 8mM KC1, 1.6mM Na2HP04 , llmM D-glucose, 42mM HEPES 
(pH7.05) and deionised water to 132ul. 9ul of 2M CaCl2 was 
added and samples immediately vortexed for 0.5min. The 
tubes were allowed to stand at room temperature for lOmin. 
The medium was then removed from 80% confluent cell 
monolayers grown in 35mm Petri dishes and they were overlaid 
with the calcium phosphate precipitate and incubated at 37 C
for 30min, with intermittant rocking.
2ml of ETC1q medium was added to each monolayer and
the incubation continued for a further l-3h at 37 C. The
medium was then removed from the cells and 25% v/v dimethyl
sulphoxide in lx HeBS was applied for 4min at room 
temperature (Stow and Wilkie, 1976). The dimethyl 
sulphoxide was removed and cells were washed twice with
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ETC10' a ^urtller 2ml of ETC was added and monolayers were 
incubated at either 31°C, 378C or 38.5°C as appropriate. 
Infection with virus, when required, was performed after lh. 
Incubation was then continued for 3 to 4Oh as appropriate.
5.2.2 Preparation of cell extracts
TK assays: medium was removed from the cell monolayers which 
were then washed with ice cold PBS. 1ml of fresh PBS was 
added and cells were scraped into this medium. Cell 
suspensions were transferred to 1.5ml reaction tubes and 
centrifuged at 5,000rpm for lmin in a benchtop microfuge.
The supernatant was carefully removed and cells were 
resuspended in lOOul ice cold TK lysis buffer (20mM Tris HCl 
(pH7.5), 2mM MgCl2 , lOmM NaCl, 6.5mM beta mercaptoethanol, 
0.5% v/v NP4 0) by vortexing and the tubes placed on ice for- 
5min. Samples were centrifuged at 13,000rpm for 2min in a ’ 
benchtop microfuge and then the supernatant transferred to 
fresh tubes and maintained on ice or stored at -70°C.
For CAT assays: medium was removed and the monolayers were 
washed in PBS as above. The cells were scraped in 1ml of 
ice cold TEN (lOOmM NaCl, 50mM Tris HCl (pH7.5), lOmM EDTA) 
and transferred to 15ml Falcon tubes. The cells were 
centrifuged at 2,000rpm for lmin in a MSE coolspin 
centrifuge and resuspended in 75ul 0.2M Tris HCl (pH7.5).
The cells were lysed by sonication, transferred to 1.5ml 
vials and centrifuged at 13,000rpm for 2min in a benchtop 
microfuge to remove debris. The cell extract supernatants 
were stored at -20°C.
5.2.3 Estimation of protein concentration 
Estimation of protein concentration was performed
using the method of Bradford (1976). lOul of protein 
sample/cell extract was diluted in 9 0ul of H20 and mixed 
with 1ml Bradford reagent (0.01% Coomassie brilliant blue G, 
0.0003% SDS, 4.75% v/v ethanol, 8.5% v/v phosphoric acid) 
and left at RT for lOmin. The absorbance of the solution 
was measured at 59 5nm and converted to milligrams of protein 
by comparison to a standard curve produced by using known 
quantities of BSA made up in H2q or 0.2M Tris HCl (pH7.5).
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5.2.4 TK assays of transfected cells
Samples of cell extract (lOul) were assayed for TK 
activity in a reaction mix containing lOOmM sodium phosphate 
(pH6.0), lOmM MgCl2 , lOOuM dTTP, 5mM ATP and lOOuCi/ml 
[ H]-thymidine (47 Ci/mmol) in a 50ul volume at 30°C for 2h. 
The reaction was terminated by the addition of thymidine to 
33uM and tubes were heated at 9 0°C for 4min. They were 
cooled on ice for 5min and centrifuged at 13,000rpm for 2min 
in a benchtop microfuge. 50ul of the supernatant was 
spotted onto a DE81 filter paper disc. The discs were 
washed three times in 4mM ammonium formate (pH4.0), lOmM 
thymidine at 37°C and twice in absolute alcohol. Discs were 
then dried under a heat lamp and placed in vials containing 
5ml of scintillation fluid. Conversion of [ Hj-thymidine to 
nucleotides was determined by scintillation counting.
5.2.5 CAT assays of transfected cells
CAT assays were performed using the method of 
Gorman (1982). Assay mixtures containing 25ul of cell 
extract (section 5.2.2), lul 50mM acetyl co-enzyme A, 14ul 
H20 and 0.5ul [14C]-chloramphenicol (45uCi/mmol), were 
incubated at 37° for lh. The reaction was stopped by 
extracting chloramphenicol and acetylated products in 200ul 
ethyl acetate. The ethyl acetate was evaporated under 
vacuum, and the pellets were then dissolved in a smaller 
volume (20ul) of ethyl acetate before spotting onto thin 
layer chromotography (TLC) plates. After running in 9 5% v/v 
chloroform / 5% v/v methanol, plates were air dried and 
autoradiographed. The amount of radioactivity in the 
chloramphenicol and its 3 1-monoacetylated product was 
determined by scintillation counting, enabling the 
percentage conversion of substrate to product to be 
calculated. The amount of radioactivity in 1'-acetylated 
chloramphenicol was not significant.
5.2.6 Marker rescue analysts
Marker rescue was carried out as described by Stow 
et al., (1978). plasmid and virus DNA were co-transfected 
into cells and the cells incubated as described in section 
5.3.2. Infected cells were scraped into growth medium,
disrupted by sonication, and virus yield at both the PT and 
the NPT determined by titration.
5.2.7 In vitro transcription and translation of plasmids
Plasmids were digested with an endonuclease
restriction enzyme to produce linear molecules that were 
cleaved 3' to the coding sequence. In vitro transcription 
was performed using the Riboprobe system (Promega Biotech) 
following the manufacturer's protocol. lug of linear DNA 
was mixed at RT with 5ul SP6 buffer (200mM Tris HCl (pH7.5), 
30mM MgCl2 , lOmM spermidine), 0.01% BSA, lOmM DTT, 0.4mM 
ATP, OTP, CTP, GTP, 0.5mM G(5 ' )ppp( 3' ) , 40 units RNAasein 
(Promega Biotech) and 10 units T7 RNA polymerase in a total 
volume of 25ul. The reaction mixtures were incubated at 
37°C for lh.
In vitro translation was carried out by addition of
2.5ul of transcription reaction mixture to 20ul of rabbit
reticulocyte lysate (Amersham). Duplicate samples were
incubated for 9 0min at 30°C either in the presence or in the
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absence of 25 to 50uCi [ S]-methionine (>800Ci/mol) in a 
25ul reaction mixture. Non-radioactive samples were stored 
at -70°C for use in gel retardation assays. The 
radiolabelled translation mixture was treated with 200ug/ml 
RNAase for 15min at 3 0°C and then processed for SDS-PAGE as 
described in section 5.2.10.
5.2.8 3'-end labelling of probes
lOug of plasmid DNA was digested with restriction 
enzyme. Following phenol/chloroform extraction and ethanol 
precipitation, the DNA fragments were labelled in T4 
polymerase buffer (33mM Tris acetate (pH7.9), 66mM sodium 
acetate, lOmM magnesium acetate) containing lOmM DTT, 0.1% 
BSA, 0.5mCi/ml alpha-[32P]-dATP, 0.5mCi/ml alpha-[32P]-dTTP, 
lOOuM dGTP, lOOuM dCTP and 1 unit of T4 polymerase in a 
total volume of 20ul at 37°C for lh. The radiolabelled 
fragments were separated in a non-denaturing polyacrylamide 
gel (section 5.1.2) and the appropriate band was identified 
by autoradiography, isolated and purified (section 5.1.3).
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5.2.9 Gel retardation assay with proteins synthesised in 
vitro
Formation and analysis of protein-DNA complexes was
performed as described by Preston et al (19 88). DNA
fragments were end-labelled with 32P (section 5.2.8) and
purified from a polyacrylamide gel (section 5.1.3).
Reaction mixtures contained the following components: lOmM
HEPES (pH7.9 ), 0.6mM dithiothreitol, 2.3mM MgCl2 , 85mM NaCl,
O.lmg/ml BSA, 4ug poly dl. poly dC., approximately 0.2ng 
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P-3' end labelled fragment, 5.0ug mock infected HeLa cell 
nuclear extract (section 5.2.11) and 5ul reticulocyte lysate 
which had been incubated with in vitro synthesised Vmw65 
mRNA (section 5.2.7) or 0.3-1.0ug of virion extract that 
contained Vtnw65 (section 5^4.5). Incubation was at 25°C for 
30 min, and reaction mixtures were analysed by 
non-denaturing PAGE on a 3.5% polyacrylamide gel (section
5.1.2). After electrophoresis for 3.5h at 160V, the gel was 
dried and exposed for autoradiography.
5.2.10 SDS polyacrylamide gel electrophoresis 
40ml of gel mix was prepared containing the
required amount of 30% acrylamide / 3% DATD to give a final 
concentration of between 8% and 10% acrylamide in lxGB (4xGB 
= 1.5M Tris HCl (pH8.9), 0.4% SDS). Polymerisation was 
initiated by the addition of 0.5ml 10% w/v APS and 40ul 
TEMED, and the mixture was poured into a vertical gel mould 
(17Ommxl3Ommxl.5mm). While still liquid the acrylamide was 
overlaid with 2ml 0.25xGB and allowed to polymerise for 
30min.
24ml stacking gel solution was prepared, containing 
5% acrylamide , 0.5% DATD, lxSGB (4xSGB = 0.5% Tris HCl 
(pH6.7) , 0.4% SDS), 0.5ml of 10% APS and 35ul of TEMED. The 
buffer was removed from the surface of the running gel and 
after washing, the mould was filled with the stacking gel 
solution and a suitable teflon comb was inserted.
Samples were prepared by boiling for 5min in a 
denaturing buffer of final concentration 50mM Tris HCl 
(pH6.7), 2% SDS, 10% glycerol, 5% beta mercaptoethanol.
Gels were electrophoresed for 3-4h in a buffer containing 
50mM Tris, 65mM glycine and 0.1% SDS and fixed by soaking
57
overnight in 25% methanol, 6% acetic acid. Gels containing 
low levels of radioactivity were shaken for lh in EN^HANCE, 
followed by lh in H20 prior to being dried. Autoradiographs 
were made using Xomat-S film (Kodak).
5.2.11 Nuclear extracts
HeLa cell nuclear extracts were prepared from 
monolayer cultures using a modification of the method of 
Dignam et al . (1981). Cells were scraped from 90mm diameter 
Petri-dishes and centrifuged at 2000rpm in a Sorvall SS34 
rotor for 5min at 4°C. Cell lysis was performed by 
resuspending the cell pellet in 2 packed volumes of Buffer A 
(lOmM HEPES pH7.9, 1.5mM MgCl2, lOmM KC1, 0.5mM DTT and 
0.5mM phenylmethylsulphonyl fluoride [PMSF]) containing 0.5% 
NP40, with intermittant mixing at 4°C for lOmin. Nuclei 
were pelleted by centrifugation at 15000rpm in a Sorvall 
SS34 rotor for 15min at 2°C. The supernatant was carefully 
discarded and the nuclei lysed by resuspending the pellet in 
3ml per 10^ cells of Buffer C (20mM HEPES pH7.9, 25% v/v 
glycerol, 0.42M NaCl, 1.5mM MgCl2 , 0.2mM EDTA, 0.5mM PMSF 
and 0.5mM DTT), with intermittant mixing at 4°C for 30min. 
The suspension was centrifuged at 15000rpm in a Sorvall SS34 
rotor for 15min at 2°C and the supernatant (nuclear extract) 
collected and stored in small samples at -70°C.
5.3 CONSTRUCTION AND PREPARATION OF VIRUSES
5.3.1 Tissue culture
BHK cells were grown in 800ml plastic culture
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flasks from a seed stock of approximately 1x10 cells at 
37°C in 50ml of ETC1Q and an atmosphere of 5% C02 and 9 5% 
air. Two days later confluent monolayers were harvested in 
2ml trypsin/versene (1:1 v/v), 5ml of fresh ETC^q was added 
and cells were resuspended by pipetting. This suspension 
was used to seed subsequent monolayers.
5.3.2 C o - transfect ion of virus DNA and plasmid DNA— into
cells
0.5ug of virus DNA and 0.5ug of linearised plasmid 
DNA (cleaved within the vector sequence) was transfected
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into cells as described in section 5.2.1, except that 2.0ug 
of calf thymus DNA was used as carrier and precipitates were 
gently mixed upon addition of CaCl2 and not vortexed. 
Transfected monolayers were incubated in ETC1Q at 31°C for 3 
days and virus progeny were harvested by scraping the 
infected cells into the growth medium. The medium was 
transferred to a 5ml glass vial, cells disrupted by 
sonication and the sonicate stored at -70°C.
5.3.3 Isolation of virus plaques
Virus was titrated on cell monolayers at dilutions 
calculated to give rise to approximately two plaques per 
Petri dish. The monolayers were incubated for 3 days in 
EHUjj at 31°C. The medium was removed, the cells washed 
twice with 2ml PBS and then 0.5ml of PBS was applied to the. 
monolayers. Single plaques were scraped up in approximately 
20ul PBS using a micropipette, transferred to 500ul ETC^q , 
sonicated and stored at -70°C.
5.3.4 Small-scale preparation of virus-infected cell DNA 
200ul of virus plaque stocks was used to infect
cells in multi-well plates containing 15mm diameter wells. 
The cells were incubated in ETC^q at 37°C for 2-3 days, or 
until a cytopathic effect was observed. The medium was then 
removed and stored at -70°C as a viral stock. 0.2ml of CLB 
(0.5% SDS, 20mM Tris HCl (pH7.5), 2mM EDTA) containing 
0.25mg/ml proteinase K was added to the cells and incubation 
was continued for 3h at 3 7°C. The glutinous cell extract 
was then transferred to a 1.5ml vial and NaCl was added to a 
final concentration of 0.3M. DNA was extracted once with 
phenol pH8.0 (saturated with 0.5M Tris HCl (pH7.5) and 50mM 
EDTA) and once with chloroform, precipitated in two volumes 
of ethanol, dried and dissolved in 50ul H20.
5.3.5 Southern blot analysis of virus DNA
5.3.5.1 Internal labelling of probes by nick translation
DNA was labelled with 32P as described by Rigby et 
al., (19 77). l.Oug of plasmid DNA was incubated in a 
reaction mix containing 40mM dATP, 40mM dTTP, 2.5ul of
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lOxNTB (5M Tris HCl <pH7.5), 1M MgCl2 , 1M DTT and 5mg/ml 
BSA) and 2x10 ug DNAase at RT for 3min. The mix was placed 
on ice and diluted to 25ul by the addition of 30uCi of both 
alpha-[32P]-dCTP and alpha-[ 32P)-dGTP, 3 units of E.coli DNA 
polymerase I plus distilled water. The reaction was
incubated at 15°C for lh. 32P labelled DNA was then
separated from unincorporated triphosphates by 
centrifugation (2000rpm in a MSE coolspin centrifuge, 4min) 
through a 1ml Sephadex (fine) G50 column that had been 
tightly packed by centrifugation (2000rpm in a MSE coolspin 
centrifuge, 4min) in a 1ml plastic syringe.
5.3.5.2 Transfer of DNA to nitrocellulose
The method used was essentially that of Southern 
(1975). The agarose gel to be blotted was shaken for 45min_ 
in Gel Soak I (200mM NaOH, 600mM NaCl), then for a further . 
45min in Gel Soak II (1M Tris HCl (pH8.0), 0.6M NaCl) at 
room temperature. The gel was then transferred to two 
sheets of Whatman 3MM filter paper, supported by a glass 
plate. The edges of the filter paper were dipping into a 
tray containing 6xSSC. A sheet of nitrocellulose, the same 
dimensions as the gel, was placed on top covered by two 
sheets of 3MM paper and a stack of paper towels, also cut to 
size. The towels were weighted and the blot left overnight 
in order for the DNA to transfer to the nitrocellulose. The 
following day the nitrocellulose was removed and allowed to 
dry in air and baked at 80°C for 2h.
5.3.5.3 DNA/DNA hybridisation
Hybridisations were carried out under conditions of 
high stringency by the method of Southern (19 75). The 
nitrocellulose containing separated DNA fragments was 
prehybridised in 100ml 6xSSC, 5xDenhardts (0.5% w/v Ficoll, 
0.5% w/v polyvinylpyrollidone, 0.1% w/v SDS, 0.5% w/v BSA) 
and 20ug/ml denatured calf thymus DNA at 65 C for 2h in a 
sealed polythene bag. Meanwhile the probe was denatured by 
incubation in 0.2M NaOH for lOmin at RT, followed by 
neutralisation by the addition of 0.2M HCl.
The pre-hybridisation mixture was removed and 
replaced with the denatured probe in a mix of same final
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composition as the pre-hybridisation solution. The 
nitrocellulose filter was shaken overnight at 65°C then 
washed in lOxDenhardts, 4xSSC for 30min at RT, followed by 
three washes in 0.3xSSC, 0.1% SDS at 65°C. It was air dried 
and autoradiographed.
5.3.6 Large-scale preparation of virus stocks 
Confluent BHK monolayers in 850cm2 roller bottles
were infected with 0.003 pfu virus per cell in 50ml ETC10. 
After incubation at 31°C for 3-4 days, when extensive cpe 
had developed, cells were shaked into the medium and the 
cell debris pelleted out by low speed centrifugation 
(l,500rpm in a Sorvall GSA rotor, 15min). Cell-released 
virus in the supernatant was concentrated by centrifugation 
at 12,000 rpm for 2h at 4°C in a Sorvall GSA rotor. The 
virus pellet was resuspended in 10ml ETC^q , sonicated and • 
stored at -70°C in small samples.
5.3.7 Large-scale preparation of virus DNA
Virus infected cells showing extensive cpe (from 5
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850cm roller bottles), were harvested into the medium, 
pelleted by low speed centrifugation and the supernatant 
retained. Cell released virions were pelleted by 
centrifugation (12,000rpm for 2h in a Sorvall GSA rotor), 
resuspended in 20mM Tris HCl (pH7.5), lOOmM NaCl, 2mM EDTA, 
0.2 %SDS containing 0.25mg/ml proteinase K and incubated 
with gentle agitation at 37°C overnight. DNA was extracted 
three times with phenol/chloroform and once with chloroform, 
precipitated in 2 volumes of ethanol, dried and dissolved in 
0.4ml H20.
5.4 ANALYSIS OF VIRUSES
5.4.1 Titration of virus stocks
Serial tenfold dilutions of stock virus were made 
in eTC^q. The medium was removed from confluent cell 
monolayers, and 200ul of diluted virus was added to to each 
dish. Following virus adsorption for 60min at 37 C, cells 
were overlaid with EHU5 to prevent the spread of released 
virus. After incubation at either 38.5°C or 31 C for 3
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days, the medium was removed from the dishes and the cells 
stained with Giemsa for lOmin at RT. The monolayers were 
washed with water to remove the stain, and virus plaques 
were counted under a dissecting microscope.
5.4.2 Virus particle counts
Particle counts were determined by electron 
microscopy, kindly performed by Mr. J. Aitken.
5.4.3 Virus adsorption assay
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5.4.3.1 Preparation of [—H]-thymidine-labelled virus
Cell monolayers in 9 0mm Petri dishes were infected 
with 3 pfu/cell and incubated in ETC^q at 37°C for 5h.
[^H]-thymidine was added to the dishes to a final 
concentration of 20uCi/ml and incubation was continued 
overnight or until extensive cpe was observed. The medium, 
containing cell-released virus, was collected and cell 
debris was pelleted out by low speed centrifugation. The 
virus was pelleted from the supernatant by centrifugation 
through a 10% sucrose / 10% PBS cushion at 12,000rpm for 2h 
in a Sorvall SS34 rotor. The supernatant was discarded, the 
pellet washed twice in ETC^q and resuspended in 0.5ml ETC-^q 
by sonication. The number of cpm/ml was determined by TCA 
washing and scintillation counting (section 5.4.10) and the 
number of virus particles/ml was determined by electron 
microscopy.
5.4.3.2 Estimation of virion adsorption rate 
[3H]-thymidine-labelled virus was adsorbed to cell
monolayers in 30mm plates using a moi of 100 particles/cell, 
for 0, 2 and 4h at 37°C. Cells were washed twice with H2<3 
and harvested at the appropriate time by scraping into 0.5ml 
of H20. The cells were transferred to conical tubes and 
incubated on ice for 30min in 5% TCA. The samples were 
filtered through 25mm diameter GF/C discs, the discs were 
TCA washed (section 5.4.10), the amount of radioactivity 
retained on the discs determined by scintillation counting 
and the percentage adsorption calculated.
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5.4.4 Quantitation of viral DNA in nuclei
Cell monolayers in 9 0mm Petri dishes were infected 
with 100 particles of virus/cell in ETC^q containing 
200ug/ml cycloheximide. The dishes were incubated at 38.5°C 
for 3h before cells were harvested. Cell extracts were made 
as described in section 5.2.2 for TK extracts, except that 
the cytoplasm (supernatant) was discarded and the nuclei 
(pellet) was retained. The nuclei were centrifuged through 
a 10% w/v sucrose / 10% PBS cushion and then lysed in 50mM 
Tris HCl (pH7.8), lOmM EDTA, lOOmM NaCl and 0.4% SDS 
containing 200ug/ml proteinase K. DNA was extracted twice 
with phenol/chloroform and once with chloroform, 
precipitated in 2 volumes of ethanol, dried and dissolved in 
lOOul H^O. The amount of virus DNA present was determined 
by endonuclease restriction enzyme digestion, agarose gel 
electrophoresis (section 5.1.2) followed by Southern blot 
analysis (section 5.3.5).
5.4.5 Extraction of virion proteins for gel retardation
assays
1 x 1 0 ^  cell released virus particles (prepared as 
described in section 5.3.7) were concentrated by 
centrifugation at 25,000xg for 2h, resuspended in PBS/0.5% 
calf serum, and centrifuged through a cushion of 10% w/v 
sucrose in 10% PBS at 25,000xg for 2h. The pellet was 
resuspended in lOmM Tris HCl, 50mM NaCl, ImM EDTA (pH7.5), 
NP40 added to a final concentration of 0.03%, and the 
samples kept on ice for lh. The extract was centrifuged at 
50,OOOxg for lh and the supernatant stored at -70 C.
Before the samples were analysed in gel retardation 
assays (section 5.2.9) protein level comparisons were made 
by SDS-PAGE and coomassie brilliant blue staining (section 
5.2.10) .
5.4.6 Virus transinduction assay
Cell monolayers in 35mm Petri dishes were 
transfected with 3ug of plasmid as described in section 
5.2.1, except that the DMSO boost was performed lh after the 
medium overlay. The cells were incubated at 38.5 C for a 
further lh and then superinfected with 1000 particles/cell.
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After adsorption for lh, ETC^q was added and incubation was 
continued for 3h. Cytoplasmic extracts were made (section
5.2.2) and CAT assays performed (section 5.2.5).
5.4.7 Dot blot analysis of virus mRNA
5.4.7.1 Preparation of cytoplasmic RNA
Cells in 35mm Petri dishes were infected with 1000 
particles of virus/cell in the presence of 200ug/ml 
cycloheximide. After adsorption for lh at 38.5°C, ETC1Q 
containing 200ug/ml cycloheximide was added and the 
incubation continued for 4h. Cytoplasmic RNA was extracted 
using the method of White and Bancroft, (19 82). Medium was 
removed from the dishes, the cells washed with PBS and 
scraped into 1ml PBS. The cells were transferred to a 1ml - 
vial and pelleted by low speed centrifugation. The cells 
were resuspended in ice cold TE (lOmM Tris HCl (pH7.0), ImM 
EDTA) containing 0.5% v/v NP40 and incubated on ice for 
5min. The samples were centrifuged at 12,000rpm for 2min in 
a benchtop microfuge and the supernatant retained. The 
extracts were denatured by incubation at 60°C for 15min in 
6xSSC and 20% v/v formaldehyde and stored at -70°C.
5.4.7.2 Transfer of RNA to nitrocellulose
A nitrocellulose filter was washed in H20 and then 
20xSSC and placed on a Hybridot multi-well vacuum aparatus. 
RNA dilutions were made in 20xSSC and applied to 
nitrocellulose under suction. The filter was air dried and 
then baked at 80°C for 2h.
5.4.7.3 DNA/RNA hybridisation
Hybridisations were carried out using the method of 
White and Bancroft (1982). The nitrocellulose containing 
bound, denatured RNA was prehybridised in 50% formamide, 
5XSSPE (lOOmM NaCl, 50mM NaH2PC>4 (pH7.4), 20mM EDTA 
(pH7.4) ), 5xDenhardts solution (0.5% w/v Ficoll, 0.5% w/v 
polyvinylpyrollidone, 0.1% SDS, 0.5% w/v BSA) and lOOug/ml 
denatured calf thymus DNA at 4 2 C for 2h in a sealed 
polythene bag. Meanwhile the probe was denatured by 
incubation in 0.2M NaOH for lOmin at RT, followed by
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neutralisation by the addition of 0.2M HCl.
The prehybridisation mixture was removed and 
replaced with the denatured probe in a mix of the same final 
composition as the pre-hybridisation solution (except using 
lxDenhardts). The nitrocellulose was shaken overnight at 
42°C and then washed twice in 2xSSC/0.1% SDS and twice in 
0.1xSSC/0.1% SDS at RT for 15min each time. It was then air 
dried and autoradiographed.
5.4.7.4 Internal labelling of probes by primer-extension 
Primer extension was carried out using the method 
of Feinberg and Vogelstein (1983). 20ng of purified DNA 
fragment was incubated at 9 0°C for 2min in a total volume of 
20ul, and cooled on ice. The DNA was then incubated in a 
reaction mix containing 0.4mg/ml BSA, 4mM Tris HCl (pH8.0),. 
0.4mM MgCl2 , 0.4% beta mercaptoethanol, 200mM HEPES (pH6.6)/ 
2 OD units hexa-deoxynucleotides (Pharmacia), 20uM dATP,
20uM dTTP, 30uCi alpha-[32P]-dGTP, 30uCi alpha-[32P]-dCTP, 
and 6 units of Klenow fragment polymerase (LFP) at RT 
overnight. The DNA was then separated from unincorporated 
triphosphates in a 1ml Sephadex G50 column as described in 
section 5.3.5.1.
5.4.8 SI nuclease analysis of mRNA 5* terminus
5.4.8.1 5'-end labelling of probes
lOug of plasmid containing the appropriate insert 
was digested with restriction enzyme. Following 
phenol/chloroform extraction and ethanol precipitation the 
DNA pellet was dried and dissolved in kinase buffer (70mM 
Tris HC^ (pH7.6), lOmM MgCl2 , 5mM DTT). 50uCi of 
gamma-[ 2PJ-ATP plus 2 units of T4 polynucleotide kinase 
were added and the mixture incubated at 37°C for 3h. The 
labelled sample was loaded on a non—denaturing acrylamide 
gel, as described in section 5.1.2. Bands were detected by 
autoradiography using Xomat-S film. The appropriate band 
was cut out and DNA extracted according to the method in
section 5.1.3.
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5•4.8.2 DNA/RNA hybridisation and SI nuclease digestion
Cytoplasmic extracts from infected 35mm Petri 
dishes were prepared as described in section 5.2.2 for TK 
extracts and RNA was extracted twice with phenol/chloroform 
and once with chloroform, precipitated in ethanol, dried and 
dissolved in water.
Approximately 0.5ug of 5 '-end labelled DNA was 
precipitated with lOug of cytoplasmic RNA. The resultant 
pellet was resuspended in 20ul of 9 0% v/v deionised 
formamide, 0.4M NaCl, 40mM PIPES (pH6.8), ImM EDTA and 
heated at 9 0°C for 5min. The samples were then transferred 
rapidly to a water bath at 58°C and incubated for 16h. They 
were then placed on ice. 4,000 units of SI nuclease was 
added in SI buffer to give a final concentration of 2 5mM 
NaCl, 3mM sodium acetate (pH4.5), O.lmM ZnSO^ in a volume of 
200ul.
The samples were incubated at 37°C for 9 0min. EDTA 
(pH7.5) was then added to a concentration of 20mM and sodium 
acetate (pH7.0) to 0.3M. The samples were phenol/chloroform 
extracted, ethanol precipitated and electrophoresed on a 
denaturing polyacrylamide gel.
5.4.8.3 Denaturing polyacrylamide gels
50ml of acrylamide solution was prepared, which 
contained 8-10% acrylamide (diluted from a stock of 29% 
acrylamide, 1% N ,N 1-methylene-bisacrylamide, 7M urea), 21ml 
of 10M urea, 0 .5 5 xTBE, 300ul of 10% APS and 50ul TEMED.
This solution was poured into a mould (230mmx450mmx0.35mm). 
After polymerisation the gel was prerun at 40W for lh prior 
to loading samples. The samples were dissolved in 80% 
de-ionised formamide, 0.55xTBE, ImM EDTA, 0.1% w/v xylene 
cyanol and 0.1% bromophenol blue and denatured by heating at 
100°C for 3min before loading. Electrophoresis was 
performed in 0.55xTBE at 4 0W for approximately 2h.
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5.4*9 Analysis of viral proteins
5.4.9.1 Radiolabelling of viral polypeptides
IE polypeptides: an incubation temperature of
38.5°C was used throughout. Cell monolayers in 35mm Petri
dishes were infected with a moi of 1000 particles/cell and
the virus was adsorbed in the presence of 200ug/ml
cycloheximide for lh. The cells were then overlaid with 2ml
ETC10 containing 200ug/ml cycloheximide and incubated for a
further 4h. The medium was removed from the dishes and the
cells washed three times with ETC^q containing lug/ml
actinomycin D and once with PBS containing lug/ml
actinomycin D. 0.3ml of PBS containing lug/ml actinomycin D 
3 5and lOOuCi/ml [ S ]-methionine was added and the monolayers
incubated for a further lh before being harvested.
Early and late polypeptides: cell monolayers in
35mm dishes were infected with 1000 particles/cell, adsorbed
for lh at 38.5°C and incubated with 2ml ETC-, n >for 8h.
35[ S]-methionine was added to a final concentration of 
lOOug/ml and the cells were harvested after a further 
incubation period of lh.
5.4.9.2 Preparation of protein samples for SDS-PAGE 
The medium was removed from each dish and the
monolayers washed with ice cold PBS. The cells were then 
rapidly washed in ice cold TE (lOmM Tris HCl (pH7.5), ImM 
EDTA), 0.3ml TE was added and the monolayers incubated at 
4°C for lOmin. The cells were transferred to a 1.5ml vial 
and denatured by boiling for 20min in "boiling mix" (50mM 
Tris HCl (pH6.7), 2% SDS and'l0% glycerol, 5% beta 
mercaptoethanol). The amount of radioactivity in the 
samples was determined by TCA washing and scintillation 
counting (section 5.4.10). Samples of 25ul were analysed by 
SDS-PAGE (section 5.2.10).
5.4.10 Determination of incorporation of radiochemicals— in 
labelled substrates
lOul samples were spotted on 25mm Whatman no.l 
filter paper discs. The discs were washed once in 10% w/v
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TCA and twice in 5% TCA, rinsed with ethanol and dried. The 
discs were placed in vials containing 5ml scintillation 
fluid and the radioactivity was measured by scintillation 
counting.
5.4.11 TK assays of infected cells
Cells in 35mm Petri dishes were infected with the 
appropriate moi in the presence of 200ug of phosphononacetic 
acid (PAA) per ml. After incubation for 15h at 38.5°C 
cytoplasmic extracts were made (section 5.2.2) and TK assays 
were performed (section 5.2.4).
5.4.12 Virus complementation assay
Cells in 35ram Petri dishes were transfected with 
3ug of plasmid DNA (section 5.2.1) and treated with DMSO lh 
later. After a further lh at 37°C, virus was titrated on ’ 
the monolayers and plaques counted 3 days later.
5.4.13 Virulence assay
This study was performed by J.M.Ryan and 
J.M.Cameron of Glaxo Group Research Ltd. Female Charles 
River mice, each weighing approximately 15g, were inoculated 
either intracranially (ic) or intraperitoneally (ip) with 
200ul of 10-fold dilutions of virus stocks. Ten mice were 
inoculated for each virus dilution, and the number of 
survivors after 21 days was recorded. The mean LD5Q values 
from two experiments were calculated.
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6. RESULTS
6.1 OBJECTIVE
The aim of the work presented in this thesis was to 
produce and study an HSV-1 mutant virus that lacked the 
ability to transinduce IE genes, with the aim of 
understanding the biological importance of this phenomenon. 
The approach taken was to construct and characterise mutant 
Vlmw65 polypeptides encoded on plasmid DNA and then attempt 
to introduce mutations that abolished the transinducing 
activity of the protein into viral DNA. Preliminary 
experiments indicated that Vmw65 was required for viral 
replication (section 6.2), and studies on the HSV-2 mutant 
ts2203 revealed that the polypeptide has an essential role 
in virus assembly, probably at the level of encapsidation of 
viral DNA (F.Ramsay, thesis). Therefore mutations that 
disrupted this function would not be tolerated in virus.
For this reason the initial aim of the project was to map 
functional domains of the polypeptide by linker insertion 
mutagenesis. It was hoped that mutations could be targetted 
to regions of Vmw65 that were important for transinduction 
but not involved in the essential role of DNA packaging.
6.2 VMW65 IS ESSENTIAL FOR VIRUS VIABILITY
A preliminary experiment was performed to determine 
whether Vtaw65 is essential for virus growth by attempting to 
construct virus mutants that lacked an intact gene encoding 
the polypeptide. Plasmid pFTK contains a disrupted copy of 
the Vmw65 gene in which the entire promoter and coding 
sequence of the HSV-1 TK gene has been inserted at the PvuII 
site (amino acid position 189 of Vmw65; figure 5). This 
plasmid was cotransfected with DNA of the TK deletion 
mutant, HSV-1(17)TK1302 (Sanders et al., 1982) and the 
progeny harvested after 3 days. The progeny were then used 
to infect BHK cell monolayers, and TK levels assayed after 
16h. An increase in TK level above that of TKl302-infected 
cells would indicate thr presence of TK recombinants. 
Homologous recombination between the plasmid encoded TK gene 
in pFTK and its natural locus in the virus (and therefore
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Fig. 5. Rescue of HSV-1(TK)1302 with DNA fragments 
containing a TK gene. Plasmid pTKl contains the BamHI p 
fragment in which the TK gene is located. Plasmid pFTK 
contains the BamHI f fragment in which a disrupted copy of 
the Vmw65 gene (with an inserted TK gene) is located.
HSV-1(TK)1302 DNA contains a deletion in the TK coding 
sequence which extends past the 5' Pvull site. BamHI and 
PvuII sites are represented by B and P respectively. Dotted 
lines indicate regions of DNA where homologous recombination 
is possible.
Table 3.
Marker rescue of HSV-1(17)TK1302
Virus TK activity (cts/min.
/min. assay/ug protein)
Mock infected 2.9
TK1302 + pUC9 2.6
TK1302 + pTKl 30.0
TK1302 + pFTK 3.9
BHK cells were infected with progeny virus from 
cotransfections of HSV-1(17)TK1302 and pUC9, pTK or pFTK.
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not within the Vtnw65 gene) could not have readily occurred 
since the deletion in TK1302 extended past the 5' limit of 
the insertion (a PvuII site) in pFTK (figure 5). Table 3 
shows that TK+ recombinants could not be detected using 
pFTK, whereas TK recombinants were readily identified when 
pTKl (a plasmid which contains the TK gene in its normal 
locus) was used in the cotransfection. This result 
indicates that viruses which contain a large insertion (the 
TK gene) within the Vmw65 coding sequence are not viable, 
and therefore that the protein is essential for viral 
replication. Subsequent analysis of the HSV-2 mutant 
ts2203/ which was found to contain a mutation in the coding 
sequences for Vmw65, confirmed this conclusion (F. Ramsay, 
thesis and section 6.3.7).
6.3 ANALYSIS OF IN-FRAME INSERTION MUTATIONS IN PLASMID
ENCODED VMW65
6.3.1 Construction of insertion mutants
The gene encoding V)nw65 lies between map 
coordinates 0.669 and 0.685 in the U r region of the
JLi
prototype HSV-1 genome, and is contained within plasmid pMCl 
(figure 6; Campbell et al., 1984; Dalrymple et al., 1985? 
Pellett et a l ., 1985 ). The approach used to mutagenise 
Vlmw65 was to construct a series of mutants each with a 12 bp 
BamHI oligonucleotide inserted into pMCl at a different 
location within the Vmw65 coding region. To achieve this, 
oligonucleotides (5'-CGCGGATCCGCG-31) were ligated with 
partially restricted, linear pMCl molecules which had been 
cleaved at only one of a number of Haelll sites within the 
plasmid (figure 6). The ligation products were cleaved with 
BamHI and religated to ensure that the insertions did not 
consist of multimers of linker; pMCl contains no BamHI 
sites, and so the introduced site is unique. Plasmids with 
insertions at ten of the seventeen Haelll sites within the 
gene were identified by restriction enzyme analysis and 
isolated (figures 7 and 8). The mutant plasmids were named 
pMCl.in(x). The resultant amino acid changes introduced by
each mutation is shown in figure 28.
The rationale for employing small insertions for
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^  A  ' X  isolate linearooo m olecules
I ligate with BamHI linkers. Cleave 
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006 isolate insertion p lasm ids ,  iden tify  in se r t io n s  in Vmw65
Fig* 6. The upper section shows a map of the HSV-1 genome
in the prototype orientation, and position of Vmw65. (J and
L
Us are the long and short unique regions bounded by repeated 
sequences represented by open boxes. pMCl contains the 
HSV-1 sequence between Sail and Xhol sites cloned into pUC9. 
The lower section shows the construction of insertion 
mutants within the gene encoding Vmw65. Plasmid pMCl was 
cleaved with Haelll in the presence of ethidium bromide 
using conditions designed empirically to produce a maximum 
of singly cut linear molecules. Plasmid DNA (2ug) was 
digested with 2 units of Haelll for 30 min at 37°C with 
concentrations of ethidium bromide varying from lOug/ml to 
500ug/ml, in a total volume of 2 0ul. Samples containing a 
high proportion of singly cut molecules were identified, and 
0.2ug of DNA was ligated with a 50-fold molar excess of 
phosphorylated 12 bp BamHI linker oligonucleotide 
(CGCGGATCCGCG). DNA ligase was inactivated by heating for 5 
min at 60°C and DNA was digested with BamHI. Linear 
molecules were resolved by electrophoresis on a 1% agarose 
gel, eluted from the gel and religated. Plasmids containing 
linker insertions were identified by analysis of small scale 
plasmid preparations. The locations of linker insertion 
sites were determined by restriction endonuclease mapping.
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Fig. 7. Position of insertion linkers (a) and deletions (b) 
introduced into Vmw65. Fine mapping of the location of 
linkers was achieved by restriction enzyme analysis using 
BamHI and the enzymes shown in the figure. In-frame 
deletions were created by excising the coding region 
represented between two seperate insertion mutant plasmids 
whose BamHI linker sites were in the same reading frame.
The location of insertions and deletions represent BamHI 
sites which dissect the wt EcoRV/EcoRI fragment into two 
fragments of the length indicated (in base pairs).
A separate sheet showing the DNA sequence of the 
Vmw65 gene and position of linker insertions is included at 
the back of this thesis.
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Fig. 8. Restriction enzyme digestion pattern of mutant 
plasmids containing insertions and deletions. The plasmids 
were cleaved with EcoRV, EcoRI and BamHI, the fragments 
separated on a 1% agarose gel and stained with ethidium 
bromide. The resultant fragments of the pMCl.in (top) and 
pMCl.dl (bottom) series correspond to those depicted in 
figure 7. The lengths of marker fragments (first lane) are
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mutagenesis was that their effect would be expected to be 
local within the polypeptide, and therefore separable 
domains of Vttiw65 could be mapped. Furthermore, mutations in 
the same reading frame could be used to construct in-frame 
deletions in the Vmw65 coding sequences (section 6.3.4).
6.3.2 Construction of plasmid pIE4/5CAT
A plasmid that contained the IE4/5 promoter linked 
to the CAT coding sequences was constructed to act as an 
assayable reporter of transinduction in co-transfection 
experiments. Plasmid pIE4/5CAT was constructed by replacing 
the HSV-2 promoter in pLW2 (Gaffney et al ., 1985) with the 
promoter and upstream regulatory fragments of the HSV type 1 
(HSV-1) IE gene 4/5 (figure 9).
6.3.3 Transinducing activity of insertion mutants
Previous studies have shown that cloned HSV DNA
fragments which encode Vmw65 can stimulate transcription 
from IE promoters in short-term co-transfection assays 
(Campbell et a l ., 19 84). This approach was used to analyse 
the transinducing phenotype of insertion mutants, and the 
results of a representative experiment are shown in figure 
10. When a plasmid containing the HSV-1 IE4/5 promoter and 
upstream regulatory sequences linked to the CAT gene 
(pIE4/5CAT) was transfected into BHK cells a basal
level of CAT expression from this promoter was detected 
(figure 10, track 5). When pMCl was included in the 
transfection, however, CAT activity increased by 6-8 fold 
(figure 10, track 1). The insertion in Haelll site 4 (in4) 
did not affect transinduction (figure 10, track 2) whereas 
the insertion in Haelll sites 8 (in8) and 14 (inl4) (figure 
10, tracks 3 and 4) essentially abolished the effect. Since 
transfection experiments are inherently variable at a 
quantitative level, this experiment was repeated to ensure 
reproducibility of the effects. In some cases (for in2, in7 
and inl2), independent isolates of the same mutant were 
tested. A summary of the results from three to six 
experiments using the complete series of plasmids, together 
with calculated standard errors, is shown in table 4.
Six of the mutant plasmids (in2, in4, in7, inll,
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Fig. 9. Construction of pIE4/5CAT. the IE 4/5 upstream 
fragment used was defined by EcoRI and Sail sites in plasmid 
pTKN7 (Preston et a l ., 19 84) which represent nucleotides
•i<r
-402 and -240 respectively. (1) The EcoRI site was 
converted to Clal by insertion of an oligonucleotide linker 
(CATCGATG). The IE4/5 promoter was contained in a Sail 
(converted from Smal)/NruI fragment spanning nucleotides -69 
to +99 in plasmid pS20TK (Murchie and McGeoch, 19 82; Preston 
et a l ., 19 84). (2) The upstream and promoter fragments were
ligated together at the Sail site. (3) The resultant 3 30 
base pair (bp) Clal/Nrul product was inserted into pLW2 
between the AccI site and a filled-in BamHI site. Thus the 
HSV-2 IE4/5 promoter in pLW2 was replaced by the upstream 
and promoter sequences of the HSV-1 IE4/5 gene, without the 
HSV-1 c>ris sequences (Stow and McMonagle, 1983; Preston et 
al., 19 84).
This fragment contains two TAATGARAT elements, 
referred to as 1 c' and 'd' in figure 4 and table 2.
pMC'l ini in 8 m1i PUC9 
1 2 3 i  5
3-AC. CAM >
CAM ►
Fig. 10. Transinduction of IE transcription by mutant 
plasmids. CAT assays were carried out on extracts of BHK 
cells co-transfected with l.Oug pIE4/5CAT plus l.Oug pMCl 
(lane 1), mutant plasmids in4 (lane 2), in8 (lane 3) or in 
(lane 4), or pUC9 (lane 5) after 16h of incubation at 37°C 
The positions of chloramphenicol (CAM) and 3'-acetyl 
chloramphenicol (3'-AC. CAM) are shown.
Table 4.
Transinducing activity of Vmw65 mutants on IE4/5:CAT
Plasmid Transinducing activity
★
(%)
pMCl 100
in2 88 (.9 )
in4 104 ( 4 )
in7 78 ( G )
in8 4 ( 4 )
in9 10 ( 3 )
inll 112 ( 3 )
inl2 46 ( G )
inl4 3 ( 4 )
inl5 111 ( 3 )
inl7 105 ( 3 )
no pMCl 0
* The stimulation of expression from the IE4/5 promoter is 
given as a percentage of that obtained in parallel 
experiments with pMCl.
The mean of a number of independent determinations 
(presented in brackets) is shown.
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inl5 and inl7) were indistinguishable from pMCl in their 
ability to stimulate IE transcription, showing that 
insertions of four amino acids can be tolerated in certain 
regions of Vtaw65. Three mutants, in8, in9 and inl4, were 
reduced by 90% or more in their transinducing ability and 
thus represent plasmids in which the insertion caused a 
strong impairment of activity, within the limits of 4
sensitivity of the assay. Any residual activity of in8 and 
inl4 amounted to not more than 5% of the pMCl level. One 
plasmid, inl2, gave an activity which was reduced by about 
50% but not abolished. Thus the ten insertion mutants 
exhibited transinducing phenotypes ranging from no 
alteration to abolition of activity.
6.3.4 Construction and analysis of deletion mutant
plasmids
A series of deletions in Vmw65 was constructed by 
joining together the coding regions upstream and downstream 
of in-frame BamHI sites from separate linker insertion 
plasmids. Figure 7 shows a summary of the deletions 
constructed in Vmw65 and figure 8 shows a restriction enzyme 
profile of the plasmids. The plasmids were named 
pMCl.dl(x). The deletion mutants were analysed for 
transinduction at 31°C and 37°C in the same manner as the 
insertion plasmids (figure 11). Although the mutants (lanes 
2 to 7) appeared to have residual activity above levels of 
p(JC9 (lane 8), all of the polypeptides are believed to lack 
transinducing function since further analysis of dll5-17 
revealed that it exhibited no detectable activity (T.McKee, 
personal communication). Rather, it was thought that the 
negative control sample in this experiment was at fault. 
Thus, allowing for the problem with the negative control and 
the fact that only a single experiment was performed, it was 
concluded that all of the deletions constructed abolished 
transinduction by Vmw65.
6 .3 . 5  Expression of mutant Vmw65 polypeptides in vitro
A high level expression system was' required to
synthesise insertion mutant Vmw65 polypeptides such that 
they could be assayed for their ability to bind cell
a3-AC. C A M  
C A M
b
pMC1 2 -8  8-9  9-12 12-15 15-17 4 -7  no pMC1
1 2 3 4 5 6 7 8
pMC1 2-8  8-9  9-12 12-15 15-17 4 -7  no pMC1
1 2 3 4 5 6 7 8
3-AC. C A M
Fig. 11. Transinducing activity of deletion mutant plasmids. 
CAT assays were performed on extracts of BHK cells 
co-transfected with l.Oug pIE4/5CAT plus l.Oug pMCl, mutant 
plasmids dl2-8, dl8-9, dl9-12, dll2-15, dll5-17 or dl4-7, or 
pUC9 (lanes 1 to 8 respectively) after incubation for 16h at 
either 37°C (panel a) or 31°C (panel b).
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proteins and form the IE complex (section 6.3.6). 
Essentially, the insertion mutant genes were cloned 
downstream of a T7 promoter in the pGEM2 expression vector 
(Promega Biotech), as described below.
A 1521 bp EcoRV/FokI fragment of pMCl, containing 
the entire coding sequence for Vtaw65, was cloned into the 
Hincll site of pUC9 to give pMCl7 (figure 12.1). The 
Hindlll/EcoRl fragment from pMC17 was inserted into the 
corresponding sites of the multilinker in pGEM2 (Promega 
Biotech) to give pGEMTIF (figure 12.2). Plasmid pGEMTIF 
therefore contained the entire coding sequence of Vmw65 
under the control of the bacteriophage T7 promoter.
Insertion mutations of Vmw65 were introduced into pGEMTIF by 
exchanging DNA fragments of pGEMTIF containing coding 
sequence with corresponding fragments of the pMCl.in series 
of plasmids that contained the insertion (figure 12.3). Due 
to the distribution of convenient sites, only those 
mutations between the unique Apal and SstI restriction sites 
(in7, in8, in9, inll, inl2, inl4 and inl5) were introduced 
into pGEMTIF, and the resulting constructions were 
designated pGEMTIF.in(X).
The pGEMTIF.in(X) expression templates were 
transcribed and translated in vitro. Figure 13 shows that 
Vmw65 is the mRNA-dependent protein sythesised in vitro 
using the wt and mutant plasmid templates. This result 
rules out the possibility that frameshift mutations, 
resulting from deletion of a terminal nucleotide during 
cloning, occurred during construction of the insertion 
mutants. In all cases, Vmw65 appeared to run as a multiple 
band. This phenomenon has been observed before (Campbell et 
al. , 1984) and may be due to initiation of protein synthesis 
at a downstream AUG cod^on (Dalrymple et al., 19 85).
6.3.6 Formation of a protein-DNA complex directed by
Vmw65 synthesised in vitro
Vhiw65 associates with cellular factors to form a 
complex, IEC, which binds specifically to TAATGARAT elements 
(McKnight et al., 1987; Preston et al., 1988). The 
supposition inherent in these findings, that IEC is 
important for IE gene induction, was investigated by
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correlating the ability of mutated forms of Vmw65 to produce 
the complex with their transinducing phenotypes. Wt and 
mutant V)mw65 were synthesised by coupled in vitro 
transcription and translation, using the pGEM system 
described above. The products were incubated with HeLa cell 
nuclear extracts and IEC was detected by analysis of 
retardation of the electrophoretic mobility of a 74 bp DNA 
fragment containing the regulatory region, including 
TAATGARAT, of HSV-1 IE gene 4/5.
When Vinw65 extracted from virus particles was added
to reaction mixtures containing HeLa cell nuclear extract 
32and P-labelled 74 bp DNA fragment, the slow migrating 
complex IEC was formed (figure 14, track 1). Addition of 
reticulocyte lysate containing Vmw65 synthesised in vitro, 
in place of HSV virion extract, also resulted in the 
production of IEC (track 2), whereas this complex was not 
formed when reticulocyte lysate incubated without mRNA was 
added (track 3). The complex labelled HC3, present in all 
tracks, is the result of HeLa cell nuclear proteins binding 
to TAATGARAT (Kristie and Roizman, 1987; O'Hare and Goding, 
1988; Preston et al ., 1988), and the band in track 3 which 
migrated more rapidly than IEC probably represents the 
previously described complex HC4, which results from 
nonspecific binding of Hela cell proteins to DNA fragments 
(Preston et a l ., 19 88). HC4 was observed only when 
reticulocyte lysate without transcription mix was used in 
the gel retardation assay, presumably because pGEM DNA from 
the transcription mix acts as an additional nonspecific 
competitor. In control experiments, it was found that HeLa 
cell nuclear extract was neccessary for the formation of 
IEC, thus the reticulocyte lysate did not contain 
significant amounts of the cell polypeptide which interacts 
with Vmw65 ( C . M . Preston, unpublished results) in agreement 
with the observations of Gerster and Roeder (1988). When 
mutant Vmw65 synthesised in vitro was used in the gel 
retardation assay, a strong correlation between complex 
formation and transinducing activity was observed (figure 
14, tracks 4 to 10). Mutant polypeptides in7, inll and inl5 
all formed IEC and were also capable of stimulating 
transcription from IE promoters (section 6.3.3). Similarly
FokI EcoRI
EcoRV
pMC17 ) Hindlll
I
SstI Apal
SstI
Apal
pMCtin
pGEMTIF) 17
Fig. 12. Construction of templates for in vitro 
transcription. (1) pMC17 was constructed by insertion of a 
1521 bp EcoRV/Fokl fragment from pMCl into the HincII site 
of pCJC9 . (2) The 1521 bp fragment was excised from pMC17
with Hindlll and EcoRI and cloned between the Hindlll and 
EcoRI sites of the pGEM2 transcription vector, to give 
pGEMTIF. (3) Construction of insertion mutants. A 1048 bp 
Apal/Sstl fragment from the pMCl.in plasmids was excised and 
exchanged with the corresponding fragment in pGEMTIF to give 
the pGEMTIF.in series.
ex,
<  2
2 S  INSERTION MUTANTS 
T  a 7 8 9 11 12 14 15 
1 2 3 4 5 6  7 8 9
Vmw65
Fig. 13. In vitro translation of Vmw65 polypeptides. RNA
transcribed from the pGEMTIF.in plasmid series was
o S
translated in vitro radiolabelled with [ S]-methionine.
Lane 1 represents lysate without added RNA. Lane 2 shows 
the translated products of RNA transcribed from pGEMTIF, and 
lanes 3 to 9 show the translated products from pGEMTIF.in7 
to pGEMTIF.inl5.
INSERTION MUTANTS 
7 8 9 11 12 U  15
Fig. 14. Gel retardation assay using in vitro synthesised 
Vmw65 products. A 74 bp DNA fragment containing IE gene 4/5 
specific TAATGARAT sequences located between the Smal sites 
at -362 and -297 relative to the transcription start site 
plus extra nucleotides due to the presence of BamHI and 
Bglll linkers (Preston et a l ., 1988) was incubated with HeLa 
cell nuclear extract and virion extract (lane 1), rabbit 
reticulocyte lysate (lane 3), lysate containing Vftiw65 
synthesised in vitro (lane 2), or lysate containing mutant 
proteins synthesised in vitro (lanes 4 to 10).
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mutants in8, in9 and in!4 did not form IEC and did not 
transinduce IE transcription. The correlation is highlighted 
by inl2 which had intermediate transinducing activity and 
formed the IEC but in lesser amount. These results strongly 
suggest that the production of IEC is an important stage in 
the stimulation of transcription from IE promoters.
6.3.7 Marker rescue of ts2203 by insertion mutants
To investigate domains of Vmw65 important for the 
correct assembly of virions, mutant plasmids were analysed 
for the ability to rescue the _ts mutation in the HSV-2 
mutant ts2203. Mutant ts2203 was produced by F.H. Ramsay 
and V.G. Preston from the double mutant ts!3 (Halliburton 
and Timbury, 19 76), which was known to contain a jts mutation 
in the alkaline exonuclease and a second ts mutation located 
between genome coordinates 0.64 and 0.70 which affects the , 
virus particle (Moss et a l ., 1979). The Bglll i fragment 
(genome location 0.62-0.72) of tsl3 was subcloned, 
recombined with wt HSV-2 DNA, and a ts mutant, ts2203, was 
isolated and purified. The location of the mutation in 
ts2203 was established by marker rescue experiments using 
cloned HSV-2 DNA fragments. The mutation was mapped to a DNA 
fragment which overlaps the 5 ‘ end of the gene encoding 
Vmw65, as deduced from comparison with the known gene 
arrangement of HSV-1 (F.H.Ramsay, thesis).
The mutation in ts2203 did not affect the 
production of IE polypeptides at 3 8.5°C over a range of 
input moi, and cloned Bglll i from ts!3 was as effective as 
Bglll i from wt HSV-2 in transinducing IE promoters at 31° 
or 38.5° in transient expression assays (F.H.Ramsay, 
thesis). The mutation in ts2203 therefore appears to have 
no effect on IE transcription, and further studies have 
revealed 0  block in DNA packaging and virus assembly at 
38.5°C (F.H. Ramsay and V.G. Preston, personal
communication).
Intertypic marker rescue was carried out using pMCl 
and the insertion mutants, on the assumption that (i) the 
HSV-2 equivalent is functionally homologous to vmw65, and 
(ii) that plasmids which fail to rescue ts2203 have defects 
incompatible with the proper assembly of virions, provided
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the ts2203 mutation is in the HSV-2 counterpart of Vmw65.
It was found that pMCl rescued ts2203 although, as expected 
from DNA sequence differences, the efficiency was lower than 
with HSV-2 fragments (table 5). Five mutants (in2, in7, 
inl4, inl5 and inl7) rescued _ts2203, whereas five (in4, in8, 
in9, inll and inl2) did not. One conclusion from this 
experiment is that the ts2203 mutation must lie within the 
coding sequences of the HSV-2 homologue of Vmw65, since this 
is the only gene affected by the oligonucleotide insertions 
in4, in8, in9, inll and inl2. Furthermore, the failure of 
these plasmids to rescue _ts2203 indicates that the 
insertions affect regions essential for virus assembly. The 
interpretation of positive rescue is less clear, since two 
mechanisms might operate. Such a result may be obtained 
because the insertion genuinely does not affect virion 
assembly, but it is also possible that the insertion lies 
sufficiently far from the ts2203 mutation that intragenic 
recombination, without incorporation of the insertion 
mutation into viral DNA, could account for the observations. 
The latter argument does not apply to in7, since the 
flanking mutations in4 and in8 are unable to rescue, nor to 
in2 if the jts2203 mutation is truly at the 5' end of the 
coding sequences. Attempts were made to identify the 
presence of the BamHI linker in rescued, recombinant viruses 
by restriction enzyme analysis and Southern blot 
hybridisation. However, after considerable effort it was 
apparent that ready interpretations using this approach were 
hampered by an incomplete knowledge of restriction sites and 
their location in the corresponding region of HSV-2.
Although preliminary evidence for the incorporation of in2, 
in7, inl4, inl5 and inl7 into viral DNA was obtained, 
attempts to purify recombinant plaques were unsuccessful.
Nevertheless, in situations where mutant plasmids 
failed to rescue Us2203, recombinant virus DNA is presumed 
to contain the linker insertion (which is lethal) since its 
presence is the only difference from the wt DNA fragment of 
pMCl. Thus, of the five sites at which insertions prevent 
rescue, only two (in8 and in9) are loci of major importance 
for both virus assembly and transinduction of IE 
transcription. The features of Vmw65 required for virion
Table 5.
Marker rescue of ts2203 by mutant plasmids
Mutation Marker rescue (NPT/PT
Bgllli 22.0
Bgllli (tsl3) <0.001
pMCl 2.6
in2 2.1
in4 <0.001
in7 0.2
in8 <0.001
in9 <0.001
inll <0.05
inl2 <0.001
inl4 0.77
inl5 1.2
inl7 1.8
no pMCl <0.02
* The ability of mutant plasmids to rescue the ts lesion in 
HSV-2 ts2203 is expressed as the percentage of resulting 
non-ts recombinants in the total virus progeny. The results 
are a mean of two independent determinations.
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assembly are not invariably the same as those involved in 
transcription activation and thus there are at least short 
regions of the polypeptide, if not domains, that are 
functionally separated. Mutant inl4 is unable to 
transinduce but can rescue ts2203, suggesting that it is 
defective only for transinduction. In turn, this 
interpretation implies that viable viruses containing the 
inl4 mutation could be constructed, and that transinduction 
is not essential for viral growth.
6.4 ANALYSIS OF A VIRUS CONTAINING A MUTATION IN VMW65
6.4.1 Construction of a mutant virus containing an 
insertion within the Vmw65 gene 
As described in section 6.3.3, a 4 amino acid 
insertion at codon 39 7 in Vmw65, encoded on plasmid 
pMCl.inl4 (figure 15), abolished the transinducing activity 
of the polypeptide. The mutation disabled the binding of 
Vmw65 to the host cell factor(s) and thus defined a region 
of the polypeptide involved in this interaction (section 
6.3.6). The mutation, however, did not appear to affect the 
polypeptide’s essential role during virion assembly as 
inferred from its ability to rescue a HSV-2 mutant with a ts 
mutation in Vmw65 (section 6.3.7), suggesting that a viable 
virus could be constructed that contained the transinducing 
mutation specified by pMCl.inl4. Since attempts to isolate 
an intertypic recombinant by marker rescue of ts2203 were 
unsuccessful, it was decided to recombine the inl4 insertion 
directly into wt HSV-1 DNA. To construct a mutant virus, 
pMCl.inl4 was cotransfected with intact wt HSV-1 DNA into 
BHK cells, and the structure of progeny virus DNA was 
examined by restriction enzyme analysis and Southern blot 
hybridisation. One plaque from a total of 84 screened was 
identified as a recombinant that contained the BamHI linker 
insertion (figure 16.a). This mutant isolate was titrated 
on BHK cells and progeny plaques were screened. It was 
apparent that the original plaque was contaminated with wt 
HSV-1 (figure 16.b) and so a secondary plaque was titrated 
and screened in an attempt to purify the mutant DNA (figure 
16.c). A further round of plaque purification was necessary
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to obtain progeny that displayed only the mutant DNA profile 
(figure 16.d), and a large scale stock of virus was prepared 
from one of these plague stocks. The mutant virus was 
called in!814
6.4.2 Marker rescue of in!814
To rule out the possibility of a second site 
mutation in in!814 that might affect the phenotype of the 
mutant virus, a rescued virus was constructed by recombining 
rnl814 DNA with pMCl. If, as desired, the phenotype of 
in!814 depended on the insertion mutation, then a rescued 
virus should behave as wt HSV-1. Initial observation of the 
properties of in!814 suggested that it grew poorly in 
comparison with wt HSV-1, thus it was expected that rescued 
recombinants would outgrow in!814 during successive passages 
of a mixed population. This turned out to be the case since 
after a single passage of the progeny virus from the initial 
cotransfection of jlnl814 DNA and pMCl, 25 out of 33 of the 
plaques screened had the wt DNA structure (figure 17).
These viruses were unlikely to result from spontaneous 
reversion of ^ 1 8 1 4  since no reversion was detected at any 
stage during the passaging and propagation of mutant virus 
stocks. A stock of rescued virus, 1814R, was prepared after 
plaque purification. Figure 18 shows a Southern blot of wt 
HSV-1, _inl814 and 1814R DNA which was digested with BamHI 
and probed with pMC17, a plasmid containing the Vmw65 coding 
sequences. The BamHI f fragment of 8 kilobase pairs (kbp) 
was seen in wt HSV-1 (lane l)and 1814R (lane 3) whereas in 
ijil814 (lane 2) this fragment was replaced by two fragments 
of predictable sizes (5 kbp and 3 kbp) expected from the 
presence of the BamHI linker insertion. Overexposure of the 
autoradiograph (figure 18, bottom) revealed no detectable 
BamHI f fragment in in!814 and therefore that the stock of 
mutant virus was essentially pure.
6.4.3 The efficiency of plaque formation by in!814 is
markedly reduced and dependent on cell type
The successful isolation and propagation of inl814 
confirms that the insertion mutation is compatible with 
virus growth in BHK cells. When ini814 was titrated on BHK
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Fig. 15. (a) Map location of the Vmw65 gene and position of 
IE genes in the HSV-1 genome. (b) DNA and amino acid 
sequence of the insertion mutation in Vmw65 encoded on a 
Sail(S)/XhoI(X) fragment in plasmid pMCl.inl4.
8 Kb (BamHI f) M
5 Kb 
3 Kb Ji
• . • ••••
8 Kb • • • I t * *
8 Kb
8 Kb • • ••
8 Kb (BamHI f)
5 Kb 
3Kb i
8 Kb (BamHI f) 
5 Kb 
3 Kb
8 Kb (BamHI /)
3Kb
Fig. 16. Screening for mutant recombinants by Southern blot
analysis. (a) DNA was prepared from sub-cultures of 84
plaques isolated from the initial co-transfection event,
cleaved with BamHI, the fragments separated on a 1.5%
agarose gel, transferred to nitrocellulose and hybridised to 
32 P-labelled pMC17 (which contains the DNA sequence of the 
Vftiw65 gene). The position of the wt HSV-1 BamHI f fragment 
(8 Kbp), which encodes the entire Vmw65 gene, and the 
fragments expected to result from the presence of the 
mutation (5 Kb and 3 Kb) are indicated. One recombinant, 
indicated by the arrow, was identified. The recombinant was 
purified by successive rounds of titrating and screening of 
progeny plaques (b, c and d); the plaques isolated at each 
stage are indicated by arrows.
I
8 Kb (BamHI f)  • • •  Q  •  • •  %  %  | | g 9 | |  • • •
5 Kb m  •  *
3 Kb a . • •• • I
Fig. 17. Screening for "revertants" constructed by marker
rescue of the in!814 mutation. Plaques were isolated from
the initial co-transfection, grown up and DNA prepared. The
infected cell DNA was cleaved with BamHI, the fragments
separated on a 1.5% agarose gel, transferred to
32nitrocellulose and hybridised to P-labelled pMC17. The 
position of wild-type (8 Kb) and mutant (5 Kb and 3 Kb) DNA 
fragments are shown. One recombinant (arrowed) was grown up 
and used as a stock of 1814R.
B a m H I  f
1 2 3
HSV-1 1814 1814R
• •
1 2 3
HSV-1 1814 1814R
B a m H I  f
Fig. 18. Structure of in!814 genome. (top) Wt HSV-1 (lane
1), i_nl814 (lane 2) or 1814R (lane 3) DNA was cleaved with
BamHI and the fragments separated on a 1.5% agarose gel,
3 2transferred to nitrocellulose and hybridised to P-labelled 
pMCl7. The position of HSV-1 BamHI f is indicated.
(bottom) Overexposure of this autoradiograph reveals that 
there are no detectable BamHI f fragments in in!814
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cells it was observed that the morphology of the mutant 
plaques differed from that of wt HSV-1. Plaques of in!8l4 
were smaller and their borders more defined. The plaque 
morphology of the rescued virus, 1814R, was 
indistinguishable from that of wt HSV-1. It was also 
noticed that the titre of the mutant virus was significantly 
lower than wt HSV-1 stocks, and therefore virus particle 
concentrations were determined (table 6). It was found that 
the particle concentrations of wt HSV-1, in!814 and 1814R 
stocks were comparable. However, titration of the 
virus stocks on BHK, Vero, HeLa and HFL cell monolayers 
revealed that although wt HSV-1 and 1814R plaqued with 
similar efficiencies/ the ability of
i_nl814 to form plaques was reduced by >100-fold on BHK, Vero 
and HeLa cells and as much as 25,000-fold on HFL cells 
(table 6). Consequently the particle/pfu ratio of in!814 
was >2.0x10^ on BHK, Vero and HeLa cells and >1.0x10^ on HFL 
cells. The severely reduced titre of in!814 on HFL cells is 
not easily explained by the particles being defective, since 
when the same number of particles were titrated on the other 
cell types, a significantly increased proportion of these 
particles were infectious.
The apparent titre of a given preparation of in!814 
on BHK cells varied by as much as 10-fold on different 
batches of cells, whereas the titres of wt HSV-1 and 1814R 
were much more consistent, suggesting that the cellular 
metabolic state affects the efficiency of plaque formation 
by JJ11814. In view of the variation in titre of in!814 when 
expressed in terms of pfu, cell monolayers were infected 
with equal numbers of particles of wt HSV-1, in!814 or 1814R 
in subsequent experiments.
6.4.4 Adsorption and penetration of cells by in!814
Vhiw65 is a major structural protein of the virion 
and therefore the mutation in ini814 may affect adsorption, 
penetration or uncoating of the virus at the onset of 
infection. Consequently, the high particle/pfu ratio 
exhibited by the mutant may reflect the presence of a large 
number of structurally defective particles in the virus 
population. Therefore the early stages of infection by
Table 7.
Binding of in!814 to cells
Time (h ) cpm bound to cells (percent input)
wt HSV-1 inl814
0 5.0 2.5
2 10.0 6.0
4 16.0 10.0
Labelled virus particles were adsorbed to cells at 3 7°C j
The input radioactivity was 270 and 1200 cpm per 
30mm plate for wt HSV-1 and inl814 respectively (100 
particles/cell in each case).
i 2 3 4
MI HSV-1 1814 1814R
BamHI p
Fig. 19. DNA migration to the nucleus. DNA isolated from 
nuclei of cells mock infected (lane 1) or infected with wt 
HSV-1 (lane 2), in!814 (lane 3) or 1814R (lane 4) was 
cleaved with BamHI and the fragments separated on an agarose 
gel, transferred to nitrocellulose and probed with pTKl.
The position of BamHI p is indicated.
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lnl814 were examined. In an initial experiment, the rate of
adsorption of wt HSV-1 or in!814 preparations (radiolabelled
3by incubation with [ H]-thymidine during virus propagation) 
to BHK cell monolayers was investigated. The adsorption 
rates of wt HSV-1 and inl814 particles were not 
significantly different (table 7).
The efficiency of DNA migration to the cell nucleus 
was also determined. BHK cell monolayers were infected in 
the presence of cycloheximide (CH) with 100 particles of wt 
HSV-1, i_nl814 or 1814R per cell, nuclei were prepared at 3 h 
post infection, and nuclear DNA was analysed by Southern 
blot hybridisation (figure 19). No differences were 
detected in the levels of HSV DNA, showing that the nuclear 
migration of in!814 DNA is not impaired and thus the 
particles are not defective for penetration.
This result reemphasises the requirement to use 
equal numbers of particles rather than pfu as a basis for 
the design of experiments with in!814, since preparations of 
_inl814 that exhibit the same titre as wt HSV-1 and 1814R 
contain significantly more viruses capable of penetrating 
cells and releasing DNA to the nucleus; 1 pfu of wt HSV-1 
and _inl814 represent 38 and 10,000 particles, respectively.
6.4.5 Vmw65 of in!814 does not direct the formation of 
IEC
The ability of Vmw65, encoded by _inl814, to form
the protein-DNA complex IEC was investigated since this
property was disrupted in pMCl.inl4 (section 6.3.6)
Extracts of wt HSV-1, Jjal814 and 1814R virions were
prepared and analysed by SDS-PAGE (figure 20). The levels
of Vmw65 in these extracts were very similar and a slightly
increased molecular weight (mol.wt) of the mutant
polypeptide, presumably due to the 4 amino acid insertion,
was apparent (lane 2). The virion extracts were incubated
32with HeLa cell nuclear extract and a P-labelled 74 bp DNA 
fragment containing the TAATGAGAT sequence motif of IE gene 
4/5. As shown in figure 21, the complex IEC was readily 
detected using extracts of wt HSV-1 (lane 2) and 1814R (lane 
4) virions, but not with extracts of in!814 (lane 3) or when 
no virion extract was present (lane 1). This result
1 2 3
HSV in1814 1814R
Vmw65
Fig. 20. Proteins extracted from virions of wt HSV-1 (lane 
1), in!814 (lane 2) and 1814R (lane 3) and used as a source 
of Vmw65 for gel retardation analysis. A gel stained with 
coomassie brilliant blue is shown.
1 2  3 4
-EXT HSV-1 1814 1814R
SEC
H C 3
HC1
Fig. 21. IEC formation by Vmw65. A 74 bp DNA fragment 
containing the IE gene 4/5 TAATGAGAT sequence (see figure 14 
legend) was incubated with HeLa cell nuclear extract alone 
(lane 1) or with virion extract from wt HSV-1 (lane 2), 
in!814 (lane 3) or 1814R (lane 4) and analysed by gel 
electrophoresis. The position of IEC and the cell-specific 
complexes HCl and HC3 (Preston et a l ., 19 88) are indicated.
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demonstrates that Vmw65 specified by _inl814 is not capable 
of binding the cellular protein(s) required for IEC 
formation due to the mutation in the viral polypeptide.
6.4.6 in!814 does not exhibit virion-mediated 
transinduction of IE genes
The ability of _inl814 to transinduce IE gene 
expression was investigated since this property correlates 
with IEC formation in plasmid pMCl.inl4. The level of 
activation from a transfected IE promoter in the presence or 
absence of superinfecting virus was investigated (figure 
22). BHK cells were transfected with pIE3CAT (which 
contains the HSV-1 IE-3 gene promoter and regulatory 
sequences linked to the CAT gene (Stow et a l ., 1986)) and 
infected with 1000 particles of wt HSV-1, jjil814 or 1814R 
per cell. An increase of approximately 6-fold in CAT 
activity was observed when cells were superinfected with wt 
HSV-1 (lane 2) or 1814R (lane 4), but infection with in!814 
(lane 3) gave no stimulation over the level in mock-infected 
cells (lane 1).
Taken together, these results and those from 
sections 6.4.5 confirm that the properties of the mutant 
Vmw65 polypeptide in the viral context reflect the 
observations and expectations implicit in the initial 
characterisation of the mutation in cloned copies of the 
gene; that is, the mutation in _inl814 disables the ability 
of the virus to direct the formation of IEC and consequently 
abolishes its transinducing activity.
6.4.7 Immediate early gene expression in in!814-infected 
cells
It would be expected that the abolition of 
transinduction by Vmw65 would affect the expression of viral 
genes, especially IE genes. The accumulation of IE RNA was 
quantitated by dot-blot analysis using IE gene-specific 
probes for hybridisation. BHK cells were infected in the 
presence of CH with 1000 particles of wt HSV—1, ini814 or 
1814R per cell for 4h, and cytoplasmic RNA was applied to 
nitrocellulose and separately hybridised with radiolabelled 
DNA fragments corresponding to the IE—1, IE-2, IE-3 or IE—4
1
Ml
2
HSV-1
3
1814
4
1814R
3 - AC.  
CAM
CAM
Fig. 22. Transinduction of IE transcription. Cells were 
transfected with pIE3CAT and mock infected (lane 1) or 
infected with wt HSV-1 (lane 2), in!814 (lane 3) or 1814R 
(lane 4) for 3h at 38.5°C. CAT assays were carried out on 
cytoplasmic cell extracts.
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genes (figure 23). The levels of IE-1 and IE-2-specific 
RNA, as determined by densitometric analysis, were reduced 4 
to 5-fold in ini814-infected cells compared to wt HSV-1 and 
1814R-infected cells (figure 23, a and b), whereas the 
reduction in IE-4-specific RNA was only 2-fold (figure 23, 
d) and no significant effect on IE-3-specific RNA was 
detected (figure 23, c). The accumulation of correctly 
initiated IE-4/5 mRNA was also determined by SI nuclease 
mapping of the 5'-terminus (figure 24). Infections were 
carried out as described above, and in addition infections 
using equal numbers of pfu were compared. Again, it was 
apparent that the levels of IE-4/5 RNA species were reduced 
by only 2 to 3-fold in _inl814-infected cells during 
infections using equal numbers of virions (lanes 2 to 4) .
As expected, the level of RNA accumulation in 
_inl814-infected cells was approximately 10-fold greater than 
in wt HSV-1 when infections were performed using equal pfu 
(lanes 5 to 7), since this criterion dictates that a much 
larger number of _inl814 virus particles are used.
The expression of IE polypeptides in BHK (figure 
25) and HFL (figure 26) cells was also investigated. Cells 
were infected as described above, but after 4h CH was washed 
from the cells and polypeptides were radiolabelled in the 
presence of actinomycin D and separated by SDS-PAGE. 
Densitometric analysis was used to determine the relative 
rates of synthesis of individual IE polypeptides, and the 
values were normalised to that of actin.
In BHK cells, the rates of synthesis of VmwllO and 
Vtnw63, the products of IE genes 1 and 2 respectively, were 
reduced by 4 to 5-fold in in!814-infected cells, whereas the 
rate of synthesis of Vmwl75, the product of IE gene 3, was 
e quckl for the three viruses (figure 25). It was not
possible to measure accurately the rate of synthesis of 
Vmw68, the product of IE gene 4, since this polypeptide
migrated as a diffuse band. In addition to those already
mentioned, a low molecular weight polypeptide was present in 
wt HSV-1 and 1814R but not in!814-infected cell extracts.
The origin of this protein species is unknown, but it may be 
a degradation product of one of the IE polypeptides that is
synthesised at higher levels in wt virus.
aIE-1
b
IE-2
c
IE-3
d
IE-4/5
Ml
HSV-1 •  •  •
#  # \
1814 #  • •  ' • •  •
1814R •  •  • •  •  • •  •
• • •
Fig. 23. Production of IE RNA. Cells were mock infected
(row 1) or infected with wt HSV-1 (row 2), in!814 (row 3) or
1814R (row 4) in the presence of CH. RNA was prepared after
4 h and applied to nitrocellulose filters in 4 sequential
dilutions (3ug, lug, 0.3ug and O.lug). Filters were
3 ?
separately hybridised with P-labelled DNA probes 
corresponding to IE genes 1, 2, 3 and 4/5 (panels a, b, c 
and d respectively). Gene-specific probes were DNA 
fragments that corresponded to IE genes 1 (a 1367 bp 
Sall/Nrul fragment from pJR3 [Everett, 1984b), 2 (a 2760 bp 
Mlul/BamHI fragment from BamHI b [McGeoch et a l ., 1988]), 3 
(a 3 210 bp HincII fragment from Xhol c [McGeoch et al .,
19 86] ) and 4 (a 2 200 bp Nrul/Mlul fragment from BamHI n 
hybridising predominantly to IE RNA 4 [McGeoch et a l .,
1985] ).
1000 partic les 1 pfu/cel! 
/ce l l
wt 1814 R  wt 1814 R
2 3 5 6 7
Fig. 24. SI 5 '-terminus analysis of IE4/5 mRNA. Cells were 
mock infected (lane 1) or infected with wt HSV-1, in!814 or 
1814R at a moi of 1000 particles / cell (lanes 2 to 4 
respectively) or 1 pfu / cell (lanes 5 to 7 respectively). 
Infections were done in the presence of 200ul/ml of 
cycloheximide for 4h at 38.5°C.
RNA was hybridised to a 5 1-terminally labelled 
Avail d fragment derived from pGX35 (Preston et a l ., 1984).
Vmw175
Vmw136
Vmw110
Vmw68
Vmw63
actin
Fig. 25. IE polypeptide synthesis in BHK cells. Cells were
mock infected (lane 1) or infected with wt HSV-1 (lane 2),
_inl814 (lane 3) or 1814R (lane 4) in the presence of CH.
35Proteins were labelled with [ S ]-methionine after removal 
of CH by washing at 4 h post infection. The position of 
viral IE polypeptides and cellular actin are indicated.
Vmw175
Vm wl36
V m w lio
Vmw63
actin
c
Fig. 26. IE polypeptide synthesis in HFL cells. The 
procedure and lane arrangement are as described in the 
legend to figure 25.
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In HFL cells, the level of VimwllO in inl814 was 
reduced by approximately 10-fold and the reduction in Vmw63 
would appear to be even greater, since its synthesis was not 
readily detectable (figure 26). The greater reduction in IE 
protein synthesis in inl814-infected HFL cells may explain 
the mutant's lower plaqueing efficiency on this cell type.
It is clear, however, that the data on IE RNA 
levels and IE protein synthesis rates in BHK cells are in 
good agreement and show that the expression of IE genes 1 
and 2, and to a lesser extent IE genes 4 and, presumably, 5, 
is reduced in _inl814-infected cells but the expression of IE 
gene 3 is essentially unaffected. Expression of the large 
subunit of ribonucleotide reductase (Vtnwl36), seen in 
"immediate-early" conditions, also appears to be unaffected 
in in!814 (figures 25 and 26).
6.4.8 Early and late gene expression in in!814-infected
cells
Protein synthesis at 8 h post infection, a time at 
which early and, especially, late polypeptides are 
synthesized, was also examined (figure 27). The profiles of 
wt HSV-1, JJ11814 and 1814R-infected cells were very similar, 
the increased mol.wt of Vmw65 specified by in!814 being the 
only major difference.
Thus, upon infection of BHK cells with 1000
particles of inl814 per cell, the level of expression of IE
genes 1, 2, 4 and, presumably, 5 is reduced but infection 
procedes normally to the late stage, suggesting that there 
is no overall effect of reduced IE gene expression. From 
the high particle/pfu ratio, however, it appears that the 
growth of inl814 is inefficient when cells are infected with 
1 particle of virus per cell. To investigate whether the
incapacity of in!814 at low multiplicity of infection is
reflected in reduced gene expression, synthesis of TK, an 
early enzyme that can be detected with high sensitivity, was 
examined. BHK cells were infected with 1000, 100, 10 or 1 
particle of wt HSV-1, inl814 or 1814R per cell, and 
incubation was continued for 15 h in the presence of PAA, to 
prevent secondary spread of virus. Table 8 shows the 
results of TK assays performed on the cell extracts. The
1 2  3 4
Ml HSV-1 1814 1814R
Vmw65
Fig. 27. Late polypeptide synthesis. Cells were mock
infected (lane 1) or infected with wt HSV-1 (lane 2), in!814
(lane 3) or 1814R (lane 4) and proteins labelled with 
35[ S ]-methionine at 8 h post infection. The position of 
Vhiw65 is indicated.
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level of TK after infection with 1000 or 100 particles per
cell was indistinguishable for wt HSV-1, in!814 and 1814R,
reemphasizing that ijal814 is not detectably impaired at high 
moi. At 10 particles per cell, the TK level in 
_inl814-inf ected cells relative to that in wt HSV-l-infected 
cells was reduced by 5-fold, and at 1 particle per cell the 
decrease was 30-fold. Therefore the expression of TK (and 
presumably of other early and late genes) is more strictly 
dependent on moi for _inl814 than for wt HSV-1 or 1814R, and 
it is likely that the observed reduction in expression, if 
exhibited by all early and late genes, is large enough to 
account for the inefficiency of plaque formation by the 
mutant.
6.4.9 Complementation of in!814 by VmwllQ
If jLnl814 fails to form plaques at low moi due to ’
the reduction in IE gene expression, then complementation of 
this state should increase the efficiency of plaque 
formation and consequently the apparent titre of the mutant 
virus. In contrast, a compensating increase in IE gene 
expression would not complement jjil814 growth if the mutant 
phenotype resulted from a defect at a stage before the onset 
of IE transcription, ie. cell penetration. To test these 
possibilities, BHK cells were transfected with pill (a 
plasmid encoding the HSV-1 transactivator VmwllO) or pUC9 
and then separately used for titration of wt HSV-1, in!814 
or 1814R (table 9). Although the titre of wt HSV-1 and 
1814R was constant in both cell samples, the apparent titre 
of i_nl814 increased approximately 10-fold on cells 
transfected with pill. Therefore, raising the level of 
VmwllO can (at least partially) rectify the defect of 
in!814, and thus the restricted growth of the mutant at low 
moi correlates with a failure to express IE gene products at 
sufficient levels.
6.4.10 in!814 has reduced virulence in mice
The following study was performed by J.M.Ryan and 
J.M.Cameron (Glaxo Group Research Ltd., Middlesex).
An assessment of the in vivo properties of in!814 
was made by studying virulence after inoculation of mice
Table 9 .
Complementation of in!814 by VmwllO
wt HSV-1 inl814 1814R
+ pUC9 1.2xl010 4.OxlO6 1.7xl09
+ pill 9.5xl09 4.2xl07 2.2xl09
BHK cells were initially transfected with pill or p(JC9 
plaqueing efficiencies were subsequently determined by 
titrating virus stocks onto the monolayers as indicated
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either ic or ip. The results (table 10) show that in!814 
was much less virulent than wt HSV-1 or 1814R regardless of 
the method of inoculation. In fact, all mice challenged 
with _inl814 survived, with the exception of 3 mice injected 
ic with undiluted virus. In these cases, death was 
atypically rapid, occurring within 12 h as opposed to the 
usual 3 to 5 days, and it is suspected that the effect was 
due to the large number of virus particles injected. The 
LD^q values in terms of particles per mouse, the more
relevant value, show that virulence of in!814 was reduced by
3 4a factor of at least 3x10 for ip or 2.5x10 for ic
inoculation, compared with wt HSV-1 or 1814R. The reduction
was much greater when results were calculated on the basis
of pfu per mouse. The reason for the small reduction in
virulence of 1814R with respect to wt HSV-1 is unknown, and-
similar observations have been made for revertants of other'
mutants (Cameron et al .y 19 88). However, it is suspected
that wt HSV stocks are comDosed of viruses of 
(Taha et al., 1988) 
heterogeneous virulence, which is likely to be a dominant
trait, and that a pfu picked at random (for instance when
isolating mutants and revertants of them) will be less
virulent than the virulence of the original population.
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7. DISCUSSION
7.1 FUNCTIONAL REGIONS OF THE VMW65 POLYPEPTIDE
Insertion of a 12 bp oligonucleotide into the 
coding sequences is a convenient method for making 
relatively small changes in the amino acid sequence of a 
protein. Among the ten mutations constructed in plasmid 
encoded Vmw65 described here, three different amino acid 
sequence changes were possible depending upon the reading 
frame at the site of insertion, as shown in figure 28. 
Alteration in the properties of a protein could result from 
local or overall physical distortion or charge imbalance, 
but in a similar study of the HSV-1 IE polypeptide VmwllO 
Everett concluded that the properties of the mutated protein 
correlated more strongly with the position than with the 
nature of small insertions (Everett, 1987). A summary of th6 
phenotypes of mutant plasmids is presented in figure 2 8.
Three insertion mutants, in8, in9 and inl4, were 
strongly reduced in their ability to transinduce IE 
transcription, and, since Haelll sites 8 and 9 are only 15 
bp apart, it is probable that these three mutants define 
only two important regions. The resultant structure of the 
deletion mutant dl8-9 is a 1 amino acid deletion with a four 
amino acid change. This mutant is also defective for 
transinduction, reemphasising the importance of this region 
of the polypeptide. In addition, the predicted secondary 
structure (Chou and Fasman, 1978) of in9 indicates that the 
insertion at this position causes a strong alteration in 
structure in this region of the protein (F.Ramsay, thesis). 
However, such correlations may be of little consequence 
since the predicted structure at the site of inll was also 
disrupted but transinduction was unaffected, and activity 
was lost in inl4 but the insertion did not alter the 
predicted secondary structure (F.Ramsay, thesis). If the 
mutations exert their effects only at the site of insertion 
rather than by disruption of gross secondary or tertiary 
structure, it is possible that the regions defined by in8/9 
and inl4 are in close proximity to form a single domain in 
the properly folded protein. The observation that all of 
the deletion mutants are non-functional, including dl4-7
IEC formation-  nd nd
Transinduct ion:  +
Res cue  of 
t s 2 2 0 3
+  -
I n s e r t e d  aa.s= a  b 
in. = 2 4
+  -  -  +  ±  -  +  nd
+  - - + + - +  +
+ - - - - + + +
b a a c a  b a a
7 8  9 11 12 14 15 17
5 0 aa .
Fig. 28. A summary of the phenotypes of mutated Vhiw65 
polypeptides. A (+) sign denotes that the polypeptide has 
wt phenotype, a (-) sign indicates that the function has 
been abolished, and (*) represents intermediate activity.
The inserted amino acids, determined by the reading frame of 
the insertion site, are either (a) ARIR, (b) ADPR or (c) 
RGSA.
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which lacks a region of the polypeptide not recognised as 
important by insertion mutagenesis, indicates that the 
overall structure of the protein as a whole is important for 
function.
No striking feature of the amino acid c* pience at 
the sites of the insertions is obvious at present, and a 
computer-assisted search of the NBKF d a t a & e  did not reveal
A
any proteins with clearly meaningful homologies to these 
regions. There is, however, a region of nine amino acids 
(ELRAREESY) only three amino acids upstream from the ini 
site which is strongly conserved between 1/mw65 and its VZV 
homologue (Dalrymple et a l ., 19 85). However, recent 
evidence suggests that the VZV homologous polypeptide does 
not function as a transinducing factor (TIF) in transfection 
assays (T.McKee, personal communication'.). The VZV protein .. 
lacks an acidic carboxy-terminus (discussed below) and also- 
does not appear to form a protein complex that associates 
with TAATGARAT sequences present upstream of the VZV major 
IE gene (T.McKee, personal communication). Therefore, 
unless the homology is an evolutionary vestigial remnant, it 
is unlikely that amino acids responsible for trassinducing 
domains would be conserved between the two polypeptides. 
Rather, regions of homology may be more significant with 
regard to virion structural properties provided that this is 
the function of the VZV homologue.
In addition to the in8/9 (amino acids 172 and 171) 
and inl4 (amino acid 379) regions, the region between amino 
acids 411 and 453 is also known to be important for 
transinduction, since deletion back to a Sinai site (amino 
acid 453) has no detectable effect whereas a frameshift 
insertion at a Sail site (amino acid 411) abolishes 
transinduction (C.M. Preston, personal ccramunication). This 
C-terminal domain of the polypeptide contains a high 
proportion of acidic residues and corresponds to the “acid 
tail" of Vmw65, also shown by others to be important for 
transinducing activity (Sadowski et al.,, 1988; Triezenberg
et a l ., 1988a).
Proteins containing insertions at sites 8 ,  9 asnd 14 
all failed to form 1EC, suggesting that these mutations 
prevented Vtnw65 from interacting with the cellular
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polypeptide(s) contained in IEC. It may be, therefore, that 
one or more of these sites defines amino acids involved in 
the protein-protein interactions that are essential for the 
production of IEC (Preston et a l ., 1988). The observation 
that the ability to transinduce IE transcription correlates 
well with the formation of IEC provides evidence that the 
complex is an essential intermediate in IE gene activation. 
The insertion mutants that abolish transinduction all lie 
within the more N-terminal, internal domain of Vtnw65 
implicated by others to be important for binding with 
celluar factors (Triezenberg et al . , 1988; Sadowski et al ., 
19 88). None of the insertion mutants isolated were located 
within the "acid tail" of the protein, but such mutations 
would probably not affect the function of this region since 
activating regions of other eukaryotic polypeptides appear, 
only to require the presence of acidic residues rather than 
conserved structural amino acid sequences (see section 3.2). 
Therefore, there appear to be two essential domains of Vmw65 
involved in transinduction: first, the N-terminal and 
internal region which is responsible for binding cellular 
factors, and, second, the C-terminal acidic "tail". One 
model to explain these observations is that VHiw65 is 
targeted to TAATGARAT sequences in the form of the IEC such 
that the "acid tail" comes into close proximity of basic 
transcriptional machinery (e.g. TFIID and/or RNA polymerase) 
which it subsequently modulates to promote the rate of 
transcription. Both targeting and modulation of 
transcription factors would therefore be required for 
transinduction, and so deletion or disruption of either the 
N-terminal or the C-terminal domain would abolish the 
activity of the polypeptide. Other phenotypes of Vmw6 5 
mutants can be envisaged, for example, a protein unable to 
mediate transinduction might form an aberrant IEC which 
could not interact correctly with additional transcription 
factors.
The experiments described here show that the 
structural requirements of Vmw65 for transcription 
activation and virion assembly differ (summarised in figure 
28). The mutants in4 and inll define sites which are 
important for virion structure but not transinduction, and
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the mutation of ts2203 also falls into this category. 
Presumably these observations reflect the fact that Vmw65 is 
a multifunctional protein which interacts with virus 
structural proteins during virion assembly, whereas it is 
complexed with one or more host cell proteins when acting as 
a transinducing factor. Insertions which affect both 
functions may disrupt a domain important for both 
properties, or they may change severely the secondary and 
tertiary structure, resulting in a grossly altered protein. 
Mutant inl4 is unable to transinduce but can rescue ts2203, 
suggesting that it is defective only for transinduction. In 
turn, this interpretation implied that viable HSV-1 viruses 
containing the inl4 mutation could be constructed.
7.2 CONSEQUENCES OF TRANSINDUCTION IN HSV-1 IN TISSUE .
CULTURE
The isolation of a virus mutant defective in 
transinduction of IE transcription is a crucial step in 
determining the biological role of Vmw65. The 12 bp 
insertion mutation in _inl814, constructed using plasmid 
pMCl.inl4, appears to be stable since no revertants have 
been detected during passage and growth of virus stocks.
Any reversion to the phenotype of wt HSV-1 would readily be 
detected, as shown by the ease with which the rescued virus, 
1814R, was isolated.
A meaningful interpretation of the properties of 
in!814 hinges on the assertion that its phenotype is a 
consequence of the transcriptional defect rather than any 
additional block in the correct uncoating of the virus, and 
four lines of evidence suggest that an equivalent proportion 
of virus particles in wt HSV-1 and in!814 stocks proceed 
normally to the stage of IE gene transcription. First, 
direct measurement of DNA migration to the nucleus revealed 
no difference between wt HSV-1, ini 814 and 1814R, indicating 
that the three viral genomes are uncoated and transported 
with similar efficiencies. Second, the fact that synthesis 
of IE gene 3-specific RNA, and hence Vmwl75, is 
indistinguishable in wt HSV-1, i_nl814 and 1814R-infected 
cells under IE conditions suggests that the number of 
genomes available for transcription is comparable. Third,
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the progression of wt HSV-1, inl814 and 1814R to an 
equivalent stage of infection after 8 h again shows that the 
number of active genomes is not very different. Fourth, 
complementation of in!814 by transfection with plasmids 
which encode VmwllO indicates that the inability to form 
plaques is the result of inefficient IE gene expression 
rather than an uncoating problem. In addition, in!814 c a n  
be complemented to wt levels of growth in HeLa cells with 
UV-inactivated wt HSV-1, indicating that wt VmwSS can fully 
rectify the defect in ini814 in trans (T.McKee, personal 
communication). This observation would be unexpected if the 
mutation caused a structural aberration of the virion since 
the nature of such a defect is more likely to be exerted In 
a els-dominant fashion at the initiation of infection. Fro® 
these considerations, it is concluded that the abolition of* 
transinduction is the only significant effect of the 
insertion mutation.
Although the results presented here suggest that 
transinduction by Vmw65 is not essential for HS¥ 
replication, this interpretation: must be taken cautiously as 
the assays available are of limited sensitivity. The degree 
of impairment of transinduction is difficult to assess 
because the stimulation of expression from a transfected IE 
promoter is only 5 to 10-fold, and thus it is possible to 
state only that ini814 is reduced by at least 9 0% in its 
ability to stimulate IE transcription. Analysis of the 
ability to form IEC, as shown in figure 21, is more 
sensitive and by this criterion inl.814 is disabled by 95% or 
more. Nevertheless, each BSV particle contains 
approximately 1000 molecules of Vmw85 (Seine et a l ,, 19/;4)y 
and therefore a cumulative e_ nrm of a low residual activity 
might be sufficient to endow __nldl4 with the ability to for® 
plaques at the observed low efficiency.
In the absence of transinductioa b y  VmwS5r the I E  
genes would be expected to be transcribed according to the 
inherent strengths of their promoters, a feature that is 
presumably determined by interaction with cellular 
transcription, factors. For IE genes 1 and 2 W the 4 to 
5-fold reduction in RHA accumulation and protein synthesis 
correlates well with the 5 to 10—fold stimraiL cation of
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transcription in BHK cells from transfected IE promoters by 
Vmw65 (C.M.Preston, personal communication). The expression 
of IE genes 3 and 4, however, is greater than would be 
anticipated from transfection studies since these promoters 
are also activated by more than 5-fold (Preston et al.,
1984; Bzik & Preston, 1986; results in this thesis), and it 
is difficult to offer an obvious explanation for this 
apparent discrepancy. One possibility is that the 
enhancer-like sequence which lies between the promoters of 
IE genes 3 and 4 (Lang et al., 1984; Preston and Tannahill, 
19 84), rather than cis-responsive TAATGARAT elements, is the 
major requirement for transcription of these genes in the 
context of the viral genome. It is also noteworthy that the 
four upstream nucleotides of the TAATGARAT elements which 
control IE genes 1 and 2 confer a strong homology to the 
NFIII/OTF-1 binding site, the 'octamer1 element ATGCAAAT, 
whereas this is not the case (with one exception) for the 
TAATGARAT elements located between IE genes 3 and 4/5 (table 
2). If this correlation were meaningful it could be argued 
that the octamer sequences, rather than TAATGARAT elements, 
confer the response to Vmw65 in the context of the viral 
genome. Indeed, it has recently been shown that the virus 
induced complex that binds to TAATGARAT sequences of IE gene 
1 is composed of Vmw65 and OTF-1, and that the OTF-1 
specific binding site nucleotides (ATGC) are required for 
complex formation at this promoter region (Gerster and 
Roeder, 1988). However, this observation is not entirely 
consistent with the results presented here and by Preston et 
a l . (19 88) which demonstrate that IEC formation occurs at 
the IE4/5 TAATGARAT element (GCGGTAATGAGAT), a sequence, 
which does not contain a strong octamer homology.
Alternatively, the discrepancy between observations 
made from transfections and virus infections may result from 
considerable differences in stoichiometric relationships 
between DNA and protein factors under these different 
conditions. The findings using virus-infected cells are 
probably the more relevant.
Even though jjil814 lacks transinducing activity, 
the major polypeptides synthesized under 1 IE' conditions are 
still the IE proteins. Activation by Vmw65 is therefore not
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a definitive characteristic of IE genes, and other features 
must distinguish them from early and late genes. It may be 
that the presence of strong promoters and enhancer-like 
sequences determines the relatively high efficiency of IE 
gene transcription in the absence of IE proteins, but 
equally the TAATGARAT or other IE-specific elements might be 
responsible. It is known that cellular proteins bind to 
various sequences in IE gene upstream regions (Kristie and 
Roizman, 1987; Kristie and Roizman, 1988; Treizenberg et 
al., 1988b, O'Hare and Goding, 1988), and these factors 
might increase the availability of IE promoters to 
transcription components in the absence of Vmw65. Thus, the 
involvment of cellular transcription factors with 
IE-specific DNA sequences, rather than Vlmw65, may be the 
primary determinant of an IE gene.
Transinduction by Vmw65 is important for infection' 
only at low moi. At a superficial level, it is 
straightforward to view this property as a reasonable 
adaptation, since the initial interaction of HSV with an 
organism is likely to involve a small number of virus 
particles. The inability to replicate at low moi appears to 
result from the failure to produce IE proteins at levels 
sufficient to initiate infection, and it is probable that 
the reductions in VmwllO and Vmw63 are crucial, since these 
polypeptides are required for gene expression (Sacks et a l ., 
1985; Sacks and Schaffer, 1987; Stow and Stow, 1986). Thus, 
it seems that "threshold" levels of IE polypeptides must be 
attained before the lytic cascade ensues, and the role of 
Vmw65 is to ensure that such levels are reached, especially 
at low moi. The degree of stimulation of transcription of 
IE genes by Vmw65 at high moi is at best 4 to 5-fold in BHK 
cells. It is not clear whether this relatively small effect 
is wholly responsible for the greatly increased plaqueing 
efficiency that Vmw65 confers on virus. It is possible that 
transinduction is significantly greater than 4 to 5-fold at 
low moi. At high moi the transinducing function of Vinw65 
appears to be redundant, presumably because the basal 
expression of a higher number of IE genes per cell can 
override or compensate for an uninduced state. It is not 
clear whether the few cells in which infection with ini814
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results in the formation of a plaque represent a 
subpopulation in a particular metabolic state or simply 
random variation in the number of genomes per cell in 
response to infection.
Recently, Friedman et a l . (19 8 8 ) have shown that a 
transformed cell line which expresses the protein binding 
portion of Vmw65 supports virus growth poorly, presumably 
because the expressed protein sequesters the cell factor 
required to mediate transinduction. In essence, 
transinduction by Vmw65 is thought to be abrogated in the 
transformed cell line. The experiments dealt only with 
infection at low moi (0 . 1  or 0 . 3  pfu per cell), but the 
results are similar to those found with in!814, namely a big 
reduction in the efficiency of plaque formation, inefficient 
virus growth and a decrease (by 1 2 -fold) but not abolition ‘ 
of IE RNA accumulation (Friedman et a l ., 1988). From the 
results reported here, it would be predicted that virus 
replication in the transformed cells should not be as 
severely affected at high moi.
HSV-1 mutants with insertions and deletions within 
IE gene 1 (encoding VmwllO) have been constructed (Stow and 
Stow, 1986; R.D.Everett, personal communication), and the 
phenotypes of these mutants resemble _inl814 to an extent. 
Mutants lacking functional VmwllO grew efficiently in HeLa 
cells, inefficiently in BHK and Vero cells and very 
inefficiently in HFL cells. in!814 grew inefficiently in 
BHK, HeLa and Vero cells and very inefficiently in HFL 
cells. Therefore, although these mutants exhibit some 
similarities in plaqueing characteristics, qualitative 
differences also exist. Thus it is unlikely that the sole 
consequential function of Vmw65 is to control the level of 
VmwllO gene expression.
7 . 3  SPECULATIONS ON THE BIOLOGICAL RELEVANCE OF VMW65
DURING IN VIVO INFECTION
The basis for the difference in behaviour of in!814 
in BHK and HFL cells remains undefined. However, inl814 IE 
polypeptide synthesis appears to be more reduced in HFL 
cells than it is in BHK cells, especially with regard to
< X r\dV M W |lO  .
Vmw63- This might explain why in!814 growth is more
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restricted in HFL cells, since both of these proteins are 
known to be important for growth (Sacks et a l ., 1985; Sacks 
and Schaffer, 1987; Stow and Stow, 1986). Thus it may be 
that IE transcription in the absence of Vtnw65 is 
significantly less in HFL cells than in BHK cells at low 
moi. Alternatively, uninduced IE transcription may not be 
significantly different in the two cell-types, but HFL cells 
may be worse at compensating for reduced levels of IE 
proteins. If this were the case, then the more "permissive" 
cell-types may contain a factor(s) that can partially 
complement the defect in Vinw65, such as a cellular Vmw65 
homologue, IE protein homologues or a ubiquitous 
transactivator. A speculative analogy would be that certain 
in vivo cellular environments which lack such complementing 
factors would be less prone to lytic infection by viruses 
lacking Vmw6 5. Whatever the mechanism, it is clear that 
Vmw65 alleviates the cell-type dependent, cytopathic 
restrictions that in!814 exhibits in tissue culture. If 
this phenomenon was related to in vivo infections, then the 
presence of a Vmw65 gene may promote "infectivity" thereby 
increasing the chances of a virus's ability to infect a 
wider range of hosts, especially considering that OTFI/NFIII 
exists in a wide range of cell types. However, it is 
difficult to find any good evidence to support the 
correlation implied in this statement when comparisons with 
other herpesviruses are made. For instance, pseudorabies 
virus (PRV) does not apppear to possess a TIF since 
superinfection with this virus does not transinduce the PRV 
major IE gene promoter when transfected (Campbell and 
Preston, 19 87), and yet PRV grows efficiently in a wide 
variety of tissue cultures and host organisms. As 
disscussed in section 7.1, current evidence suggests that 
VZV also lacks a TIF and, although its growth is greatly 
reduced in tissue culture, the virus is very infectious in 
vivo. In addition, complementation of VZV with Vftiw65 
(UV-irradiated HSV-1) does not increase the cytopathicity of 
the virus in tissue culture (T.McKee, personal 
communication) suggesting that its restricted growth is not 
simply due to the absence of a functional TIF, It is 
interesting, however, that both PRV and VZV (alpha
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herpesviruses) contain good consensus TAATGARAT homologies 
upstream of their immediate early genes and that these 
genes, although unable to respond to components within their 
own respective virions, are stimulated by Vmw65 of HSV-1 
(Campbell and Preston, 19 87; T.McKee, personal 
communication). HCMV (a beta herpesvirus) does not contain 
TAATGARAT elements but has been reported to respond to HSV-1 
virion components (Spaete and Mocarski, 19 85), although this 
claim is not supported by other workers (Stinski and Roehr, 
1985; C.M.Preston, personal communication). HCMV does not 
transinduce HSV-1 IE genes (Batterson and Roizman, 1983; 
Stinski and Roehr, 1985) but does possess a virion factor 
capable of stimulating its own major IE gene (Spaete and 
Mocarski, 19 85; Stinski and Roehr, 19 85). Thus although 
HCMV is analagous to HSV-1 in that it possesses a TIF, the' 
host range of HCMV is limited in comparison. Therefore, the 
evolutionary molecular events that have led to these 
situations and their relevance, if any, to host range 
characteristics remain obscure.
The effect of Vmw65 on virus growth in tissue 
culture is only manifest at low moi. However, these 
conditions are probably a truer reflection of the initial 
stages of natural infections and so Vmw65 may contribute 
significantly to the pathogenicity of infections in vivo. 
Indeed this suggestion is supported by the finding that 
inl814 is avirulent in mice, even after injection of high 
doses. vmw65 may therefore be a good target for the design 
of new antiviral drugs. Furthermore, synthetic 
oligopeptides that correspond to the host factor binding 
domain of the polypeptide might interfere with the formation 
of the IE complex and consequently the function of Vmw65. 
Analogous studies have been used to disrupt the interaction 
between ribonucleotide reductase subunits (Dutia et al .,
1986; Cohen et a l ., 1986).
It is interesting to speculate on the role of Vmw65 
in HSV latency in the light of the phenotype of in!814, 
since the majority of genes, including IE genes, are silent 
during latency (Stevens et a l ., 1987; Spivack & Fraser,
1987), suggesting that an early transcriptional block may 
operate. One hypothesis is that Vmw65 may be lost or
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rendered inactive during transport of the HSV nucleocapsid 
from the neuronal cell surface to the nucleus (Kristie and 
Roizman, 19 88). Since the function of vmw65 as an IE gene 
inducer is manifest at the earliest stages of infection, it 
is possible that the biological circumstances of the 
polypeptide dictates wether a lytic or latent infection will 
be pursued. For instance, if Vtaw65 was absent or disabled 
in infected nuclei, then the viral DNA may become more 
susceptible to mechanisms that operate to establish the 
latent state (conceivably the suppression of IE genes). 
Conversely, the availability of functional Vmw65 in infected 
nulei could predispose HSV DNA to the mechanisms that 
operate to establish the lytic state (i.e. full expression 
of IE genes). From the results presented here, it is 
possible to predict that under circumstances of low moi, 
virus replication would not ensue and thus latency might be 
established. Support for this view comes from a recent 
finding that •noninfectious1 particles of in!814 can be 
retained by tissue culture cells after infection at low moi 
and can subsequently be reactivated to form plaques 
{C.M.Preston, personal communication). A similar 
observation was first made in studies with a mutant lacking 
VSmwllO (N.D. Stow & E.C. Stow, 1989). Therefore, the 
failure to transinduce IE transcription by interference with 
Vinw65 function is worthy of serious consideration as a basic 
precondition for latency.
7.4 FUTURE PROSPECTS
Future work concerns further understanding of the 
functional aspects of Vmw65 and its interaction with • 
cellular proteins, and expanding the knowledge of the 
biological relevance of transinduction in HSV.
Having defined certain regions of Vmw6 5 important 
for the formation of the transcription complex, it is 
possible to construct oligopeptides corresponding to these 
regions and to test their ability to competitively inhibit 
the association of the proteins involved. Inhibitive 
oligopeptides would be predicted to have antivirai effects. 
Alternatively, a detailed mutational analysis of targeted 
regions of Vmw65 may be required to localise more accurately
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specific amino acids involved in cell protein interaction.
In addition, it remains unknown whether Vtnw65 assembles into 
dimers or multimers in the transcription complex. Using the 
insertion and deletion mutants described here, it may be 
possible to determine whether Vtnw65 polypeptides function as 
a jnultimer, since mutant polypeptides with different 
aberrations might then be expected to complement each other 
when present together. This possibility could be 
investigated in cotransfection assays and by gel retardation 
analysis using mixtures of mutant proteins.
Regarding the biological relevance of 
transinduction in HSV, the possession of the mutant virus, 
_inl814, will facilitate many further aspects of 
investigation. For instance, the basis for cell type 
dependency which _inl814 exhibits remains obscure and 
warrants further study. Similarly, the events which 
determine "silent infections" by in!814 at low moi are of 
significant interest but are at present unknown. It will 
also be important to investigate the latency properties of 
_inl814 since the role of Vmw65 may influence the 
establishment of the latent state. In addition, the 
potential for Vmw65 to regulate cellular genes could be 
investigated since such events may influence HSV infections. 
Since _inl814 is the first Vmw65 transinducing mutant to be 
reported in the literature, the virus should provide a 
unique opportunity to the study of IE gene induction.
"Occam is the root of all knowledge"
Tony Cullen
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S U M M A R Y
T h e  h e r p e s  s im p le x  v iru s  ty p e  1 (H S V -1 )  p o ly p e p tid e  V m w 6 5  is a  stru ctu ra l 
c o m p o n e n t  o f  th e  v iru s p a r t ic le  a n d  is  a lso  r e sp o n s ib le  fo r  tr a n s-in d u ctio n  o f  im m e d ia te  
ea r ly  (IE ) tr a n sc r ip t io n . F u n c t io n a l d o m a in s  o f  th is  p o ly p e p tid e  w ere  in v e s t ig a te d  b y  
c o n str u c t in g  a se r ie s  o f  10 p la sm id s  e a c h  w ith  a 12 bp  in se r tio n  in  th e  g e n e  e n c o d in g  
V m w 6 5 . P la s m id s  w ere  a n a ly se d  for th e ir  a b ility  to  s t im u la te  IE  tr a n sc r ip t io n  in  sh o rt  
term  tr a n s fe c t io n  a ssa y s , an d  th e  a ltered  V m w 6 5  p o ly p e p tid e s  w ere  a ssa y e d  for th e  
a b ility  to  fo rm  an  IE -s p e c if ic  p r o t e in - D N A  c o m p le x  (IE C ) in vitro. A  d ir e c t c o r r e la tio n  
w a s  o b se r v e d  b e tw e e n  s t im u la t io n  o f  tr a n sc r ip t io n  a n d  fo r m a tio n  o f  IE C , stro n g ly  
su g g e s t in g  th a t  IE C  is an  im p o r ta n t  in te r m e d ia te  in  tr a n sc r ip t io n  a c t iv a t io n . P la sm id s  
w ere  a lso  te s te d  fo r  th e ir  a b ility  to  r escu e  th e  te m p e r a tu r e -se n s it iv e  m u ta t io n  in  th e  
H S V -2  a sse m b ly  m u ta n t  ts2 2 0 3 , s in c e  m a rk er  rescu e  a n a ly s is  in d ic a te d  th a t  th is  
m u ta tio n  m a p s  w ith in  th e  g e n e  e n c o d in g  V m w 6 5 . F iv e  p la sm id s  fa ile d  to  rescu e  
ts2203, th e r e b y  d e f in in g  r e g io n s  o f  V m w 6 5  req u ired  for  v iru s a sse m b ly . T h e  resu lts  
sh o w  th a t  d is t in c t  d o m a in s  e x is t  in  V m w 6 5  for a c t iv a t io n  o f  tr a n sc r ip t io n  a n d  a sse m b ly  
o f  v iru s.
I N T R O D U C T I O N
H e r p e s  s im p le x  v iru s (H S V ) g e n e  e x p r e s s io n  c a n  b e  c la ss if ie d  in to  th r ee  p h a se s , im m e d ia te  
e a r ly  (IE ), early  a n d  la te . T h e  IE  g e n e s  are th e  first to  b e  tr a n sc r ib e d  a fter  in fe c t io n  a n d  th e  g e n e  
p ro d u cts  (IE  p o ly p e p tid e s )  are e s s e n t ia l  for  ea r ly  a n d  la te  g e n e  e x p r e s s io n  (H o n e ss  &  R o iz m a n ,  
1 974; C le m e n ts  etal., 1977). A  d is t in c t iv e  fea tu re  o f  H S V  g e n e  a c t iv a t io n  is th e  s t im u la t io n  o f  IE  
tr a n sc r ip t io n  b y  th e  la te  p o ly p e p tid e  V m w 6 5 , th e  m a jo r  te g u m e n t  p r o te in  o th e r w ise  referred  to  
a s trans-in d u c in g  fa c to r  (T IF )  (P o s t  et ah, 1981;  B a tte r so n  & R o iz m a n , 1983; C a m p b e ll et al., 
1 984; P e lle tt  et al., 1985). T h e  tr a n s-in d u ctio n  o f  IE  g e n e  tr a n sc r ip t io n  b y  V m w 6 5  is d e p e n d e n t  
o n  th e  cis-a c t in g  reg u la to ry  e le m e n t  T A A T G A R A T  (w h e r e  R  r e p resen ts  a  p u r in e  res id u e)  
w h ic h  is lo c a te d  u p str e a m  o f  th e  m R N A  c a p  s ite s  o f  a ll IE  g e n e s  (M a c k e m  & R o iz m a n , 1982  a,b\ 
K r is t ie  &  R o iz m a n , 1 984; P r e sto n  et al., 1 984; G a ffn e y  et al., 1985; B z ik  &  P resto n , 1986;  
O ’H a re  &  H a y w a r d , 1987).
P o ly p e p t id e  V m w 6 5  is th e  o n ly  v ira l p r o te in  req u ired  for  r e c o g n it io n  o f  T A A T G A R A T , s in c e  
tr a n s-in d u ctio n  c a n  b e  a c h ie v e d  b y  tr a n s fe c t io n  o f  p la sm id s  w h ic h  e n c o d e  V m w 6 5  a lo n e  
(C a m p b e ll et al., 1 984; P e lle tt  et al., 1985). It  h a s re c e n tly  b e e n  sh o w n  th a t  V m w 6 5  in te ra c ts  w ith  
c e ll fa c to r s , p ro b a b ly  in c lu d in g  n u c lea r  fa c to r  II I , to  fo rm  a  c o m p le x  (IE C ) w h ic h  b in d s  
s p e c if ic a lly  to  D N A  se q u e n c e s  c o n ta in in g  T A A T G A R A T  (M c K n ig h t  et al., 1 987; O ’H a re  &  
G o d in g , 1 988; P r e sto n  et al., 1988), a n d  it  is  th o u g h t th a t IE C  is an  im p o r ta n t  in te r m e d ia te  in  
th e  in d u c tio n  o f  IE  g e n e  tr a n sc r ip t io n . T h u s , V m w 6 5  is  in v o lv e d  in  in it ia t io n  o f  v ira l g e n e  
e x p r e s s io n  a t a v ery  ea r ly  sta g e  o f  in fe c t io n .
A p a r t  fro m  its  ro le  in  s t im u la t in g  IE  tr a n sc r ip t io n , V m w 6 5  is an  a b u n d a n t  v ira l stru ctu ra l 
p r o te in , e s t im a te d  to  b e  p r e se n t  a t a p p ro x . 1000  m o le c u le s  p er  v ir io n  (H e in e  et al., 1974;
f  Present address: Department of Molecular Biology, Edinburgh University, K ing’s Buildings, Mayfield Road, 
Edinburgh EH9 3JR, U .K .
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R o iz m a n  & F u r lo n g , 1974). It  is  th e  m a jo r  p o ly p e p tid e  o f  th e  te g u m e n t, a n d  th e r e fo r e  w o u ld  be  
e x p e c te d  to  b e  im p o r ta n t  fo r  th e  m a in te n a n c e  o f  v iru s  stru ctu re .
T o  d e fin e  fu n c t io n a l d o m a in s  o f  V m w 6 5  a n d  h e n c e  o b ta in  fu r th er  in fo r m a t io n  o n  its  m o d e  o f  
a c t io n  b o th  as a tr a n sc r ip t io n  a c t iv a to r  a n d  as a stru ctu ra l p r o te in , w e  h a v e  co n str u c te d  a ser ies  
o f  in -fr a m e  o lig o n u c le o t id e  lin k e r  in se r tio n  m u ta n ts  in  th e  g e n e  th a t  e n c o d e s  th e  p o ly p e p tid e . 
T h is  a p p r o a c h  w a s  p o ss ib le  b e c a u se  th e  g e n e  h a s  b e e n  id e n tif ie d , c lo n e d  a n d  its  n u c le o t id e  
se q u e n c e  d e te r m in e d  (C a m p b e ll et al., 19 8 4 ; D a lr y m p le  et al., 1 9 8 5 ; P e lle tt  et al., 1985). T h e  
resu lts  fro m  a n  a n a ly s is  o f  10 m u ta n ts  in d ic a te  th a t  th e  a b il ity  o f  V m w 6 5  to  fo rm  IE C  co rre la tes  
w ith  its  tra n s-in d u c in g  a c t iv ity , a n d  th a t  sp e c if ic  d o m a in s  req u ired  fo r  fra /w -in d u ctio n  an d  
co rre c t  v ir io n  a sse m b ly  c a n  b e  d is t in g u is h e d  w ith in  th e  p o ly p e p tid e .
M E T H O D S
Cells and viruses. BHK-21 (C l3) cells (Macpherson & Stoker, 1962) were used throughout. The HSV type 2 
(HSV-2) temperature-sensitive (ts) mutant ts2203 was derived from strain HG52.
Plasmids. Plasmid pIE4/5CAT was constructed by replacing the HSV-2 promoter in pLW2 (Gaffney et al., 
1985) with the promoter and upstream regulatory fragments o f the HSV-1 IE gene 4/5. The IE4/5 upstream 
fragment used was defined by EcoRI and Sail sites in plasmid pTK N7 (Preston et al., 1984) which represent 
nucleotides —402 and —240 respectively. The EcoRI site was converted to a Clal site by insertion of an 
oligonucleotide linker (CATCGATG). The IE4/5 promoter was contained in a Sail (converted from Smal)/Nrul 
fragment spanning nucleotides —69 to +  99 in plasmid pS20TK (Murchie & M cGeoch, 1982; Prestoneta l., 1984). 
The upstream and promoter fragments were ligated together at the SalI site, and the resultant 330 bp Clal/Nrul 
product was inserted into pLW2 between the Accl site and a filled-in BamHl site. Thus the HSV-2 IE4/5 promoter 
in pLW2 was replaced by the upstream and promoter sequences o f the HSV-1 IE4/5 gene, without the HSV-1 oris 
sequences (Stow & McMonagle, 1983; Preston et al., 1984).
Plasmid pMC17 was constructed from pM C l, a plasmid that consists o f a 2609 bp fragment defined by map 
coordinates 0-669 to 0-685 on the prototype HSV-1 genome (Campbell et al., 1984) cloned into pUC9 (Fig. 1). A  
1521 bp EcoRV/Fokl fragment of pM C l, containing the entire coding sequence for Vmw65, was cloned into the 
H incll site o f pUC9 to give pMC17 (Fig. 2). The ///«dIII/£’coRI fragment from pMC17 was inserted into the 
corresponding sites o f the multilinker in pGEM 2 (Promega Biotech, Madison, Wis., U .S.A .) to give pGEM TIF  
(Fig. 2). Plasmid pGEM TIF therefore contained the entire coding sequence of Vmw65 under the control of the 
bacteriophage T7 promoter. Insertion mutations of Vmw65 were introduced into pGEM TIF by exchanging D N A  
fragments o f pGEM TIF containing coding sequence with corresponding fragments o f the pM C l, in series of  
plasmids that contained the insertion (Fig. 2). Only those mutations between the unique Apal and Sstl restriction 
sites were introduced into pGEM TIF, and the resulting constructions were designated pG EM TIF.in(X).
Construction o f  insertion mutants. Plasmid pMC 1 was cleaved with H a elll  in the presence o f ethidium bromide 
using conditions found empirically to produce a maximum of singly cut linear molecules (Fig. 1). Plasmid D N A  (2 
pg) was digested with 2 units o f H a elll for 30 min at 37 °C with concentrations of ethidium bromide varying from 
10 to 500 pg/ml, in a total volume of 20 pi. Samples containing a high proportion of singly cut molecules were 
identified, and 0-2 pg of D N A  was ligated with a 50-fold molar excess of phosphorylated 12 bp BamHl linker 
oligonucleotide (CGCGGATCCGCG). D N A  ligase was inactivated by heating for 5 min at 60 °C and the D N A  
was digested with BamHl. Linear molecules were resolved by electrophoresis on a 1 % agarose gel, eluted from the 
gel and religated. Plasmids containing linker insertions were identified by analysis o f small scale plasmid 
preparations. The locations of linker insertion sites were determined by restriction endonuclease mapping.
Transfections o f  BH K cells and chloramphenicol acetyltransferase (CAT) assay analysis. Monolayers o f 106 BHK  
cells were co-transfected at 37 °C with 1 pg of insertion mutant plasmid and 1 pg of pIE4/5CAT by the calcium  
phosphate precipitation method (Campbell et al., 1984). The total amount of D N A  present was adjusted to 3-0 pg 
by the addition of pUC9.
CAT assays were carried out as described by Gorman et al. (1982). The radioactivity in the substrate and the 
acetylated product spots was determined by scintillation counting to calculate the percentage conversion of 
substrate to product. The protein concentration of each extract was determined (Bradford, 1976) and the 
percentage conversion per mg of protein calculated. The amount of extract tested was varied to ensure that the 
linear response range of the assay was used.
In vitro transcription o f  pGEM TIF .in plasmids and translation o f  RNA templates. The pGEM TIF. in plasmids 
were cleaved with EcoRl before the transcription reaction. In vitro transcription was performed using the 
Riboprobe system (Promega Biotech) following the manufacturer’s protocol and incubating 1 pg of plasmid D N A , 
0-5 mM-G(5')ppp(5')G (Pharmacia) and 0-4 mM o f each nucleoside triphosphate in a total volume o f 25 pi at 37 °C 
for 1 h.
In vitro translation was carried out by addition o f 2-5 pi of transcription reaction mixture to 20 pi of rabbit
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Fig. 1. A map of the HSV-1 genome in the prototype orientation, and position o f Vmw65 (upper 
section). U L and U s are the long and short unique regions bounded by repeated sequences represented 
by open boxes. pM Cl contains the HSV-1 sequence between Sail and Xhol sites cloned into pUC9. The 
lower section shows the construction of insertion mutations within the gene encoding Vmw65, as 
described in Methods.
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Fig. 2. Construction o f templates for in vitro transcription, (i) pMC17 was constructed by insertion of a 
1521 bp EcoRN jFokl fragment from pM Cl into the H in d i  site o f pUC9. (ii) The 1521 bp fragment was 
excised from pMC17 with H indlll and £coRI and cloned between the H indlll and EcoRl sites of the 
pGEM 2 transcription vector, to give pGEMTIF. (iii) Construction of insertion mutants. A 1048 bp 
Apal/Sstl fragment from the pM Cl .in plasmids was excised and exchanged with the corresponding 
fragment in pGEM TIF to give the pG EM T IF.in series.
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reticulocyte lysate (Amersham). Duplicate samples were incubated for 90 min at 30 °C either in the presence or in 
the absence of 25 to 50 pCi [35S]methionine (sp. act. >  800 Ci/mmol) in a 25 pi reaction mixture. Non-radioactive 
samples were stored at - 7 0 ° C  for use in gel retardation assays. The radiolabelled translation mixture was 
processed for SD S-PA G E  as described by Preston (1979).
Gel retardation analysis o f  mutant polypeptides. Formation and analysis o f protein-D N A  complexes was 
performed as described by Preston et al. (1988). A 77 bp D N A  fragment, containing IE4/5-specific sequences 
located between Smal sites at — 362 and — 297 relative to the transcription start site plus extra nucleotides due to 
the presence o f BamHl and B glll linkers, was end-labelled with 32P and purified from a polyacrylamide gel. 
Reaction mixtures contained the following components: 10 mM-HEPES pH 7-9, 0-6 mM-dithiothreitol, 2-3 mM- 
M gCl2, 85 mM-NaCl, 0-1 mg/ml bovine serum albumin, 4 pg poly(dI)-poly(dC), 0-2 ng 32P-3' end-labelled 
fragment, 5-0 pg mock-infected HeLa cell nuclear extract and 5 pi reticulocyte lysate which had been incubated 
with Vmw65 m R N A  synthesized in vitro. Incubation was at 25 C for 30 min, and reaction mixtures were loaded 
directly onto a 3-5% polyacrylamide gel. After electrophoresis for 3-5 h at 160 V, the gel was dried and exposed for 
autoradiography.
Marker rescue analysis. Marker rescue was carried out as described previously (Stow et al., 1978). D N A  (0-2 pg) 
of the HSV-2 ts mutant W2203 and linearized plasmid D N A  (0-5 pg) was co-transfected onto monolayers of 106 
BHK cells by the calcium phosphate method (Campbell et al., 1984). The total amount o f D N A  added was 
adjusted to 3-0 pg using calf thymus D N A . After 3 to 4 h the monolayers were treated with 25% dimethyl 
sulphoxide and incubated at 31 °C for 3 days. Virus was harvested and titrated at the permissive temperature (PT) 
of 31 °C and the non-permissive temperature (NPT) o f 38-5 °C. The efficiency of marker rescue was determined 
from the formula (titre at NPT/titre at PT) x 100.
R E S U L T S
Isolation o f insertion mutants within the Vmw65-coding region
P la s m id  p M C l c o n ta in s  th e  g e n e  e n c o d in g  V m w 6 5  a n d  n o  o th e r  c o m p le te  rea d in g  fram es  
fro m  H S V -1  o f  a c c e p ta b le  c o d o n  u sa g e  (D a lr y m p le  et al., 1 985; P e lle tt  et al., 1985). T h e  
a p p r o a c h  u sed  to  m u ta g e n iz e  V m w 6 5  w a s  to  co n str u c t  a se r ie s  o f  m u ta n ts  e a c h  w ith  a 12 bp  
BamHl o l ig o n u c le o t id e  in se r te d  in to  p M C l  at a  d iffe r e n t lo c a t io n  w ith in  th e  V m w 6 5 -c o d in g  
reg io n , as d e sc r ib e d  in  M e th o d s  (F ig . 1).
P la s m id s  w ith  in se r tio n s  a t 10 o f  th e  17 H aelll  s ite s  w ith in  th e  g e n e  w ere  iso la te d . A  su m m ary  
o f  th e  m u ta n ts  o b ta in e d , to g e th e r  w ith  th e ir  p o s it io n s  an d  th e  resu lta n t a m in o  a c id  c h a n g e s , is 
sh o w n  in  F ig . 6.
T r a n s-inducing activity o f insertion mutants
P r e v io u s  s tu d ie s  h a v e  sh o w n  th a t  c lo n e d  H S V  D N A  fr a g m e n ts  w h ic h  e n c o d e  V m w 6 5  can  
s t im u la te  tr a n sc r ip t io n  fro m  IE  p ro m o ter s  in  sh o rt term  c o -tr a n s fe c tio n  a ssa y s  (C a m p b e ll et a l, 
1984). T h is  a p p r o a c h  w a s  u se d  to  a n a ly se  th e  fra n s-in d u c in g  p h e n o ty p e  o f  in se r tio n  m u ta n ts, 
a n d  th e  resu lts  o f  a r e p r e se n ta tiv e  e x p e r im e n t  are sh o w n  in  F ig . 3. W h e n  a  p la sm id  c o n ta in in g  
th e  H S V -1  IE 4 /5  p ro m o ter  a n d  u p strea m  reg u la to ry  se q u e n c e s  l in k e d  to  th e  C A T  g e n e  
(p I E 4 /5 C A T )  w a s tr a n sfe c te d  a lo n e  in to  B H K  c e lls  a b a sa l le v e l o f  C A T  e x p r e s s io n  fro m  th is  
p ro m o ter  w a s  d e te c te d  (F ig . 3, la n e  5). W h e n  p M C l w a s in c lu d e d  in  th e  tr a n sfe c t io n , h o w e v e r , 
C A T  a c t iv ity  in c r e a se d  by six -  to  e ig h tfo ld  (F ig . 3, la n e  1). T h e  in ser tio n  in  H aelll s ite  4  ( in 4 )  
d id  n o t  a ffec t frarcs-induction  (F ig . 3, la n e  2), w h erea s  th e  in se r tio n  in  H aelll s ite s  8 ( in 8 ) a n d  14 
( in  14) (F ig . 3, la n e s  3 a n d  4  r e sp e c t iv e ly )  e s se n tia lly  a b o lish e d  th e  e ffe c t. A  su m m a ry  o f  th e  
resu lts  from  th ree  to  s ix  e x p e r im e n ts  u s in g  th e  c o m p le te  se r ie s  o f  p la sm id s  is sh o w n  in  T a b le  1.
S ix  o f  th e  m u ta n t p la sm id s  ( in 2 , in 4 , in 7 , in i  1, i n l 5  a n d  in  17) w ere  in d is t in g u ish a b le  from  
p M C l in  th e ir  a b ility  to  s t im u la te  IE  tr a n sc r ip tio n , sh o w in g  th a t in se r tio n s  o f  fo u r  a m in o  a c id s  
c a n  b e  to lera te d  in  c e r ta in  r e g io n s  o f  V m w 6 5 . T h r e e  m u ta n ts , in 8 , in 9  an d  in l4 ,  w ere  red u ced  by  
90%  or m o re  in  th e ir  rran s-in d u cin g  a b ility  a n d  th u s rep resen t p la sm id s  in  w h ic h  th e  in ser tio n  
c a u se d  a  stro n g  im p a ir m e n t o f  a c t iv ity , w ith in  th e  l im its  o f  s e n s it iv ity  o f  th e  a ssa y . A n y  res id u a l  
a c t iv ity  in  in 8  a n d  i n l 4  a m o u n te d  to  n o  m o re  th a n  5%  o f  th e  p M C l le v e l. O n e  p la sm id , in l2 ,  
g a v e  a n  a c t iv ity  w h ic h  w a s  red u ced  b y  a b o u t 50% .
In  an  a d d itio n a l c o - tr a n s fe c tio n  e x p e r im e n t  p la sm id  p IE 2 T K , w h ic h  c o n ta in s  th e  H S V -1  IE  
g e n e  2 p r o m o te r  a n d  u p str e a m  regu la to ry  re g io n  l in k e d  to  th e  H S V -1  th y m id in e  k in a se  (T K )-  
c o d in g  se q u e n c e s , w a s su b s titu te d  for p I E 4 /5 C A T  a n d  tr a n s fe c t io n s  w ere  carr ied  o u t at b o th  31
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Fig. 3. Trans-induction of IE transcription by mutant plasmids. CAT assays were carried out on 
extracts o f BHK cells co-transfected with pIE4/5CAT plus wt plasmid (lane 1), mutant plasmids in4 
(lane 2), in8 (lane 3) or in l4  (lane 4), or pUC9 (lane 5). The positions of 3-acetyl chloramphenicol (3- 
A C .C A M ) and chloramphenicol (CAM) are indicated.
T a b le  1. T r a n s-inducing activity o f Vmw65 mutants 
Plasmid Trans-inducing activity (%)*
pM Cl 100
in2 88 (13)
in4 104 (34)
in7 78 (19)
in8 4 (1 )
in9 10 (5)
ini 1 112 (13)
in l2 46 (13)
in l4 3 (4)
in 15 111 (13)
in l7 105 (30)
No pM Cl 0
* The stimulation of expression from the IE4/5 promoter is given as a percentage of that obtained in parallel 
experiments with pM C l. The mean of at least three independent determinations was calculated and the standard 
error is presented in parentheses.
a n d  38-5 °C . T h e  e ffe c t  o f  th e  in ser tio n  m u ta n t p la sm id s o n  T K  e x p r e ss io n  from  p IE 2 T K  
(resu lts  n o t  sh o w n ) w a s a n a lo g o u s  to  th e  e ffe c t  o n  C A T  e x p r e ss io n  from  p I E 4 /5 C A T  at e ith er  
tem p er a tu re , sh o w in g  th a t th e  n a tu re  o f  th e  ‘rep o rter’ g e n e  or IE  p rom o ter  d id  n o t a ffec t th e  
c o n c lu s io n s  a n d  th a t n o n e  o f  th e  in ser tio n s  resu lted  in  a p ro te in  ts for tra^ s-a ctiv a tio n .
T h u s th e  10 in se r tio n  m u ta n ts  e x h ib ite d  trans-'mducing p h e n o ty p e s  ra n g in g  from  n o  a ltera tio n  
to  a b o lit io n  o f  a c t iv ity .
Formation o f a protein-DNA complex directed by Vmw65 synthesized in  v itro
V m w 6 5  a ss o c ia te s  w ith  ce llu la r  fa c to r s to  fo rm  a c o m p le x , IE C , w h ic h  b in d s sp ec ifica lly  to  
T A A T G A R A T  e le m e n ts  (M c K n ig h t  et al., 1987; P resto n  et al., 1988). T h e  su p p o s it io n  in h eren t  
in  th e se  f in d in g s , th a t IE C  is im p o r ta n t for IE  g e n e  in d u c tio n , w a s in v e st ig a te d  by co rre la tin g  
th e  a b ility  o f  m u ta ted  fo rm s o f  V m w 6 5  to  p ro d u ce  th e  c o m p le x  w ith  th e ir  fran s-in d u cin g  
p h e n o ty p e s . W ild -ty p e  (w t) an d  m u ta n t V m w 6 5  w ere  sy n th e s iz e d  by co u p led  in vitro 
tr a n sc r ip tio n  a n d  tra n sla tio n , u sin g  th e  p G E M  sy stem . T h e  p ro d u cts w ere  in cu b a ted  w ith  H e L a
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Fig. 4. In vitro translation of Vmw65 polypeptides. R N A  transcribed from the pG EM TIF.in plasmid 
series was translated in vitro in the presence o f [35S]methionine. Lane 1, lysate without added RNA; 
lane 2, the translated products of R N A  transcribed from pGEM TIF; lanes 3 to 9 show the translated 
products from pG EM T IF.in7, -8, -9, -11, -12, -14 and -15 respectively.
c e ll n u c lea r  ex tr a c ts  an d  IE C  w a s d e te c te d  b y  a n a ly s is  o f  re ta r d a tio n  o f  th e  electrophoretic  
m o b ility  o f  a 77 bp  D N A  fr a g m e n t c o n ta in in g  th e  reg u la to ry  r e g io n , in c lu d in g  T A A T G A R A T , 
o f  IE  g e n e  4 /5 . F ig . 4  sh o w s th a t  V m w 6 5  is th e  m R N A -d e p e n d e n t  p r o te in  sy n th esize d  in vitro 
u sin g  th e  w t an d  m u ta n t  p la sm id  te m p la te s . T h is  resu lt ru les o u t  th e  p o ss ib ility  th a t fram eshift 
m u ta tio n s , re su ltin g  from  d e le t io n  o f  a te r m in a l n u c le o t id e  d u r in g  c lo n in g , occurred  during 
co n str u c t io n  o f  th e  in se r tio n  m u ta n ts .
T h e  fo r m a tio n  o f  IE C  by V m w 6 5  sy n th e s iz e d  in vitro w a s  a n a ly se d  b y  g e l retard ation  assays 
(F ig . 5). W h e n  V m w 6 5  ex tr a c te d  fro m  v iru s  p a r t ic le s  w a s  a d d e d  to  r e a c t io n  m ix tu res contain ing  
H e L a  cell n u c lea r  e x tr a c t a n d  th e  32P -la b e lle d  77 b p  D N A  fr a g m e n t, th e  slo w ly  m igrating  
c o m p le x  IE C  w a s fo rm e d  (la n e  1). A d d it io n  o f  r e t ic u lo c y te  ly sa te  c o n ta in in g  V m w 65  
sy n th e s iz e d  in vitro, in  p la c e  o f  H S V  v ir io n  e x tr a c t , a lso  resu lted  in  th e  p r o d u ctio n  o f  IE C  (lane
2), w h erea s  th is  c o m p le x  w a s  n o t  fo rm e d  w h e n  r e t ic u lo c y te  ly sa te  in c u b a te d  w ith o u t m R N A  was 
a d d ed  (la n e  3). T h e  c o m p le x  la b e lle d  H C 3 , p r e se n t  in  a ll la n e s , is  th e  resu lt o f  H eL a  cell nuclear 
p r o te in s  b in d in g  to  T A A T G A R A T  (K r is t ie  & R o iz m a n , 1987;  O ’H a re  & G o d in g , 1988; 
P resto n  et al., 1988), a n d  th e  b a n d  in  la n e  3 w h ic h  m ig r a te d  m o r e  ra p id ly  th a n  IE C  probably  
r ep resen ts th e  p r e v io u s ly  d e sc r ib e d  c o m p le x  H C 4 , w h ic h  resu lts  fro m  n o n -sp ec ific  b inding o f  
H e L a  c e ll p r o te in s  to  D N A  fr a g m e n ts  (P r e s to n  et al., 1988). H C 4  w a s  o b ser v ed  on ly  when  
r e t ic u lo c y te  ly sa te  w ith o u t  tr a n sc r ip t io n  m ix tu r e  w a s  u se d  in  th e  g e l retard ation  assay, 
p resu m a b ly  b e c a u se  p G E M  D N A  fro m  th e  tr a n sc r ip t io n  m ix  a c ts  a s an  a d d itio n a l non-specific
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Fig. 5. Gel retardation assay using in vitro synthesized Vmw65 products. A 77 bp D N A  fragment 
containing the IE4/5 regulatory sequence was incubated with HeLa cell nuclear extract and virion 
extract (lane 1), rabbit reticulocyte lysate (lane 3), lysate containing Vmw65 synthesized in vitro (lane 2), 
or lysate containing mutant proteins synthesized in vitro from pGEM TIF. in7, -8, -9, -11, -12, -14 and 
-15 (lanes 4 to 10 respectively). The positions of the complexes IEC, HC3 and HC4 are indicated.
c o m p e tito r . In  co n tro l e x p e r im e n ts  it  w a s  fo u n d  th a t H e L a  ce ll n u c lea r  ex tra c t w a s n ecessa ry  for  
th e  fo r m a tio n  o f  I E C ; th u s th e  r e t ic u lo c y te  ly sa te  d id  n o t c o n ta in  s ig n if ic a n t  a m o u n ts  o f  th e  ce ll 
p o ly p e p tid e  th a t in te ra c ts  w ith  V m w 6 5  (resu lts n o t sh o w n ).
W h e n  m u ta n t V m w 6 5  sy n th e s iz e d  in vitro w a s  u sed  in  th e  g e l re ta rd a tio n  a ssay , a stron g  
co rre la tio n  b e tw e e n  c o m p le x  fo r m a tio n  an d  tra m -in d u c in g  a c t iv ity  w a s o b ser v ed . M u ta n ts  in 7 , 
i n l l  a n d  in  15 a ll fo rm e d  IE C  (la n e s  4 , 7 a n d  10 r e sp e c t iv e ly )  an d  w ere  a lso  c a p a b le  o f  
st im u la t in g  tr a n sc r ip tio n  from  IE  p ro m o ters. S im ila r ly  m u ta n ts  in 8 , in 9  an d  i n l 4  d id  n o t form  
IE C  ( la n e s  5, 6 a n d  9 r e sp e c t iv e ly )  an d  d id  n o t tra m -in d u c e  IE  tra n scr ip tio n . T h e  co rre la tio n  is 
h ig h lig h te d  by in  12 w h ic h  had  in te r m e d ia te  tra m -in d u c in g  a c t iv ity  an d  fo rm e d  th e  IE C  bu t in  
le sser  a m o u n ts  (la n e  8). T h e se  resu lts stro n g ly  su g g est  th a t th e  p ro d u ctio n  o f  IE C  is an  im p o r ta n t  
sta g e  in  th e  st im u la t io n  o f  tra n scr ip tio n  fro m  IE  p ro m oters.
Marker rescue ofts2203 by insertion mutants
T o  in v e s t ig a te  d o m a in s  o f  V m w 6 5  im p o r ta n t for  th e  correct a sse m b ly  o f  v ir io n s, m u ta n t  
p la sm id s  w ere  a n a ly se d  for th e  a b ility  to  rescu e  th e  ts m u ta t io n  in  th e  H S V -2  m u ta n t 152203. T h is
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T a b le  2. Marker rescue o f  t s2203 by mutant plasmids
Mutation Marker rescue (N PT /PT  x 100):
B glll i 22-0
B glll i (tel 3) <0-001
pM Cl 2-6
in2 2-1
in4 <0-001
in7 0-2
in8 <0-001
in9 <0-001
in ll <0-05
in l2 <0-001
in l4 0-77
in l5 1-2
in l7 1-8
N o pM Cl <0-02
* The ability o f mutant plasmids to rescue the ts lesion in HSV-2 te2203 is expressed as the percentage of 
resulting non-te recombinants in the total virus progeny. The results are a mean of two independent 
determinations.
m u ta n t  w a s  d e r iv e d  fro m  th e  d o u b le  m u ta n t  ts 13 (H a llib u r to n  &  T im b u ry , 1976), w h ic h  is 
k n o w n  to  c o n ta in  a ts m u ta t io n  in  th e  a lk a lin e  e x o n u c le a s e  a n d  a  se c o n d  ts m u ta t io n  loca ted  
b e tw e e n  g e n o m e  c o o r d in a te s  0 -64  a n d  0 -70  w h ic h  a ffe c ts  th e  v iru s  p a r t ic le  (M o ss  et al., 1979). 
T h e  BglII  i fr a g m e n t (g e n o m e  lo c a t io n  0 -62  to  0 -72 ) o f  to l3  w a s  su b c lo n e d , r e c o m b in e d  w ith  w t 
H S V -2  D N A ,  a n d  a ts m u ta n t , ts2203, w a s  iso la te d  a n d  p u r ified . T h e  lo c a t io n  o f  th e  m u ta tio n  in  
ts2203 w a s  e s ta b lish e d  b y  m a rk er  rescu e  e x p e r im e n ts  u s in g  c lo n e d  H S V -2  D N A  fra g m e n ts, and  
w a s m a p p e d  to  a  D N A  fr a g m e n t w h ic h  o v e r la p s  th e  5' e n d  o f  th e  g e n e  e n c o d in g  V m w 6 5 , as 
d e d u c e d  fro m  c o m p a r iso n  w ith  th e  k n o w n  g e n e  a r r a n g e m e n t o f  H S V -1  (F . H . R a m sa y  & V . G . 
P r e sto n , u n p u b lish e d  d a ta ).
T h e  m u ta t io n  in  ts2 2 0 3  d id  n o t  a ffec t  th e  p r o d u c tio n  o f  IE  p o ly p e p tid e s  a t 38-5 °C  o v er  a range  
o f  in p u t m .o .i . (resu lts  n o t  sh o w n ), a n d  c lo n e d  BglII  i fro m  fa l 3 w a s  as e f fe c t iv e  as Bglll i from  w t  
H S V -2  in  traTM -inducing IE  p ro m o ter s  a t 31 o r  38-5 °C  in  tr a n s ie n t  e x p r e s s io n  a ssa y s  (resu lts not  
sh o w n ). T h e  m u ta t io n  in  ta2203 th e r e fo r e  a p p e a r s  to  h a v e  n o  e ffe c t  o n  IE  tra n scr ip tio n , and  
furth er  s tu d ie s  h a v e  r e v e a le d  a  b lo c k  in  v iru s  a sse m b ly  a t 38-5 °C  (F . H . R a m sa y  & V . G . 
P resto n , u n p u b lish e d  d a ta ).
In te r ty p ic  m a rk er  rescu e  w a s  ca rr ied  o u t  u s in g  p M C l  a n d  th e  in se r tio n  m u ta n ts , o n  the  
a ssu m p tio n  th a t  p la sm id s  w h ic h  fa ile d  to  resc u e  ts2203 h a d  d e fe c ts  in c o m p a t ib le  w ith  the  
p rop er  a sse m b ly  o f  v ir io n s , p r o v id e d  th e  ts2203 m u ta t io n  is  in  th e  H S V -2  co u n terp art o f  
V m w 6 5 . I t  w a s  fo u n d  th a t p M C l r e sc u e d  ts2203 a lth o u g h , a s e x p e c te d , th e  e ffic ien cy  w a s low er  
th a n  w ith  H S V -2  fra g m e n ts  (T a b le  2). F iv e  m u ta n ts  ( in 2 , in 7 , i n l4 ,  i n l 5  a n d  in l7 )  rescued  
ta2203, w h e r e a s  fiv e  ( in 4 , in 8 , in 9 , in i  1 a n d  in l 2 )  d id  n o t. O n e  c o n c lu s io n  fro m  th is  ex p er im en t  
is  th a t th e  ts2203 m u ta t io n  m u st  lie  w ith in  th e  c o d in g  se q u e n c e s  o f  th e  H S V -2  h o m o lo g u e  o f  
V m w 6 5 , s in c e  th is  is  th e  o n ly  g e n e  a ffe c te d  b y  th e  o lig o n u c le o t id e  in se r tio n s  in 4 , in 8 , in 9 , i n l l  
an d  in  12. F u r th erm o re , th e  fa ilu r e  o f  th e se  p la sm id s  to  re sc u e  ts2203 in d ic a te s  th a t th e  in sertion s  
affec t  r e g io n s  e s se n t ia l for  v iru s a sse m b ly . T h e  in te r p r e ta t io n  o f  p o s it iv e  rescu e  is le ss  clear, 
s in c e  tw o  m e c h a n ism s  m ig h t  o p era te . S u ch  a resu lt m a y  h a v e  b e e n  o b ta in e d  b eca u se  the  
in se r tio n  d o e s  n o t  a ffec t  v ir io n  a sse m b ly , b u t it  is  a lso  p o ss ib le  th a t  th e  in se r tio n  lie s  sufficiently  
far fro m  th e  ts2 2 0 3  m u ta t io n  th a t in tr a g e n ic  r e c o m b in a tio n , w ith o u t  in c o r p o r a tio n  o f  the  
m u ta tio n  in to  v ira l D N A ,  c o u ld  a c c o u n t  fo r  th e  o b se r v a tio n s . T h e  la tter  a rg u m en t d o es  not 
a p p ly  to  in 7 , s in c e  b o th  in 4  a n d  in 8  w ere  u n a b le  to  r escu e  ts2203, n o r  to  in 2  i f  th e  ts2203  m u ta tion  
is  tru ly a t th e  5' e n d  o f  th e  c o d in g  se q u e n c e s .
T h u s , o f  th e  f iv e  s ite s  a t w h ic h  in se r tio n s  p r e v e n t  rescu e  o n ly  tw o  (in 8  a n d  in 9 ) are lo c i o f  
m ajor im p o r ta n c e  for b o th  v iru s a ss e m b ly  a n d  m m s-in d u c t io n  o f  IE  tr a n sc r ip tio n . T h e  features 
o f  V m w 6 5  req u ired  for v ir io n  a sse m b ly  are n o t  in v a r ia b ly  th e  sa m e  as th o se  in v o lv e d  in 
tr a n sc r ip t io n  a c t iv a tio n .
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Fig. 6. A summary of the phenotypes o f mutated Vmw65 polypeptides. A +  sign denotes that the 
polypeptide has wt phenotype, — indicates that the function has been abolished, ±  represents 
intermediate activity, and n d  means that activity was not determined. The inserted amino acids, 
determined by the reading frame o f the insertion site, are (a) ARIR, (b) ADPR or (c) RGSA. The scale 
bar represents a length of 50 amino acids.
D I S C U S S I O N
In se r t io n  o f  a  12 bp  o lig o n u c le o tid e  in to  c o d in g  se q u e n c e s  is  a  c o n v e n ie n t  m e th o d  for m a k in g  
r e la t iv e ly  sm a ll c h a n g e s  in  th e  a m in o  a c id  se q u e n c e  o f  a p ro te in . T h ree  d ifferen t in ser tio n s  w ere  
p o ss ib le  in  th e  e x p e r im e n ts  d esc r ib ed  h ere , d e p e n d in g  u p o n  th e  rea d in g  fra m e  at th e  s ite  o f  
in se r tio n , as sh o w n  in  F ig . 6. A lte r a t io n  in  th e  p ro p erties  o f  a p ro te in  co u ld  resu lt from  lo ca l or 
o v e r a ll p h y s ic a l d isto r tio n  or ch a rg e  im b a la n c e , b u t in  a stu d y  o f  th e  H S V -1  IE  p o ly p e p tid e  
V m w l 10 it  w a s  c o n c lu d e d  th a t th e  p ro p er tie s  o f  th e  m u ta ted  p ro te in  corre la ted  m ore stron g ly  
w ith  th e  p o s it io n  th a n  w ith  th e  n a tu re  o f  sm a ll in ser tio n s  (E v ere tt , 1987). A  su m m ary  o f  th e  
p h e n o ty p e s  o f  m u ta n t  p la sm id s  is p r e se n te d  in  F ig . 6.
T h re e  m u ta n ts , in 8 , in 9  a n d  in l4 ,  w ere  stro n g ly  red u ced  in  th e ir  a b ility  to  trans- in d u ce  IE  
tra n sc r ip t io n , a n d  s in c e  H aelll s ite s  8 an d  9 are o n ly  15 bp  ap art it is  p ro b a b le  th a t th e se  three  
m u ta n ts  d e f in e  o n ly  tw o  im p o r ta n t reg io n s. I f  th e  m u ta tio n s  ex er t  th e ir  e ffe c ts  o n ly  a t th e  s ite  o f  
in se r tio n  ra th er  th a n  by d isru p tio n  o f  g ro ss se co n d a r y  or tertiary  stru ctu re, it  is  p o ss ib le  th a t th e  
r e g io n s  d e fin e d  by in 8 /9  an d  in  14 are in  c lo se  p r o x im ity  an d  form  a s in g le  d o m a in  in  th e  p rop erly  
fo ld e d  p r o te in . N o  str ik in g  fea tu res o f  th e  a m in o  a c id  se q u e n c e  at th e  s ite s  o f  th e se  in ser tio n s  is 
o b v io u s  a t p resen t, an d  a c o m p u te r -a ss iste d  sea rch  o f  th e  N B R F  d a ta b a se  d id  n o t rev ea l any  
p r o te in s  w ith  c lea r ly  m e a n in g fu l h o m o lo g ie s  to  th e se  reg io n s . T h er e  is, h o w ev er , a r eg io n  o f  n in e  
a m in o  a c id s  (E L R A R E E S Y )  o n ly  th ree  a m in o  a c id s  u p strea m  from  th e  in 8  site  w h ic h  is stro n g ly  
c o n se r v e d  b e tw e e n  V m w 6 5  an d  its  v a r ice lla -zo ster  v iru s h o m o lo g u e  (D a lr y m p le  et al., 1985). In  
a d d itio n  to  th e  in 8 /9  (a m in o  a c id s  172 an d  177) an d  in  14 (a m in o  a c id  379) reg io n s , th e  reg ion  
b e tw e e n  a m in o  a c id s  411 an d  453  is a lso  k n o w n  to  b e  im p o r ta n t for trans-in d u c tio n , s in ce  
d e le t io n  b a c k  to  a  Smal s ite  ( i.e . a m in o  a c id  4 53) h as n o  d e te c ta b le  e ffe c t, w h erea s a fra m e sh ift  
in se r tio n  at a Sail s ite  (a m in o  a c id  411)  a b o lish e s  tran s-in d u ction  (C . M . P resto n  & M . E . M . 
C a m p b e ll, u n p u b lish e d  o b se r v a tio n s;  T r ie zen b erg  et al., 1988).
P r o te in s  c o n ta in in g  in se r tio n s at s ite s  8, 9 an d  14 all fa iled  to  form  IE C , su g g estin g  that th ese  
m u ta tio n s  p r e v e n te d  V m w 6 5  fro m  in te ra c tin g  w ith  th e  ce llu la r  p o ly p ep tid e (s)  co n ta in e d  in  IE C . 
It m a y  b e , th e re fo re , th a t o n e  or m ore o f  th e se  s ites  d efin es a m in o  a c id s  in v o lv e d  in  th e  p r o te in -  
p ro te in  in te r a c tio n s  th a t are e s se n tia l for th e  p ro d u ctio n  o f  IE C  (P resto n  et al., 1988). T h e  
o b se r v a tio n  th a t  th e  a b ility  to  tran s-ind u ce IE  tra n scr ip tio n  corre la tes w e ll w ith  th e  fo rm a tio n  o f  
IE C  p r o v id e s  e v id e n c e  th a t  th e  c o m p le x  is an  e s se n tia l in te rm ed ia te  in  IE  g e n e  a c t iv a tio n . O ther  
p h e n o ty p e s  o f  V m w 6 5  m u ta n ts  ca n  b e  en v isa g e d ;  for ex a m p le , a p ro te in  u n a b le  to  m e d ia te  
tra n s-in d u ctio n  m ig h t  fo rm  an  a b erran t IE C  th a t cou ld  n o t in te ra ct correctly  w ith  a d d itio n a l  
tr a n sc r ip t io n  fa cto rs.
T h e  e x p e r im e n ts  d esc r ib ed  h ere  sh o w  th a t the  structural req u irem en ts o f  V m w 6 5  for  
tr a n sc r ip tio n  a c t iv a t io n  a n d  v ir io n  a sse m b ly  d iffer. T h e  m u ta n ts in 4  an d  in i  1 d efin e  s ite s  w h ic h  
are im p o r ta n t  for  v ir io n  stru ctu re bu t n o t tran s-ind u ction , an d  th e  m u ta tio n  o f  ts2203  a lso  fa lls  
in to  th is  c a teg o ry . P resu m a b ly  th e se  o b se r v a tio n s  reflect th e  fa c t  th a t V m w 6 5  is a 
m u ltifu n c t io n a l p r o te in  w h ic h  in te ra c ts  w ith  v iru s structural p ro te in s d u rin g  v ir io n  a ssem b ly ,
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w h e r e a s  it  is  c o m p le x e d  w ith  o n e  or  m o r e  h o st  c e ll  p r o te in s  w h e n  a c t in g  a s  a I/vm s-in d u cing  
fa cto r . In s e r t io n s  th a t  a ffec t  b o th  fu n c t io n s  m a y  d isru p t a d o m a in  im p o r ta n t  fo r  b o th  p ro p erties , 
or th e y  m a y  c h a n g e  se v e r e ly  th e  se c o n d a r y  a n d  tertia r y  stru ctu re , r e su ltin g  in  a  g ro ssly  a ltered  
p ro te in . M u ta n t  i n l 4  is  u n a b le  to  trans-mduce b u t c a n  r escu e  ts2203, su g g e s t in g  th a t  it  is  
d e fe c t iv e  o n ly  for  tra n s-in d u ctio n . In  tu rn , th is  in te r p r e ta t io n  im p lie s  th a t  v ia b le  v iru se s  
c o n ta in in g  th e  in  14 m u ta t io n  c o u ld  b e  c o n str u c te d , a n d  th u s th a t tr a n s-in d u ctio n  is  n o t  e s se n tia l  
for  v iru s g ro w th . It sh o u ld  b e  n o te d , h o w e v e r , th a t  s ite  14 is  d is ta l to  th e  p r o p o se d  lo c a t io n  o f  th e  
ts2 2 0 3  m u ta t io n , a n d  th e r e fo r e  th a t  r e c o m b in a tio n  b e tw e e n  th e  tw o  m u ta t io n s  c o u ld  o ccu r . T h is  
in te r p r e ta t io n  c a n n o t  b e  ru led  o u t, a s  it  c a n  in  th e  c a s e  o f  in 2  a n d  in 7 , s in c e  b o th  d o w n str e a m  
in se r tio n s  ( in  15 a n d  in  17) rescu e  su c c e ss fu lly . A t te m p ts  to  iso la te  v iru s  m u ta n ts  c o n ta in in g  th e  
in 2 , in 7 , i n l 4  a n d  i n i 5 in se r tio n s  are cu rren tly  in  p ro g ress.
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A herpes simplex virus mutant, inl814, possessing a 12-base-pair insertion in the gene encoding the 
traQsinducing factor Vmw65 has been constructed. The insertion abolished the ability of Vmw65 to transinduce 
immediate-early (IE) gene expression and to form a protein-DNA complex with cell proteins and the IE-specific 
regulatory element TAATGAGAT. Accumulation of IE RNA 1 and 2 was reduced four- to fivefold in 
in 1814-infected cells, but the level of IE RNA 4 was reduced only by twofold, and IE RNA 3 was unaffected.
Mutant ml8I4 had a high particle/PFU ratio, but many of the particles, although unable to form plaques, were 
capable of normal participation in the early stages of infection at high multiplicity of infection. The defect of 
ml814 was overcome partially by transfection of a plasmid encoding the IE protein VmwllO into cells prior to 
titration and by prior infection with ultraviolet light-inactivated herpes simplex virus. Mutant i7sl814 was 
essentially avirulent when injected into mice. The results demonstrate that transinduction of IE transcription 
by Vmw65 is important at low multiplicity of infection and in vivo but that at high multiplicity of infection the 
function is redundant.
Herpes simplex virus type 1 (HSV-1) encodes 70 predicted 
genes which are expressed as three temporally regulated 
classes (35, 70). The five immediate-early (IE or a) genes 
are the first to be transcribed after infection, and their 
expression does not require de novo protein synthe­
sis, whereas early (P) and late (7) gene expression is depen­
dent on the prior synthesis of IE polypeptides (8, 23). 
The products of IE gene 1 (polypeptide VmwllO or ICP0) 
and IE gene 3 (Vmwl75 or ICP4) are potent transactivators 
of early- and Iate-gene promoters in transient expression 
assays (12, 18, 40, 53). The IE gene 2 product (Vmw63 
or ICP27) has also been implicated in the regulation of 
viral promoters (13, 54, 60). Analysis of temperature-sensi­
tive mutants indicates that both Vmwl75 and Vmw63 are 
essential for productive infection; Vmwl75 is required 
for early- and Iate-gene expression (11, 47, 71), whereas 
Vmw63 appears to be required after the onset of early-gene 
expression and DNA replication (56). Viable mutants 
with deletions in VmwllO exhibit restricted growth in cer­
tain cell types at low multiplicity of infection (MOI) but 
are apparently normal at high MOI (57, 65). Deletion muta­
tions in IE gene 4 (which specifies Vmw68 or ICP22) 
also confer a host range phenotype to the virus (45, 59). The 
IE gene 5 product (Vmwl2 or ICP47) appears to be unim­
portant for virus replication in tissue culture cells since 
deletions within the gene have little effect on growth of HSV 
(4, 29, 69).
A distinguishing feature of IE genes is the presence of the 
cis-acting element TAATGARAT (where R is a purine 
residue) in their 5' regulatory regions. This element responds 
to the HSV-1 virion polypeptide Ymw65 (otherwise desig­
nated VP16 or aTIF), resulting in a stimulation of transcrip­
tion from IE promoters (2, 5, 7, 9, 17, 25, 31-33, 41, 43, 44, 
48). Although Vmw65 does not itself bind to DNA (34), the 
evidence currently available suggests that the polypeptide 
mediates transinduction of IE genes by associating with 
cellular proteins, including nuclear factor III, to form an IE
* Corresponding author. GLASGOW
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complex (IEC) which is able to bind specifically to DNA 
sequences that contain TAATGARAT (1, 19, 38, 39, 49). 
Mutation analysis of cloned DNA fragments encoding 
Vmw65 suggests that the polypeptide contains at least two 
separable regions, both of which are necessary for transin­
duction of IE transcription. The amino-terminal 411 amino 
acids are sufficient for binding to the cetiulaT factor (I; T . A. 
McKee, C. I. Ace, and C. M. Preston, manuscript in prep­
aration), and the acidic carboxy-terminal domain defined by 
amino acids 411 to 490 (the “ acid tail,”  a feature common to 
many other cucaryotic and procaryotic transactivators (3, 
20, 30, 52, 58, 66, 67]) is required for stimulating transcrip­
tion and may interact with fundamental transcription com­
ponents, for example, the TATA binding factor TFIID^gcF 
RNA polymerase, or both (24).
Because Vmw65 regulates the set of genes expressed at 
the earliest stages of infection, it is important to determine 
the role of the polypeptide during HSV growth. All informa­
tion to date regarding the properties of Vmw65 has been 
obtained by transfection^grusing either stably transformed 
cell lines or transient expression assays. Such systems are 
clearly artificial, and the crucial biological question concerns 
the phenotype of virus mutants which lack the transinducing 
activity of Vmw65. A difficulty inherent in attempts to 
construct such mutants is that, apart from its role in transin­
ducing IE genes, Vmw65 is also a major structural compo­
nent which is required for virion assembly (1). To address 
this problem, functional domains of Vmw65 required for 
virion assembly and for transinduction were identified by 
insertion mutagenesis of a cloned gene fragment (1). The 
construction and characterization of a viable HSV-1 mutant 
that contains an insertion which affects only the transinduc­
ing activity of Vmw65 are described here. The results 
indicate that IE gene transinduction by Vmw65 is not 
essential for virus growth at high MOI but plays a critical 
role in determining whether infection is lytic or nonproduc­
tive at low MOI. Vmw65 is also important for the virulence 
of HSV-1 in mice.
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MATERIALS AND METHODS
Cells and viruses. BHK cells ( i (  clone 13) were grown in 
Eagle medium with 10% newborn calf serum, 10% tryptose 
phosphate broth, and 100 U of penicillin and 100 pg of 
streptomycin per ml. Human fetal lung (HFL) cells (Flow 
Laboratories) were grown in Eagle medium with 10% fetal 
calf serum and 100 U of penicillin and 100 pg of streptomycin 
per ml. The wild-type (wt) HSV-1 virus used in these studies 
was Glasgow strain 17 syn+. Virus particle concentrations 
were determined by comparison of virus stocks w ith4e^£” 
bead preparations of known concentration.
Plasmids. Plasmid pMCl, which contains the coding se­
quences for Vmw65, has been described previously (7). The 
construction of pM Cl.inl4, which contains a 12-base-pair 
(bp) BamHl oligonucleotide linker inserted in the Vmw65 
gene, has also been described (1). Plasmid pIE3CAT con­
tains the HSV-1 IE gene 3 promoter and regulatory se­
quences linked to the chloramphenicol acetyltransferase 
coding region (64), and p i l l  expresses wt HSV-1 VmwllO 
(14).
Isolation of ml814 and Southern blot analysis. A BHK cell 
monolayer in a 35-mm-diameter petri dish was cotransfected 
with 0.5 pg of intact HSV-1 DNAj 0.5 pg of an EcoRI- 
cleaved plasmid with the mutation of pMCl.inl4 in the larger 
plasmid pGX158 (which contains BamHl f  [7]), and 2.0 pg of 
calf thymus carrier DNA by the calcium phosphate precipi­
tation method (51). After incubation for 3 days at 31°C, the 
progeny viruses were harvested and titrated on BHK cells. 
Single plaques were picked and used to infect BHK cells in 
multiwell plates containing 15-mm-diameter wells. After 2 
days at 37°C, total DNA was prepared from infected cells 
(65) and the medium was retained as a viral stock. DNA 
samples were screened for the presence of viral genomes 
containing a BamHl linker insertion within the Vmw65 gene. 
DNA was cleaved with BamHl, and viral DNA analyzed by 
agarose gel electrophoresis and Southern blotting (61). Plas­
mid pMC17, which contains the Vmw65 coding sequences 
cloned in pUC9 (1), was radiolabeled with P by nick 
translation (55) and used as a probe. Hybridization, mem­
brane washing, and autoradiography conditions were as 
described previously (42). Progeny from a sample which 
contained viral DNA with a linker insertion was plaque 
purified and screened by hybridization twice more, and a 
working stock of virus was prepared from BHK cells. The 
virus was named ml814.
Marker rescue of <nl814. A BHK cell monolayer was 
cotransfected with 0.1 pg of intact ml814 DNA, 0.5 pg of 
pMCl cleaved with EcoBl, and 2.0 pg of calf thymus DNA, 
as described above. After 5 days at 31°C, progeny were 
harvested and used to infect a BHK cell monolayer on a 
90-mm-diameter petri dish at 0.0001 PFU per cell. After 3 
days, the progeny were harvested and titrated on BHK cells. 
Single plaques were picked and used to infect BHK cells on 
multiwell plates. Virus stocks were prepared from wells, and 
their genomes were analyzed as described above. Progeny 
from a sample that exhibited a wt HSV-1 DNA structure was 
plaque purified, and a working stock of virus was prepared in 
BHK cells. The virus was named 1814R.
Quantitation of viral DNA in nuclei. BHK cell monolayers 
in 90-mm-diameter petri dishes were infected in the presence 
of 200 pg of cycloheximide (CH) per ml. After incubation for 
3 h at 38.5°C, cell nuclei were isolated (46) and DNA was 
extracted. Virus DNA was quantitated by Southern blotting 
as described above but by using 32P-labeled pTKl, which
contains the cloned HSV-1 BamHl p  fragment, in the 
hybridization procedure.
Radiolabeling of viral polypeptides. For IE polypeptides, 
BHK cell monolayers were infected in the presence of 200 
pg of CH per ml. After 4 h at 38.5°C, CH was washed from 
the plates and proteins were radiolabeled for 1 h with 
[35S]methionine in the presence of 1 p.g of actinomycin D per 
ml and analyzed by sodium dodecyl sulfate polyacrylamide 
gel electrophoresis (SDS-PAGE) (46). For early and late 
polypeptides, BHK cell monolayers were infected^and pro­
teins were radiolabeled for 1 h with [35S]methionine and 
analyzed by SDS-PAGE. after-4«cubatton-fer-8-h-at-38r§0C.
Gel retardation analysis. Virion extracts were prepared 
(49), and proteins were analyzed by SDS-PAGE. The gel 
was stained with Coomassie brilliant blue. Virion extract 
was added to a mixture containing HeLa cell nuclear extract 
and a 32P-labeled 74-bp DNA fragment containing HSV-1 IE 
gene 4/5 regulatory sequences (49). Reaction conditions for 
complex formation and analysis of protein-DNA complexes 
were as described previously (49).
Transinduction assay. BHK cell monolayers in 35-mm- 
diameter petri dishes were transfected with 3 pg of pIE3CAT 
by the calcium phosphate precipitation method (7), except 
that the dimethyl sulfoxide boost was performed 1 h after the 
medium overlay. The cells were incubated at 38.5°C for 1 h 
and then superinfected. After incubation for a further 3 h at 
38.5°C, extracts were made from the cells and chloramphen­
icol acetyltransferase assays were performed (21).
Quantitation of IE RNA. BHK cells were infected in the 
presence of 200 pg of CH per ml. After incubation for 4 h at 
38.5°C, cytoplasmic RNA was extracted and quantitated by 
dot blot analysis (72) by using DNA probes radiolabeled with 
32P by primer extension (15). Gene-specific probes were 
prepared from DNA fragments that correspond to IE  genes 
1 (a 1,367-bp SaB-Nrul fragment from pJR3 [12]), 2 (a 2,760- 
bp Mlul-BamHl fragment from BamHl b [35]), 3 (a 3,210-bp 
Hindi fragment from ATtoI c [36]), and 4 (a 2,200-bp 
Nrul-Mlul fragment from BamHl n hybridizing predomi­
nantly to IE RNA 4 [37]).
TK assay. BHK cells were infected in the presence of 200 
pg of phosphonoacetic acid per ml. After incubation for 15 h 
at 38.5°C, cytoplasmic extracts were made and thymidine 
kinase (TK) assays were performed (9).
Complementation assay. BHK cejl monolayers in 35-mm- 
diameter petri dishes were transfected with 3 pg of p i l l  or 
pUC9 by the calcium phosphate precipitation method (7) and 
treated with dimethyl sulfoxide 1 h later. After a further 1 h 
at 37°C, virus was titrated on the monolayers. Alternatively, 
monolayers were treated with the HSV-1 mutant tsK, which 
had been UV irradiated to reduce its titer by 5 x 105 (48). 
The MOI of UV-irradiated tsK  corresponded to 0.1 PFU of 
unirradiated virus per cell. Wt HSV-1 or ml814 was titrated 
on the UV-irradiated-fcK-pretreated cells. After 2 days at 
37°C, plates were stained and plaques were counted.
Virulence assay. Female Charles River mice, each weigh­
ing approximately 15 g, were inoculated either intracranially 
(ic) with 20 pi or intraperitoneally (ip) with 200 pi of 10-fold 
dilutions of virus stocks, as described previously (6). Ten 
mice were inoculated for each virus dilution, and the number 
of survivors after 21 days was recorded. The mean 50% 
lethal dose values from two experiments were calculated.
RESULTS
Isolation of a mutant containing an insertion within the 
Vmw65 gene. The gene encoding Vmw65 lies between map
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FIG. 1. (a) Structure o f  the HSV-1 genom e showing the positions o f  the five IE genes (without introns) and Vm w65. The open boxes 
represent repeated sequences, (b) Structures o f the insertion mutation in Vmw65 encoded on a Sa/IfSJ-ATioIfX) fragment in plasmid 
p M C l.in l4 .
coordinates 0.669 and 0.685 in the UL region of the prototype 
HSV-1 genome and is contained within plasmid pMCl (Fig. 
1A; 7, 10). The isolation of a number of plasmids with 
in-frame BamHl linker insertion mutations within the gene 
encoding Vmw65 has been described previously (1). In 
particular, a four-amino-acid insertion at codon 397, speci­
fied on plasmid pM Cl.inl4 (Fig. IB), abolished the transin- 
ducing activity of the polypeptide in transfection assays. The 
mutation disabled the binding of Vmw65 to the host-cell 
factors and thus defined a region of the polypeptide involved 
in this interaction. The essential role of the polypeptide 
during virion assembly was not affected by the mutation, as 
inferred from its ability to rescue an HSV-2 mutant with a 
temperature-sensitive mutation in Vmw65 (1), suggesting 
that a viable virus could be constructed that contained the 
transinducing mutation specified by pMCl.inl4. To con­
struct such a mutant virus, a plasmid consisting of BamHl f  
containing the pM Cl.inl4 mutation was cotransfected with 
intact wt HSV-1 DNA into BHK cells, and the structure of 
progeny virus DNA was examined by restriction enzyme 
analysis. One plaque from a total of 84 screened was 
identified as a recombinant that contained the BamHl linker 
insertion. This mutant isolate, in 1814, was plaque purified 
twice more, and a large scale stock of virus was prepared. To 
rule out the possibility of a second site mutation in i>il814 
that might affect the phenotype of the mutant virus, a 
rescued virus was constructed by recombining ml814 DNA 
with pMCl. If, as desired, the phenotype of ml814 depended 
on the insertion mutation, then a rescued virus should 
behave as wt HSV-1. Initial observation of the properties of 
&il814 suggested that it grew poorly in comparison with wt 
HSV-1; thus, it was expected that rescued recombinants 
would outgrow in 1814 during successive passages of a mixed 
population. This turned out to be the case, since after a 
single passage of the progeny virus from the initial cotrans­
fection of ml814 DNA and pMCl, 75% of the plaques 
screened had the wt DNA structure. These viruses were 
unlikely to result from spontaneous reversion of in 1814, 
since no reversion was detected at any stage during the
passaging and propagation of mutant virus. A stock of 
rescued virus, 1814R, was prepared after plaque purification. 
Figure 2 shows a Southern blot of wt HSV-1, in 1814, and 
1814R DNA which was digested with BamHl and probed 
with pMC17, a plasmid containing the Vmw65 coding se­
quences. The B am H l/ fragment of 8 kilobase pairs was seen 
in both wt HSV-1 (lane 1) and 1814R (lane 3), whereas in 
ml814 (lane 2), this fragment was replaced by two fragments 
of the sizes (5 and 3 kilobase pairs) expected from the 
presence of the BamHl linker insertion. Overexposure of the 
autoradiograph revealed no detectable BamHl f  fragment in
1 2 3
HSV-1 1814 1814R
BamHl /
FIG. 2. Structure o f  the in 1814 genom e. Wt HSV-1 (lane 1), 
rhl814 (lane 2), or 1814R (lane 3) D N A  w as cleaved w ith B am H l, 
and the fragments w ere separated on a 1.5% agarose gel, transferred 
to nitrocellulose, and hybridized to 32P-labeled pMC17. The position 
o f HSV-1 Bam H l /  is indicated.
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T A B L E  1. Titration o f  w t H SV -1, in l814, and 1814R 
on B H K  and H FL  cells
Virus Particles/ml BHK titer (PFU/ml)
HFL titer 
(PFU/ml)
w t HSV-1 1.9 x 10u 5.0  x 109 1.7 X 10l°
in l814 1.2 x  10u 1.3 x 107 7.0 X 10s
1814R 4.6  x 1010 4.0  x 109 ND"
Particles 
per cell
W  14 R M
ND, Not determined.
ml814 and therefore that the stock of mutant virus was 
essentially pure.
The efficient^ of plaque formation by ml814 is markedly 
reduced and dependent on cell type. The successful isolation 
and propagation of ml814 confirms that the insertion muta­
tion is compatible with virus growth in BHK cells. When 
tnl814 was titrated on BHK cells, however, a low titer was 
obtained, and therefore virus particle concentrations were 
determined (Table 1). It was found that the particle concen­
trations of wt HSV-1, ml814, and 1814R stocks were com­
parable but that the particle/PFU ratio was approximately 
100 times greater for ml814 than for wt HSV-1 and 1814R. 
The apparent titer of a given preparation of ml814 on BHK 
cells varied by as much as 10-fold on different batches of 
cells, whereas the titers of wt HSV-1 and 1814R were much 
more consistent, suggesting that the cellular metabolic state 
affects the efficiency of plaque formation by ml814. When 
titrations were performed on H FL cells, an even higher 
particle/PFU ratio, 1.7 x 10s, was observed for ml814. In 
view of the variation in titer of in 1814 when expressed in 
terms of PFU, cell monolayers were infected with equal 
numbers of particles of wt HSV-1, in 1814, or 1814R in 
subsequent experiments.
DNA migration to the nucleus. The early stages of infection 
by in 1814 were examined, since it was possible that the 
insertion mutation affected virus adsorption, penetration, or 
uncoating. In initial experiments, the rate of adsorption of wt 
HSV-1 or in 1814 preparations, radiolabeled by incubation 
with [3H]thymidine during virus propagation, to BHK cell 
monolayers was investigated. The adsorption rates of wt 
HSV-1 and in 1814 particles were indistinguishable (results 
not shown). The efficiency of DNA migration to the cell 
nucleus was also determined. BHK cell monolayers were 
infected in the presence of CH with 1,000, 100, or 10 
particles of wt HSV-1, inl814, or 1814R per cell, nuclei were 
prepared at 3 h postinfection, and nuclear DNA was ana­
lyzed by Southern blot hybridization (Fig. 3). No significant 
differences were detected in the levels of HSV DNA, show­
ing that the nuclear migration of wl814 DNA is not impaired 
at either high or low MOI.
This result underlines the requirement to use particles 
rather than PFU as a basis for the design of experiments with 
ml814; 1,000 particles of wt HSV-1 and ml814 represent 26 
and 0.1 PFU, respectively.
in 1814 does not exhibit virion-mediated transinduction of IE 
genes. The ability of Vtnw65, encoded by in 1814, to form the 
protein-DNAjlEC and to transinduce expression from trans­
fected IE promoters was investigated, since both of these 
properties were disrupted in pMCl.inl4 (1).
Extracts of wt HSV-1, ml814, and 1814R virions were 
prepared and analyzed by SDS-PAGE (Fig. 4). The levels of 
Vmw65 in these extracts were very similar, and the slightly 
increased molecular weight of the mutant polypeptide due to 
the four-amino-acid insertion was apparent (lane 2). The 
virion extracts were incubated with HeLa cell nuclear ex-
FIG. 3. D N A  migration to the nucleus. D N A  isolated from nuclei 
o f  cells infected with w t HSV-1 (W), in 1814 (14), or 1814R (R) or 
m ock infected (M ), in the presence o f C H , w as cleaved with B am H l, 
and the fragments w ere separated on an agarose gel, transferred to 
G cnescreen Plus membrane, and probed with radiolabeled pT K l. 
The portion o f the blot representing Bam H l p is presented. Expo­
sure times were 0.4 h (1,000 particles per cell), 4 h (100 particles per 
cell), or 40 h (10 particles per cell).
tract and a 74-bp DNA fragment containing the TAAT 
GAGAT sequence motif of IE gene 4/5. As shown in Fig. 5, 
the IEC was readily detected with extracts of wt HSV-1 
(lane 2) and 1814R (lane 4) virions but not with extracts of 
ml814 (lane 3) or when no virion extract was present (lane 
1). This result demonstrates that Vmw65 specified by inl814 
is not capable of binding the cellular proteins required for 
IEC formation because of the mutation in the viral polypep­
tide.
The ability of wl814 to transinduce IE gene expression 
was investigated by comparing the level of activation from a 
transfected IE promoter in. the presence or absence of 
superinfecting virus (Fig. 6). BHK cells were transfected 
with pIE3CAT and infected with 1,000 particles of wt 
HSV-1, ml814, or 1814R per cell. An increase of approxi­
mately sixfold in chloramphenicol acetyltransferase activity 
was observed when cells were superinfectcd with wt HSV-1 
(lane 2) or 1814R (lane 4), but infection with fril814 (lane 3)
1 2 3
Vmw65»>
FIG. 4. Proteins extracted from virions o f  w t H SV-1 (lane 1), 
m l814 (lane 2), and 1814R (lane 3) and used as a source o f  Vmw65 
for gel retardation analysis. The gel w as stained with Coom assie 
brilliant blue.
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* FIG . 5. IEC formation- b y  Vm w65. A  74-bp D N A  fragment 
containing the IE gene 4/5 TAA TG AG AT sequence w as incubated 
(  w ith H eL a cell nuclear extract (£>$33 alone (lane 1) or with virion 
yextract/from  w t H SV -1 (lane 2), « 1 8 1 4  (lane 3), or 1814R (lane 4), 
K j p *  and w as analyzed b y  gel electrophoresis. T he positions o f  IEC and 
a  the cell-specific com plexes HC1 and HC3 (49) are indicated.
gave no stimulation over the level in mock-infected cells 
(lane 1).
Taken together, these results confirm that the properties 
of the mutant Vmw65 polypeptide in the viral context reflect 
the observations and expectations implicit in the initial 
characterization of the mutation in cloned copies of the gene; 
that is, the mutation in ml814 disables the ability of the virus 
to direct the formation of IEC and consequently abolishes its 
transducing activity.
Gene expression in in 1814-infected cells. It would be ex­
pected that the abolition of transinduction by Vmw65 would 
affect the expression of viral genes, especially IE genes. The 
accumulation of IE RNA was quantitated by hybridization 
by using IE gene-specific probes. BHK cells were infected in 
the presence of CH with 1,000 particles of wt HSV-1, in1814, 
or 1814R per cell for 4 h, and cytoplasmic RNA was applied
1
Ml
2
HSV-1
3
1814
4
181411
3-AC.
FIG. 6. Transinduction o f  IE transcription. Cells w ere trans­
fected w ith pIE3CAT and m ock infected (lane 1) or infected with wt 
HSV-1 (lane 2), in 1814 (lane 3), or 1814R (lane 4). Chloramphenicol 
acetyltransferase assays w ere carried out on cytoplasm ic cell ex­
tracts. The positions o f  chloramphenicol (CAM) and 3-acetyl chlor­
amphenicol (3-AC. CAM ) are show n.
1814R £  0
• • • 
• • •
FIG. 7. Production o f  IE R NA. Cells w ere mock infected (MI; 
row 1) or infected with wt HSV-1 (row 2), in l814 (row 3), or 1814R 
(row 4) in the presence o f CH . RNA w as prepared after 4 h and 
applied to nitrocellulose filters in four sequential dilutions (3 pg, 1 
\ig, 0.3 jig, and 0.1 tig). Filters w ere separately hybridized with  
32P-labeled D N A  probes corresponding to IE  genes 1, 2 , 3 , and 4/5 
(panels a, b, c , and d , respectively).
to nitrocellulose and separately hybridized with radiolabeled 
DNA fragments corresponding to the IE-1, IE-2, IE-3, or 
IE-4 genes. The levels of IE-1- and IE-2-specific RNA, as 
determined by densitometric analysis, were reduced four- to 
fivefold in ml814-infected cells compared with wt HSV-1- 
and 1814R-infected cells (Fig. 7, a and b), whereas the 
reduction in IE-4/5-specifid RNA was only twofold (Fig. 7d), 
and no significant effect on IE-3-specific RNA was detected 
(Fig. 7c).
The expression of IE polypeptides was also investigate^. 
BHK cells were infected as described above, but after 4 h 
CH was washed from the cells and polypeptides were 
radiolabeled in the presence of actinomycin D and separated 
by SDS-PAGE (Fig. 8). Densitometric analysis was used to
1 2  3 4
Ml HSV-1 1814 1814R
Vmw175
Vmw138
Vmw63
FIG. 8. IE polypeptide synthesis. Cells w ere m ock infected (MI; 
lane 1) or infected with w t HSV-1 (lane 2), in 1814 (lane 3), or 1814R 
(lane 4) in the presence o f CH. Proteins w ere labeled with  
[35S]methionine after removal o f CH by washing at 4 h postinfection. 
The positions o f viral IE polypeptides and cellular actin are indi­
cated.
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TA B LE 2. TK  production by wt HSV-1, in l814, and 1814R 
at high and low MOI"
Vmw65
FIG. 9. Late polypeptide synthesis. Cells w ere m ock infected  
(MI; lane 1) or infected w ith w t HSV-1 (lane 2), m l814 (lane 3), or 
1814R (lane 4), and proteins w ere labeled with [33S]methionine at 8 
h postinfection. The position o f  Vmw65 is indicated.
determine the relative rates of synthesis of individual IE 
polypeptides, and the values were normalized to that of 
actin. The rates of synthesis of VmwllO and Vmw63, the 
products of IE  genes 1 and 2, respectively, were reduced 
four- to fivefold in inl814-infected cells, whereas the rates of 
synthesis of Vmwl75, the product of IE gene 3, were 
equivalent for the three viruses. It was not possible to 
measure accurately the rate of synthesis of Vmw68, the 
product of IE gene 4, since this polypeptide ran as a diffuse 
band. It is clear, however, that the data on IE RNA levels 
and IE protein synthesis rates are in good agreement and 
show that the expression of IE genes 1 and 2 is significantly 
reduced in in 1814-infected cells but that the expression of IE 
gene 3 is essentially unaffected.
Protein synthesis at 8 h postinfection, a time when early 
and, especially, late polypeptides are synthesized, was also 
examined (Fig. 9). The profiles of wt HSV-I, inl814-, and 
1814R-infected cells were very similar, the increased molec­
ular weight of Vmw65 specified by in 1814 being the only 
major difference.
Thus, upon infection of BHK cells with 1,000 particles of 
in 1814 per cell in the presence of CH, the level of expression 
of IE genes 1, 2, 4, and presumably 5 is reduced, but under 
normal conditions infection precedes to the late stage, 
suggesting that there is no overall consequence of reduced 
IE gene expression. From the high particle/PFU ratio, 
however, it appears that the growth of in 1814 is inefficient 
when cells are infected with 1 virus particle per cell. To 
investigate whether the incapacity of in 1814 at low MOI is 
reflected in reduced gene expression, the synthesis of TK, an 
early enzyme that can be detected with high sensitivity, was 
examined. BHK cells were infected with 1,000,100,10, or 1 
particle of wt HSV-1, inl814, or 1814R per cell, and incuba­
tion was continued for 15 h in the presence of phosphono-
MOI
( p a r t i c l c s / c c l l )
Viral TK activity (cpm/min of assay 
per fig of protein)
wt HSV-1 in 1814 1814R
Ratio of wt 
HSV-l/inl814
1,000 2,693 2,285 2,789 1.2
100 1,988 2,549 2,478 0.8
10 935 161 792 6.0
1 100 3 63 33.3
'  BHK cells were infected at the multiplicities indicated. Cytoplasmic 
extracts were diluted as necessary to ensure that TK determinations were 
within the linear response range of the assay. A background of 3 cpra per min 
of assay per p.g of protein has been subtracted from all values.
acetic acid to prevent the secondary spread of virus. Table 2 
shows the results of TK assays performed on the cell 
extracts. The level of TK after infection with 1,000 or 100 
particles per cell was indistinguishable for wt HSV-1, in 1814, 
and 1814R, reemphasizing that ml814 is not detectably 
impaired at high MOI. At 10 particles per cell, the TK level 
in in 1814-infected cellg relative to that in wt HSV-l-infected 
cells was reduced by ^ fo ld , and at 1 particle per cell the 
decrease wasW-fold. Therefore, the expression of TK (andv 
presumably of other early and late genes) is more strictly f 
dependent on MOI for inl814 than for wt HSV-1 or 1814R, 
and it is likely that the observed reduction in expression is 
large enough to account for the inefficiency of plaque forma­
tion by the mutant. a¥l{( ^
Complementation of inl814 by VmwllOt If in1814 fails to 
form plaques at low MOI because of the reduction in IE gene 
expression, then complementation of this state should in­
crease the efficiency of plaque formation and consequently 
the apparent titer of the mutant virus. In contrast, a com­
pensating increase in IE gene expression would not comple­
ment in 1814 growth if the mutant phenotype resulted from a 
defect at a stage before the onset of IE transcription. Two 
experiments were carried out to test these possibilities.
BHK cells were transfected with p i l l  (a plasmid encoding 
the HSV-1 transactivator VmwllO) or pUC9 and then used 
separately for titration of wt HSV-1, tnl814, or 1814R (Table
3). Although the titers of wt HSV-1 and 1814R were constant 
in both cell samples, the apparent titer of inl814 increased 
approximately 10-fold on cells transfected with p i l l .  Since 
only a proportion of cells (normally between 5 and 50%) in a 
BHK monolayer express VmwllO after transfection of p i l l ,  
it is likely that a higher level of complementation could 
potentially be obtained. Therefore, raising the level of 
VmwllO can, at least partially, rectify the defect of in 1814 in 
BHK cells.
Complementation of in 1814 in HFL cells was achieved by 
infecting monolayers with UV-irradiated /sK, which sup­
plied functional Vmw65 in tnans (48), prior to titration of wt 
HSV-1 or in 1814. The apparent titer of in 1814 increased from 
5.7 x 106 to 1.5 x 109 PFU/ml, whereas the titer of wt HSV-1 
was 6.0 x 1010 on both cell monolayers. No plaques were
T A B L E  3. Titration o f w t H SV -1, m l814 , and 1814R on BHK  
cells transfected with pUC9 or p i l l  (encoding V m wllO )
PFU/ml
wt HSV-1 «1814 1814R
+ pUC9 
+ p l l l
1.2 x 1010 
9.5 x 109
4.0  X 10* 
4.2 X 107 h
>
r
X 
X
►-» 
h-
 
O
O <0 
'O
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TA B LE 4 . Virulence o f  w t HSV-1, m l814, and/L814R in mice
V
Virus
50% Lethal dose [PFU (particles per mouse)]
ip injection ic injection
w t HSV-1
«rtl814
1814R
9.7 x 102 (4.0 x lO4)** 
>7.4 x 104 (>2.4 x 108) 
3.0 x 103 (9.2 x 104)
3.1 (1.3 x 102)
>7.4 x 103 (>2.4 x 107) 
19.1 (5.8 x 102)
& S'oV (tfUi <£o$e .bfM $
, *6 «/vx
observed on monolayers treated only with UV-irradiated 
fsK. The titer of tnl814 on UV-irradiated-tsK-treated cells 
represented a particle/PFU ratio of 74, and after account is 
taken of the fact that the MOI for UV-irradiated tsK  was 
only 0.1 PFU per cell, it is clear that the efficiency of plaque 
formation was similar to that of wt HSV-1. Thus, the 
observed phenotype of in 1814 on HFL cells was reversed by 
provision of Vmw65 in trans, arguing against a cis-acting 
defect, for example, inhibition of uncoating by the mutant 
protein.
inl814 has reduced virulence in mice. An assessment of the 
in vivo properties of ml814 was made by studying virulence . 
after inoculation of mice either ic or ip. The results (Table 4) 
show that wl814 was much less virulent than wt HSV-1 or 
1814R, regardless of the method of inoculation. In fact, all 
mice challenged with ml814 survived, with the exception of 
three mice injected ic with undiluted virus. In these cases, 
death was atypically rapid, occurring within 12 h as opposed 
to the usual 3 to 5 days, and it is suspected that the effect was 
due to the large number of virus particles injected. The 50% 
lethal dose values in terms of particles per mouse, the more 
relevant value, show that virulence of wl814 was reduced by 
a factor of at least 3 x 103 for ip or 2.5 x 104 for ic 
inoculation, compared with wt HSV-1 or 1814R.
DISCUSSION
The isolation of a mutant defective in transinduction of IE 
transcription is a crucial step in determining the biological 
role of Vmw65. The 12-bp insertion mutation in in 1814 
appears to be stable, since no revertants have been detected 
during passage and growth of virus Stocks; reversion to the 
phenotype of wt HSV-1 would readily be detected, as shown 
by the ease with which 1814R was isolated. Two features of 
in 1814 are particularly noteworthy. At MOI of 100 or more 
particles per cell, no significant effect was observed on the 
overall pattern o f virus gene expression, whereas at low 
MOI, the efficiency of plaque formation was severely re­
duced in a cell-dependent manner. The phenotype is similar 
to that exhibited by deletion mutants which do not express 
VmwllO (57, 65).
Although the results presented here suggest that transin­
duction by Vmw65 is not essential for HSV gene expression 
at high MOI, this interpretation must be taken cautiously, as 
the assays available are of limited sensitivity. The degree of 
impairment of transinduction is difficult to assess because 
the stimulation of expression from a transfected IE promoter 
as only 5- to 10-fold, and thus, as argued previously (1), it is 
possible to state only that ml814 is reduced by at least 90% 
in its ability to stimulate IE transcription. Analysis of the 
ability to form IEC, as shown in Fig. 5, is more sensitive, 
and by this criterion ml814 is disabled by 99% or more. 
Nevertheless, each HSV particle contains approximately 
1,000 molecules of Vmw65 (22), and therefore a cumulative 
effect of a low residual activity might be sufficient to endow 
wl814 with the ability to form plaques at the observed low 
efficiency.
In the absence of transinduction by Vmw65, the IE genes 
would be expected to be transcribed according to the inher­
ent strengths of their pro0ioters, a feature that is presumably 
determined by interactionWith cellular proteins. For IE 
genes 1 and 2, th /  4- to 5-fold reduction in RNA accumula­
tion and protein synthesis correlates well with the 5- to 
10-fold stimulation of transcription in BHK cells from trans­
fected IE gene 1 and 2 promoters by Vmw65 (C. M. Preston, 
unpublished results). The expression of IE genes 3 and 4, 
however, is greater than would be anticipated from transfec­
tion studies, since these promoters are also activated by 
more than fivefold (5, 48), and it is difficult to offer an 
obvious explanation for this apparent discrepancy. One 
possibility is that the enhancer-like sequence which lies 
between the promoters of IE genes 3 and 4 (28, 50), rather 
than the TAATGARAT elements, is the major requirement 
for transcription of IE gene 3 in the context of the viral 
genome and that the strong proximal promoter suffices for IE 
genes 4 and 5 (48). It is also noteworthy that the four 
upstream nucleotides of the TAATGARAT elements which 
control IE genes 1 and 2 confer a strong homology to the 
nuclear factor III binding site, the octamer element ATGC 
AAAT, whereas this is not the case for the TAATGARAT 
elements located between IE genes 3 and 4/5. A further 
consideration is that the topology of the DNA template and 
the stoichiometric relationships between DNA and protein 
factors may vary considerably between transfected and 
infected cells. Clearly, the findings with virus-infected cells 
are the more relevant.
Even though in 1814 lacks transinducing activity, the major 
polypeptides synthesized under IE conditions are the IE 
proteins. Activation by Vmw65 is therefore not a definitive 
characteristic of IE genes, and other features must distin­
guish them from early and late genes. It may be that the 
presence of strong promoters and enhancer-like sequences 
determines the relatively high efficiency of IE gene transcrip­
tion in the absence of IE proteins, but equally, the TAATG 
ARAT or other IE-specific elements might be responsible. It 
is known that cellular proteins bind to variops sequences in 
IE gene upstream regions (26, 27, 39, 3fiy68), and these 2^, 
factors might increase the availability of IE promoters to 
transcription components in the absence of Vmw65. Thus, 1 
IE-specific DNA sequences, rather than Vmw65, maybe the 
primary determinants of an IE gene.
Transinduction by Vmw65 is important for infection only 
at low MOI. At a superficial level, it is straightforward to 
view this property as a reasonable adaptation, since the 
initial interaction of HSV with an organism is likely to 
involve a small number of virus particles. The inability to 
replicate at low MOI appears to result from the failure to 
produce IE proteins at levels sufficient to initiate infection, 
and it is probable that the reductions in VmwllO and Vmw63 
are crucial, since these polypeptides are required for gene 
expression (56, 57, 65). Thus, it seems that threshold levels 
of IE polypeptides must be attained, and the role of Vmw65 
is to ensure that such levels are reached, especially at low 
MOI. It is not clear whether the few cells in which infection 
with ml814 results in the formation of a plaque represent a 
subpopulation in a particular metabolic state or simply 
random variation in response to infection. Furthermore, the 
basis for the difference in behavior of ml814 in BHK and 
HFLcells remains undefined. It may be that IE transcription 
in theltosence of Vmw65 is less efficient in HFL cells at low y
MQLon that HFL cells are less able to compensate for low >
levclsrof IE proteins. The fact that deletion mutants in 
VmwllO are also impaired for growth at low MOI and show
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a relatively greater reduction in HFL cells than BHK cells 
(65; R. D. Everett, ~p ersomtl~communicatTon) supports the 
latter proposal, but further work is needed to clarify this 
important point.
Recently, Friedman et al. have shown that a transformed 
cell line which expresses the protein-binding portion of 
Vmw65 supports virus growth poorly, presumably because 
the expressed protein sequesters the cell factors required to 
mediate transinduction (16). In essence, transinduction by 
Vmw65 is thought to be abrogated in the transformed cell 
line. The experiments dealt only with infection at low MOI 
(0.1 or 0.3 PFU per cell), but the results are similar to those 
found with ml814, namely, a significant reduction in the 
efficiency of plaque formation, inefficient virus growth, and a 
decrease (by 12-fold) in accumulation of IE RNA 1. From 
the results reported here, it is predicted that virus replication 
in the transformed cells should not be as severely affected at 
high MOI.
The avirulence of in 1814 in mice, even after injection of 
high doses, demonstrates that transinduction is important for 
infection in vivo and emphasizes the importance of host-cell 
factors in the replication of in 1814. Furthermore, Vmw65 
may be a good target for the design of new antiviral agents.
It is interesting to speculate on the role of Vmw65 in HSV 
latency in the light of the phenotype of inl814, since the 
majority of genes, including IE genes, are silent during 
latency (62, 63), suggesting that an early transcriptional 
block may operate. One hypothesis is that Vmw65 may be 
lost or rendered inactive during transport of the HSV nucle- 
ocapsid from the neuronal cell surface to the nucleus (27). 
From the analysis of i n  1814 presented here it is possible to 
predict that under such circumstances, at low MOI, virus 
replication would not ensue, and thus latency might be 
established. Support for this view comes from our recent 
observation that noninfectious particles of ml814 can be 
retained by tissue culture cells after infection at low MOI 
and can subsequently be reactivated to form plaques (C. Ace 
and C. M. Preston, unpublished results), as found in studies 
with a mutant lacking VmwllO (N. D. Stow and E. C. Stow, 
J. Gen. Virol., in press). Therefore, the failure to transin­
map units with loss o f  U , sequences between 0.94 and the 
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The sequence of the gene for Vmw65 
We present here 2 609 base pairs of DNA sequence including 
the gene for Vmw65. The initiation site of the transcript for
this gene is shown as O-----. The terminus of the mRNA is
marked as  X. Canonical sequences implicated in the control
of transcription in other systems, and referred to individually 
in the text, are underlined. The single letter amino acid code 
is used to indicate the extent of the open reading frame for 
Vmw6 5. XrvStrfibft ,^iaKon.i arc fncA^ afecI.
GAGCCCCAGCCCGCTCCGCTTCTCGCCCCAGACGGCCCGTCGAGTGAAAACTTCCGTACCCAGACAATAAAGCACCAACAGGGGTTCATTCGGTGTTGGCGTTGCGTGCCTTTG 1 1 4
TTTCCCAATCCGACGGGGACCGGGACTGGGTGGCGGGGGGTGGGTTGGACAGCCGCCCTCGGTTCGCCTTCACGTGACAGGAGCCAATGTGGGGGGAAGTCACGAGGTACGGGG 2 2 8
O-------------->
CGGCCCGTGCGGGTTGCTTAAATGCGTGGTGGCGACCACGGGCTGTCATTCCTCGGGAACGGACGGGGTTCCCGCTGCCCACTTCCCCCCATAAGGTCCGTCCGGTCCTCTAAC 3 4 2
GCGTTTGGGGGTTTTCTCTTCCCGCGCCGTCGGGCGTCCCACACTCTCTGGGCGGGCGGGGACGATCGCATCAAAAGCCCGATATCGTCTTTCCCGTATCAACCCCACCCA
M D L L, V D E L F A D M N A D G A S P P P P R P A G G P 2 8
ATG GAC CTC TTG GTC GAC GAG CTG TTT GCC GAC ATG AAC GCG GAC GGC GCT TCG CCA CCG CCC CCC CGC CCG GCC GGG GGT CCC 5 3 7
K N T P A A P P L Y A T G R L S 0 A Q L M P S P P M P V 5 6
AAA AAC ACC CCG GCG GCC
A
A
F
CCC CCG CTG TAC GCA ACG GGG CGC CTG AGC CAG GCC CAG CTC ATG CCC TCC CCA CCC ATG CCC GTC 6 2 1
P P A A
1
L N R L L D D L G F S A G P A L C T M L D T W 8 4
CCC CCC GCC GCC CTC TTT AAC CGT CTC CTC GAC GAC TTG GGC TTT AGC GCG GGC
A.
CCC GCG CTA TGT ACC ATG CTC GAT ACC TGG 7 0 5
N E D L F e A L P T N A D L Y R E
1*4
C K F L S T L P S 0 V 1 1 2
AAC GAG GAT CTG TTT TCG GCG CTA CCG ACC AAC GCC GAC CTG TAC CGG GAG TGT AAA TTC CTA TCA ACG CTG CCC AGC GAT GTG 7 8 9
V E W G D A Y V P E R T Q I D I R A H G D V A F p T L P 1 4 0
GTG GAA TGG GGG GAC GCG TAC GTC CCC GAA CGC ACC CAA ATC GAC ATT CGC GCC CAC GGC GAC GTG GCC TTC CCT ACG CTT CCG 8 7 3
A T • R D G L G L Y Y E . A L S R F F H A E L R A R E E S Y 1 6 8
GCC ACC CGC GAC GGC CTC GGG CTC TAC TAC GAA GCG CTC TCT CGT TTC TTC CAC GCC GAG CTA CGG GCG CGG GAG GAG AGC TAT 9 5 7
R T V L
)A>
A N F C S A L Y R Y L R A S V R Q L H R 0 A H M 1 9 6
CGA ACC GTG TTG GCC AAC TTC TGC TCG GCC CTG TAC CGG TAC CTG CGC GCC AGC GTC CGG CAG CTG CAC CGC CAG GCG CAC ATG 1 0 4 1
R G R D
A
l  A 2> 
R D L G
. A 
in  g
E M L R A T I A D R Y Y R E T A R L A R 2 2 4
CGC GGA CGC GAT CGC GAC CTG GGA GAA ATG CTG CGC GCC ACG ATC GCG GAC AGG TAC TAC CGA GAG ACC GCT CGT CTG GCG CGT 1 1 2 5
V L F L H L Y L F L T R E I L W A A Y A C 0 M M R P D L 2 5 2
GTT TTG TTT TTG CAT TTG TAT CTA TTT TTG ACC CGC GAG ATC CTA TGG GCC GCG TAC GCC GAG CAG ATG ATG CGG CCC
A  
iA  U 
N G
GAC CTO 1 2 0 9
F D C L C C D L E S W R G L A G L F 0 P F M F V A L 2 8 0
TTT GAC TGC CTC TOT TGC GAC CTG GAG AGC TGG CGT CAG TTG GCG GGT CTG TTC CAG CCC TTC ATG TTC GTC AAC GGA GCG CTC 1 2 9 3
T V R G V P I E A R R L R E L N H I R E H L M L P L V R 3 0 8
ACC GTC CGG GGA GTG CCA ATC GAG GCC
A
ifv 1 7 -  
A
CGC CGG CTG CGG GAG CTA AAC CAC ATT CGC GAG CAC CTT AAC CTC CCG CTG GTG CGC 1 3 7 7
S A A T C e P G P L T T P P T L H G N 0 A R A S G Y F 3 3 6
AGC GCG GOT ACG GAG GAG CCA GGG GCG CCG TTG ACG ACC CCT CCC ACC CTG CAT GGC AAC CAG GCC CGC GCC TCT GGG TAC TTT 1 4 6 1
M V L I R A K L D S Y S S F T T S P S E A V M R E H A Y 3 6 4
ATG GTG TTG ATT CGG GCG AAG TTG GAC TCG TAT TCC AGC TTC ACG ACC TCG CCC TCC GAG GCG GTC ATG CGG GAA CAC GCG TAC 1 5 4 5
S R A P T K N N Y G S T I E G L L D L P D D D A P E E A 3 9 2
AGC CGC GCG CGT ACG AAA AAC AAT TAC GGG TCT ACC ATC GAG GGC CTG CTC GAT CTC CCG GAC GAC GAC GCC CCC GAA GAG GCG 1 6 2 9
G L A A P R L S F L P A G H T R R L S T A P P T D V S L 4 2 0
GGG CTG GCG GCT CCG CGC CTG TCC TTT CTC CCC GCG GGA CAC ACG CGC AGA CTG TCG ACG GCC CCC CCG ACC GAT GTC AGC CTG 1 7 1 3
G D E L H L D G E D V A M A H A D A L
i'a'iV  
o d  r 0 L O M L G 4 4 8
GGG GAC GAG CTC CAC TTA GAC GGC GAG GAC GTG GCG ATG GCG CAT GCC GAC GCG CTA GAC GAT TTC GAT CTG GAC ATG TTG GGG 1 7 9 7
D G D S P G P G F T P H D S A P Y G A L D H A D F E F E 4 7 6
GAC GGG GAT TCC CCG GGG CCG GGA TTT ACC CCC CAC GAC TCC GCC CCC TAC GGC GCT CTG GAT ATG GCCA
GAC TTC GAG TTT GAG 1 8 8 1
0
CAG
M
ATG
F
TTT
T
ACC
D
GAT
A
GCC
L
CTT
G
GGA
I
ATT
D
GAC
E
GAG
Y
TAC
G
GGT
G
GGG TAG
in I?
GGGGCGCGACCGGACCCGCATCCCCCGTCTGGGTTTTCCCCTCCCGTCACCGGT
4 9 1
1 9 8 0
____ X
TCGTATCCACAATAAACACGAGCACATACATTACAAAACCTGCGGTTGTCGTCTGATTATTTGGTGGTGGGGGAAAGAACTAGCCAGGAOACGGGACCGCGCAACCAACCCACT 2 0 9 4
GGGGTCTGGGTTGCCGGCGTGTGTGTTAGCCGCGTCTGCGGGCCTGTCGTGTAGATICGAAACCACGGACGGGTGATTGTGTCGCAGGGCGGCCCGCGTATAAAGGCGAGAGCG 2 2 0 8
CGGGACCGTTTCCGCATTTGGCCGGGGGCTGGGGCGGCGGGTAGCCTTCGCGGGAGATACTGCGTTTTTTTGCGCCGGCCCCGTCGCTCCCGTCCATTCCCATCGCGAGGGGGT 2 3 2 2
CCGGCGGCACCTACCCCGGCCTCCATCCGCGCTGTGGGGTCTTTTTCTTTTTTGGGGGGTAGCGGACATCCGATAACCCGCGTCTATCGCCACCATGTCGGCTCGCGAACCCGC 2 4 3 6
GGGGCGCAGGAGGCGCGCATCCACCCGCCCCCGCGCCTCGCCCGTGGCGGACGAGCCAGCGGGCGATGGGGTGGGGTTCATGGGGTACCTGCGTGCGGTGTTCCGCGGGGATGA 2 5 5 0
CG AC AGCGAGC T AG AGGCTC TGGAGGAGATGGCGGGCGACGAGCCGCCCGTGCGCCGTC
2 6 0 9
